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Abstract 
 
Magnetic Resonance Spectroscopic Imaging (MRSI) is a functional MRI technique 
allowing non-invasive biochemical mapping of the brain. MRSI is advantageous for 
characterising many neurological conditions; however, its clinical application is limited 
by lengthy scan time and low spatial resolution, which are intrinsically linked. 
This research investigated the potential of Compressed Sensing (CS) to speed-up MRSI 
or enhance spatial resolution. CS allows accelerated acquisition by reducing the data 
sampling requirements, whilst preserving image quality.  The focus of this work was 
the effect of CS-MRSI at different acceleration factors upon spatial integrity. 
CS reconstruction software was developed and applied to retrospective MRSI data. 
Imaging test objects and software simulations were developed to assess MRSI spatial 
resolution via metabolite edge response measurements. CS-MRSI was also investigated 
in realistic scenarios using data from healthy volunteers and a child with Optic Pathway 
Glioma (OPG). The potential of CS-MRSI to enable high-resolution MRSI in feasible scan 
times was investigated using simulations of focal and infiltrative OPG. 
Results suggest that CS-MRSI can reduce scan duration by up to a factor of 5 whilst 
simultaneously eliminating ringing artefacts and increasing spatial resolution 
compared with conventionally filtered MRSI. Therefore, CS could greatly increase the 
clinical utility of MRSI. 
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Abbreviations  
 
MRI     Magnetic Resonance Imaging 
FID     Free Induction Decay 
NMR     Nuclear Magnetic resonance 
SVS     Single Voxel Spectroscopy 
MRSI     Magnetic Resonance Spectroscopic Imaging 
CSI     Chemical Shift Imaging 
PRESS     Point Resolved Spectroscopy 
SE     Spin Echo 
SENSE     Sensitivity Encoding 
CS     Compressed Sensing 
TARQUIN    Totally Automatic Robust 
Quantitation in NMR 
 
TSI     Turbo Spectroscopic Imaging 
VOI     Volume of Interest 
SNR     Signal to Noise Ratio 
MTF     Modulation Transfer Function 
DC     Direct Current 
FOV     Field of View 
CT     Computerised Tomography 
EPI     Echo Planar Imaging 
PEPSI     Proton Echo Planar Spectroscopic Imaging 
PSF     Point Spread Function 
CS-MRSI Compressed Sensing Magnetic Resonance 
Spectroscopic Imaging 
TV Total Variation 
TR MRSI/MRI sequence repetition time 
 
 
TE MRSI/MRI sequence echo time 
OPG Optic Pathway Glioma 
FSSR Fully Sampled Standard Reconstruction 
LRR Low resolution Reconstruction 
NSA Number of Signal Averages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glossary of Terms 
K-space The spatial frequency domain, indicating the spatial frequencies 
present in an image. 
Voxel Three dimensional cube from which spectroscopic data is acquired. 
SVS  NMR Spectrum obtained from a single voxel. 
MRSI  NMR spectra obtained from multiple adjacent voxels. 
CSI  A previous term for MRSI called Chemical Shift Imaging. 
VOI three dimensional volumes containing multiple voxels from which 
spectroscopic data is acquired. 
Phantom A test object device suitable to be imaged, or which mimics an image 
to provide a means of verifying data quality. 
FID The decay of magnetisation with time after the excitation of nuclear 
spins with a radio frequency pulse.  
Shim Method to ensure the main magnetic field is kept uniform. This is 
particularly required at air/tissue boundaries where this field becomes 
distorted. 
MTF The quantification of the spatial frequencies presented or modulated 
by an imaging system. 
DC Represents zero frequency, or the origin of k-space. 
TARQUIN A piece of software which enables the quantification of individual 
metabolites present in an NMR spectrum. 
Metabolite Chemical metabolized in human brain tissue. 
FOV The entire area over which imaging is achieved. 
Nyquist Sampling The theory which states that a signal will be fully represented 
as long as it is sampled at a rate twice the highest frequency present. 
PSF The result from an imaging system of imaging a single point in space, 
usually resulting in a sinc function. 
Phantom A man-made construction used for the assessment of image quality. 
FSSR The fully sampled reconstructed MRSI data as achieved as standard on 
MRI scanner 
LRR Low resolution reconstruction. Data samples are uniformly sampled 
from an ellipse or circle at the centre of k-space. The number of data 
 
 
points included in the ellipse being the same as the CS acceleration 
factor it is being compared to. 
CS-MRSI  MRSI reconstructed using compressed sensing 
 
CS-MRSI(identity) CS reconstructed using the identity function as 
its sparse domain 
CS-MRSI(wavelets) CS reconstructed using the wavelets as its sparse 
domain 
 
In-vivo Subject is whole and living. 
In-vitro Subject is not whole and living. 
 
Digital phantom A software simulation of an MRSI dataset for use in 
retrospective reconstructions. 
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1 Introduction 
1.1 Magnetic Resonance Spectroscopic Imaging (MRSI) 
 What is MRSI? 1.1.1
MRSI is a non-invasive, Magnetic Resonance (MR) imaging technique providing spatial 
mappings of metabolite concentrations within tissue.  
Nuclei possessing half-integer spin when placed in an external magnetic field will tend to 
align with the field. Such nuclei within a tissue are also subject to local magnetic field 
variations resulting from the specific molecular environment. The effect of this is to produce 
an amplitude and frequency variation of the MR signal from a volume (voxel) of tissue which 
reveals a profile of content and structure of the chemical species within it. Acquisition of a 
spectrum from a single voxel is known as Magnetic Resonance Spectroscopy (MRS).  Since 
the human body is 70% water, most commonly proton (1H) MRS is used although 
phosphorous (31P) and carbon (13C) MRS is also achievable with specific hardware. A proton 
MRS profile from a voxel located within brain tissue at magnetic field strength 3 Tesla (T) is 
depicted in Figure 2-4.  
MRSI is a multi-voxel technique allowing the spatial distribution of the metabolite profiles 
present in human tissue to be acquired simultaneously. Unlike conventional proton imaging 
which disregards spectroscopic information, MRSI preserves this information to provide a 
unique insight into tissue function at a biochemical level.  The value of MRSI is its ability to 
reveal variations in metabolite profiles between healthy and diseased tissue which may not 
be seen in conventional MRI (Nelson 2001; Spratlin, Serkova et al. 2009; Posse, Otazo et al. 
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2013). This research focusses on proton MRSI although it is equally applicable to other 
nuclei. 
MRSI is a valuable technique in aiding diagnosis and monitoring of many neurological 
conditions. It has been applied to dementia, multiple sclerosis, stroke and brain injury 
(Ashwal, Babikian et al. ; Friedman, Brooks et al. 1999; Chard, Griffin et al. 2002; Schuff, 
Capizzano et al. 2003; Muñoz Maniega, Cvoro et al. 2008). It is also widely utilised in 
oncology (Golder 2004; Barker 2014).  
 The limitations of MRSI 1.1.2
Single and multi-voxel spectroscopy are available alongside the conventional anatomical 
imaging on most clinical MR scanners. Despite being a well-established research tool and 
there being evidence of a broad range of clinical applications, MRSI is not routinely used in 
every hospital. This is primarily due to technical and practical challenges which hinder its 
ease of use, (section 2.2 and section 2.3). Magnetic field inhomogeneity, low Signal to Noise 
(SNR) ratio, inter-voxel contamination, and problematic coverage of larger areas of the brain 
are some of the difficulties also outlined in this section. One of the biggest challenges to the 
routine application of MRSI in the clinic is the long acquisition time (typically 5-10mins) and 
poor spatial resolution (typically 10-15mm). These two challenges are linked such that a 
reduction in voxel size requires lengthening the acquisition time, and that reducing the scan 
duration requires an increase in voxel size (section 2.2.2.1). Poor spatial resolution is a 
hindrance to accurate diagnosis of neurological disorders and the scan duration is costly in 
terms of patient throughput, image quality, time and money.  
Faster scan times would help reduce patient movement artefacts which are a major problem 
in MRSI. Movement artefacts are particularly difficult to correct for when in conjunction with 
an inhomogeneous field. A reduction in scan duration would be particularly beneficial in 
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terms of patient comfort, in particular for children who do not tolerate lying still for long 
periods. Patient throughput could be increased enhancing healthcare efficiency, and MRSI 
may be more readily incorporated into routine clinical protocols.  
Spatial resolution is also of important clinical relevance. MRSI has the potential to indicate 
important metabolic changes such as tumour infiltration into surrounding healthy tissues. 
The delineation between tumours which remain focal to the main structure of the lesion and 
those which have infiltrated into surrounding healthy tissue is paramount. Therefore, higher 
resolution MRSI would be beneficial for the assessment of all brain tumours.   
The data in MRSI is sampled in the frequency domain (section 2.1.2). The under-sampling of 
data in this domain is one way of reducing MRSI scan duration.  However, a reduction in 
uniformly sampled data normally produces aliasing artifacts (section 2.5.1). A relatively new 
method of data reconstruction which has potential to overcome this is called Compressed 
Sensing (CS). CS has been widely investigated in anatomical MRI(Chang and Ji 2010). Scan 
time is accelerated because it allows the acquisition of fewer, randomly acquired data 
samples whilst suppressing aliasing artefacts (section 2.5) (Lustig, Donoho et al. 2008; Ge, 
Bresler et al. 2011; Haldar, Hernando et al. 2011; Xiaowei Tong 2012).  
 Motivation behind this research 1.1.3
The motivation for this study is to investigate the use of CS in MRSI as a means to reduce 
scan duration or reduce voxel size, and to determine its effect upon the MRSI image quality, 
particularly spatial resolution. The effect of CS reconstruction in MRSI (CS-MRSI) and its 
effect upon spatial resolution are relatively unexplored.  To date there is only one 
quantitative study of spatial resolution which is limited to a single scan speed-up time or 
acceleration factor of x4 (Heikal, Wachowicz et al. 2013). The investigation of the effect on 
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spatial resolution with increasing acceleration factor would be extremely beneficial to assess 
the feasibility of CS to enhance the clinical utility of MRSI. 
 Aims 1.1.4
The primary aim of this research was to investigate the potential of CS as a method to allow 
for the reduction in MRSI scan duration, and its effect on the subsequent spatial resolution. 
The secondary aim was to investigate the use of CS to enhance the spatial resolution of MRSI 
within a clinically feasible time frame. The final goal was the assessment of the potential 
application of CS-MRSI in the clinical investigation of OPG. 
 Objectives 1.1.5
 The first objective was to develop suitable CS reconstruction software applicable to 
MRSI (CS-MRSI).  
 The second objective was to devise a practical technique of providing a measure of 
relative spatial resolution.  
 The third objective was to explore the limits of CS-MRSI by comparison of the spatial 
resolution of CS-MRSI at different acceleration factors.  
 The fourth objective was to compare two different sparse representations (a 
fundamental requirement of CS reconstruction) of the data at each acceleration 
factor. 
 The final objective was to assess the reliability of CS-MRSI reconstruction for the 
delineation of tumour margins in Optic Pathway Glioma (OPG).  
 Road map 1.1.6
The first objective which was to develop CS reconstruction software for MRSI, was 
completed by the adaptation of existing CS software applicable to conventional proton MR 
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imaging (section 3). The software was adapted in order to account for the additional 
chemical shift information provided by MRSI.  
The second objective was firstly tackled by means of the development of an imaging test 
object commonly referred to as a ‘phantom’ (section 4). The development concluded in a 
phantom consisting of an uninterrupted, negligibly thin, metabolite edge consisting of two 
separate agarose gels. This provided means to examine spatial resolution by direct edge 
response measurements. A digital phantom was also developed (section 6) providing higher 
resolution MRSI datasets. The digital phantom was developed to include a simulation of an 
angled, metabolite edge (section 6.3). An investigation of the use of the simulated angled 
edge as a means to measure the Modulation Transfer Function (MTF) was also pursued in 
(section 7.2). 
For the third objective all reconstructions were compared relative to the non-filtered fully 
sampled standard reconstructions (FSSR) as available on the scanner. A comparison of the 
CS-MRSI results to those of the time equivalent Low Resolution Reconstruction (LRR) 
(section 2.2.2.1) was achieved for all investigations. Initially CS-MRSI and LRR reconstructions 
were investigated with increasing acceleration factor at standard voxel size by application to 
retrospectively under-sampled MRSI datasets from the imaging phantom, and from a 
healthy volunteer acquisition (section 5). Secondly, the digital phantom containing the 
simulated, angled metabolite edge was implemented for the investigation of CS-MRSI 
(section 6.3). This provided increased data points for the edge response measurement, and a 
means of assessment of a smaller voxel size (5mm x 5mm x 5mm) without the need for 
lengthy scan duration. The comparison of the spatial resolution relative to the non-filtered 
FSSR resulting from CS-MRSI, and the time equivalent LRR at increasing acceleration was 
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again undertaken (section 7.1). Comparison with the filtered FSSR was also included for the 
digital phantom work. 
The fourth objective was achieved by the application of CS-MRSI utilising the sparse data 
transforms of the identity and the wavelet transforms (section 3.3.1). These were compared 
in Chapter 7 and Chapter 8. 
 The final objective was initially met by scanning an OPG patient using the BCH standard, 
clinical protocol at voxel size of (13mm x13mm x13mm) (section 8.2.1). MRSI datasets were 
reconstructed using CS-MRSI and LRR and compared to the FSSR. This investigation was then 
extended by two further adaptions of the digital phantom. The first provided a high 
resolution MRSI simulation of a single, focal OPG lesion (section 8.2.2.1) and the second, an 
identical lesion exhibiting tumour infiltration into the surrounding healthy tissue. The 
comparisons of CS-MRSI and LRR relative to the FSSR at increasing acceleration were again 
undertaken (section 8.2.2.2).  
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2 Principles of MRSI and Compressed Sensing With Review of Fast 
MRSI Methods 
2.1 Theoretical basis of MRSI 
 Physical Principles of Magnetic Resonance (MR) 2.1.1
Certain atomic nuclei of the human body have an inherent half integer spin angular 
momentum. When these nuclei are placed in an external magnetic field Bo, they precess 
about the applied magnetic field (McRobbie, Moore et al. 2007). In clinical MRI the proton 
(1H) is the nucleus of most interest, because of its high natural abundance in the human 
body and high sensitivity. The resonant frequency of precession is proportional to the 
applied field strength and given by the Larmor equation  
 = B0     Equation 2-1 
Where: 
= Larmor frequency (MHz) 
 = Gyromagnetic ratio=42.56MHz/T for Hydrogen (1H) 
B0 = Applied Magnetic Field (Tesla, T) 
 
This results in an overall net magnetisation M0 which is in line with the applied magnetic 
field B0. Externally applied RF pulses at the Larmor frequency are applied for a duration 
causing the net magnetisation M0 to be tipped at an angle relative to Bo into the transverse 
x-y plane. After the RF is switched off, the magnetisation vector Mo consists of two 
components, the longitudinal magnetization Mz which is restored back along the vertical 
axis at a tissue characteristic time T1 (spin-lattice), and the transverse magnetisation Mxy 
(perpendicular to Bo) which decays along the horizontal axis with a characteristic time T2 
(spin-spin relaxation), Figure 2-1 a).  
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The recovery of the magnetisation Mz(t) at time t after application of the RF is given by 
equation 2-2. 
 𝑴𝒛(𝒕) = 𝑴𝒛𝒆𝒒(𝟏 − 𝒆
−𝒕/𝑻𝟏)  Equation 2-2 
Where: 
 𝑀𝑧𝑒𝑞 = The equilibrium magnetisation along the z-axis. 
𝑀𝑧(𝑡) = The magnetisation along the z-axis at time t. 
T1 = The characteristic relaxation time of the tissue. 
 
The magnetisation Mxy perpendicular to Bo in the x-y plane induces a signal called a Free 
Induction decay (FID) detectable by means of the current it induces in a receiver coil, Figure 
2-1 b). The magnetisation is given by equation 2-3. 
𝑴𝒙𝒚  =  𝑴𝟎 𝒆
−𝒕/𝑻𝟐    Equation 2-3 
Where: 
In practise this transverse decay is characterised by a faster relaxation time T2* which also 
includes spin dephasing due to susceptibility and field inhomogeneity effects. 
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Figure 2-1 - a) The decay of the transverse magnetisation Mxy and the longitudinal magnetisation 
Mz. b) The Transverse magnetisation Mxy induces a current in a detection coil producing the Free 
induction decay (FID). 
 
T1 and T2 vary with tissue type. RF pulses are transmitted, and the resulting MR signals are 
detected by means of RF coils placed over the anatomical area of interest.  
 MR Image Formation 2.1.2
MR image formation is based on the fact that if a magnetic field is made to vary across a 
subject, it imposes a spatial variation in resonant precession frequencies across it.  This 
variation with spatial location can therefore be exploited to pin point the location of MR 
signals. Such spatial variations have to be varied dynamically during imaging. This is achieved 
with three orthogonal 'gradient coils' which are incorporated into the MRI scanner design. 
Currents within these coils can be manipulated to achieve gradients for slice selection Gslice, 
frequency encoding Gfrequency, and phase encoding Gphase. A typical MRI pulse sequence 
depicting these gradients along with the RF and the corresponding MR signal are shown in 
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the gradient echo pulse sequence of Figure 2-2. The gradient amplitude and polarity of Gslice 
select, Gfrequency and Gphase indicate the gradient power and coil current direction respectively. 
 
Figure 2-2 – Basic gradient Echo MRI Imaging sequence 
 
The line marked ‘RF’ indicates the duration of the radio frequency pulse used to tip the net 
magnetisation M0. The angle through which the magnetisation is flipped is dictated by the 
duration and power of this pulse. The RF is usually a sinc pulse and is applied at the same 
time as the slice select gradient. A truncated sinc pulse is desirable since its Fourier 
transform is effectively a square wave. The RF pulse has a specific frequency band width 
(bw) determined by pulse duration, centred around a specific frequency. The pulse acts 
upon only those nuclei precessing at frequencies within the band. Slice selection therefore 
restricts the excited nuclei to a single slice from which to form the 2D image. The slice 
thickness T is given by: 
𝑻 =  𝒃𝒘
 𝜸𝑮𝒔𝒍𝒊𝒄𝒆 𝒔𝒆𝒍𝒆𝒄𝒕        
⁄ Equation 2-4 
Where: 
bw = the RF bandwidth 
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Gslice = Magnitude of the slice select gradient 
 = Gyromagnetic ratio=42.56MHz/T for Hydrogen (1H) 
 
The gradient echo is formed by applying a bipolar frequency-encode gradient (or readout 
gradient). The negative lobe is designed to dephase the spins, whilst the positive lobe 
rephases the spins forming an echo. The dephasing stage is designed such that it 
corresponds to half of the dephasing effect of the frequency encode gradient during data 
acquisition. 
The 2D image is formed by encoding the image signal within the chosen slice. The 
measurements of the MR signals are recorded in reciprocal space known as ‘k-space’. K-
space is the Fourier Transform (FT) of real 2D space (x,y). The x and y dimensions of the MR 
image are encoded by means of the frequency Gfrequency (or readout gradient), and phase 
encode gradient Gphase respectively. The phase-encode gradient is switched on and off for a 
duration of time such that the protons precess at a frequency dictated by their position. 
After the gradient is switched off the spins are left with a net phase shift proportional to 
their position. The frequency-encode gradient is applied whilst the MR signal is being 
acquired. The time at which the signal or echo occurs is known at the ‘Echo time’ and is 
designated as TE.  As a consequence of the frequency encode in the x-direction during this 
period, the spins will be precessing at a frequency proportional to their spatial location.  The 
frequency and phase-encode gradients work together to traverse k-space. In order for 
sufficient T1 relaxation to occur to provide useful signal contrast, the sequence is repeated 
at intervals of time TR (Repetition Time). For each sequence repetition, the phase-encode 
gradient steps to another line in k-space along which the gradient echo is sampled. To 
acquire a matrix size of 256x256 this therefore requires 256 repetitions to traverse each line 
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of k-space. The total acquisition duration is therefore dictated by the number of phase 
encode steps and the TR. 
 Principles of Magnetic Resonance Spectroscopy (MRS) 2.1.3
Since the gyromagnetic ratio () is constant for each nuclear species, the Larmor frequency 
of a particular spin-half nucleus, () depends on the external magnetic field (B0) and the 
local microenvironment. A chemical shift in the Larmor frequency arises due to the effect of 
surrounding electrons in a molecule which partially shield the nucleus from the external 
field. Therefore, the chemical environment dictates the resonant frequency of the molecule. 
These differences in frequency between different chemical species are used for 
identification. The frequency shift is measured in Hz but usually expressed in parts per 
million (ppm) and given by the following equation: 
 =  
𝐟𝐢−𝐟𝐫𝐞𝐟
𝟐 𝛑 𝐁𝟎
 𝟏𝟎 𝟔               Equation 2-5 
Where: 
f i=Frequency of metabolite (Hz) 
f ref=Reference frequency (Hz) 
B0=Main applied external magnetic field (T). 
The chemical shift dictates the position on the frequency spectrum of chemically equivalent 
molecules. This peak may in turn be split due to the individual nuclear spins from 
neighbouring nuclei within the same molecule. This is known as spin-spin or J-coupling 
Figure 2-3. In proton MRSI, the resonances of chemically equivalent protons within a 
molecule may be split by the presence of one (resulting in a doublet) or more (resulting in 
multiplets) adjacent proton(s). The MRSI spectra reveal information about the chemical 
content and concentration, while the multiplet patterns indicate chemical structure. 
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Figure 2-3– The J-coupling between two nuclei 
The proton spectrum of the human brain provides information regarding the relative 
metabolite concentrations. The Prominent neurological features in a healthy human brain 
spectrum are depicted in Figure 2-4, typical concentrations are around 10mM(Govindaraju, 
Young et al. 2000). Although not normally of detectable concentration within a healthy brain 
spectrum, the figure indicates the location of lipids which are prevalent in certain tumour 
types(Orphanidou-Vlachou, Auer et al. 2013) and may be present in a healthy spectrum from 
inter-voxel contamination (section 2.3.1). 
 
Figure 2-4- Proton spectrum of a healthy human brain (short echo time). Peaks shown are: total 
Creatine: Glycerophosphocholine (GPC) and Phosphocholine (PCh), NAA: N-acetylaspartate, and Glx: 
the combined peaks of glutamate (Glu) and glutamine (Gln), Ins: myo-inositol. Cho: choline, and lipid: 
the broad resonance of lipids and triglycerides. 
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MRS is becoming a useful tool in the diagnosis and management of neurological diseases in 
particular brain tumours(Barker 2014). MRS is acquired from a volume or voxel typically 
around (15mm x15mm x15mm). In Magnetic Resonance Spectroscopic Imaging (MRSI), the 
data is processed to form a grid of voxels defined as a Volume of Interest (VOI) allowing the 
spatial distribution of spectra to be viewed.  
2.2 Practical considerations of MRSI acquisition 
In order to obtain good quality MR spectra in MRSI, there are necessary practical steps. Each 
presents its own challenges, and each ultimately affects the outcome of the data quality. The 
general steps are outlined below: 
 Multi-Voxel Spectroscopy  2.2.1
A typical Point Resolved Spectroscopy (PRESS) MRSI pulse sequence can be seen in Figure 
2-5. Unlike conventional MRI image formation (section 2.1.2.), most MRSI techniques use 
only volume selective (Gz, Gy, Gx) and phase-encoding gradients. The phase-encoding 
gradients (Gx and Gy) are stepped with every repetition of the whole sequence at the 
sequence repetition time TR. Frequency-encoding is not used in 2D phase encoded MRSI as 
it is in MRI, since this would destroy the chemical shift information. It is possible to acquire 
3D MRSI with the addition of a third phase-encode gradient, further lengthening scan 
duration. This study is limited to 2D phase encoded MRSI, however acceleration techniques 
may also be applicable for 3D phase encoded MRSI. The gradients labelled ‘crusher’ in the 
figure is explained in (section 2.2.5). 
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Figure 2-5 The pulse sequence for 2D phase encoded MRSI (PRESS). 
 
 Data Acquisition in k-space  2.2.2
The signal in 2D phase encoded MRSI is uniformly sampled in k-space (kx,ky). K-space is the 
representation of an image in terms of its spatial frequencies. The maximum extent of 
coverage of k-space is limited due to time constraints. Measurements towards the centre of 
k-space will contain lower spatial resolution MRSI data while information relating to higher 
spatial resolution is encoded towards the periphery. For each phase encode step, the FID 
signal is sampled typically 1024 times, Figure 2-6. The bandwidth of the spectrum is 
determined by the sampling rate of the time domain signal, typically 1-2kHz. The sampling 
rate needs to obey the Nyquist sampling criteria (section 2.5.1) in order to provide sufficient 
bandwidth for all the metabolite chemical shifts of interest, and the number of samples 
must be sufficient to maintain the resolution between spectral peaks. 
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Figure 2-6 Diagram explaining how the spectroscopy data is collected in k space. Each FID is collected 
at each k-space location. One point in k-space is indicated by the black square on the figure, which 
has three sampled time points. 
 
 
A complete spectroscopic image results as the time points of the FID (t) are obtained for 
each k-space location (kx,ky) which is stepped by phase encoding, every TR time (secs). The 
time taken to collect each FID is determined by the sampling rate and the desired spectral 
resolution which is directly proportional to the number of measurements taken at that rate.  
The time taken to step through k-space is therefore governed by TR and the number of k-
space steps. Hence, the maximum extent of coverage of k-space is limited due to time 
constraints. The acquisition results in a matrix containing values (kx,ky,t).The inverse FT of 
the two k-space dimensions, along with the 1D FT of the sampled time signal, results in a 
matrix of frequency spectra at given spatial locations (x,y,f), the MRSI dataset.  
2.2.2.1 Acquisition duration and spatial resolution trade-off 
The repetition time TR between each k space step (section 2.2.1) must be long enough to 
avoid saturation effects owing to metabolite T1 relaxation times. TR is typically 2 seconds. A 
typical FOV of 160mm x 160mm is required in order to cover the brain. If a reduced FOV is 
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utilised this can lead to aliasing artefacts (section 2.5.1). The total acquisition time TA is 
given by: 
TA =Image matrix size x TR   Equation 2-6 
 
Utilising a nominal voxel size of 10mm x 10mm x 10mm (matrix size, 16 x 16 = 256 voxels), at 
a TR of 2 seconds, results in a scan duration of 8.5 minutes. If high spatial resolution and 
hence reduced voxel size is desired, then more high spatial frequency k-space locations are 
necessarily recorded, and scan time increased. If required spatial resolution is doubled for 
the same FOV, then scan duration is quadrupled. If the desire is to reduce scan duration at 
this same FOV, then this comes at the expense of spatial resolution as k-space is truncated 
to reduce the number of k-space samples and hence scan time. 
A simple method of accelerating MRSI acquisition is to uniformly sample a circular central 
region of k-space, while setting the signal at the outer edges to zero to maintain the nominal 
voxel size. This is commonly available by default on clinical MRI scanners. This technique, 
referred to as applying an elliptical or circular k-space ‘mask’ or ‘shutter’ reduces the 
number of samples required, and hence scan duration, by 25%(Philips 2011) . In practice the 
sampled area at the centre of k-space can be varied relative to the nominal k-space coverage 
by applying this standard 25% ‘shutter’ to MRSI acquisitions of different voxel sizes, and then 
using scanner options to reconstruct the acquired data to a nominal voxel size. 
  Shimming  2.2.3
Shimming is required to ensure that the main magnetic field Bo is uniform. Consideration has 
to be given to the magnetic susceptibility artefact between different tissue boundaries, 
particularly at air/tissue interfaces (Farahani, Sinha et al. 1990). This results in large 
inhomogeneities in the main magnetic field experienced by the tissue of interest. This 
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therefore can lead to discrepancies in the Larmour frequencies of such tissues and hence an 
incorrect chemical shift between their metabolites. Shimming is employed to even out these 
differences(Vikhoff-Baaz 1999; Philips 2011). It is achieved via the use of specialised shim 
coils employed in the scanner design. The currents from these coils produce magnetic fields 
to counteract the discrepancies to attempt a spatially uniform field. Algorithms are utilised 
to calculate the required shim coil currents. Current shimming algorithms however are 
hampered by complex anatomical geometry particularly over areas of stark magnetic 
susceptibility difference such as the inferior frontal cortex, due to the proximity to the 
frontal sinuses. It is difficult to optimise the currents to correct for this. A reduction in the 
apparent T2* of tissue will result and therefore cause spectral broadening and hence a 
reduction in spectral resolution.  
In MRSI the objective is usually to achieve maximum coverage in order to define 
heterogeneity of disease over large volumes. Large tissue volumes are likely to contain a 
greater diversity of field inhomogeneity profiles than smaller volumes. Therefore, since it is 
hard to simultaneously correct for all the field inhomogeneities over larger volumes, 
shimming is often more of a challenge for MRSI than for single voxel MRS, where a much 
smaller VOI is usually defined. The shimming is achieved for a volume over which shim 
currents are optimised to achieve maximum homogeneity. The shim volume is most usually 
defined over the VOI. A balance needs to be struck between a VOI which optimises the shim 
and one which allows enough coverage for comparison between disease and normal 
appearing tissue, and detection of disease infiltration. 
 Water suppression 2.2.4
The human body is approximately 70% water. Therefore in proton MRSI there is a very high 
signal from water. The water peak dominates the spectrum rendering the detection of 
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metabolite peaks a challenge. In order to overcome this, various water suppression 
techniques may be utilised. The quality of the water suppression depends upon the quality 
of the shimming. An inhomogeneous field will cause local variations in the Larmor frequency 
of metabolites and the water peak. The magnetic susceptibility artefact may have severe 
consequences for adequate water suppression. This is because the unsuppressed water may 
become sufficiently shifted in Larmor frequency, such that the water suppression bandwidth 
does not encompass it entirely. A poorly shimmed magnet will therefore have a detrimental 
effect upon the resultant MR spectral quality often producing unsuppressed water peaks 
known as residual water. These residual water peaks can often be substantial leading to 
inter-voxel contamination at distant voxels from residual water ringing artefacts (section 
2.3.1).  
There are a variety of water suppression techniques available on the Philips 3T scanner 
(Philips 2011). In this study the Excitation and (CHEmical-Shift Selective) CHESS methods 
were utilised (Haase, Frahm et al. 1985). The default water suppression method on the 
Philips 3T scanner is known as the Excitation method. This applies two bandwidth selective 
RF pulses to produce zero magnetization from water at the beginning of the acquisition. The 
water magnetization is slightly over flipped by the RF pulses, after which spoiler gradients 
are applied to destroy the transverse water magnetization, Mxy. Any small residual water 
peak will return to equilibrium through T1 relaxation. The suppression is optimal when the 
longitudinal water magnetization Mz passes through zero at the start of the measurement. 
CHESS consists of the addition of extra RF pulses along each of the three orthogonal axes. 
These pulses act to minimise the longitudinal magnetization of the water signal at the time 
of the RF excitation by adjusting the flip angle of the third RF pulse. 
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 Outer Volume Suppression 2.2.5
Signals from outside the desired volume need to be eliminated. These can arise from 
spurious stimulated echoes outside the VOI due to imperfections in pulse shape. These are 
removed via the use of crusher gradients which are placed either side of the 180 degree 
pulses Figure 2-5. An imperfect pulse profile from a volume near the scalp can inadvertently 
excite subcutaneous fat. Lipid produces a very high MR signal which can bleed into the VOI 
(section 2.3.1). These spurious signals can be reduced via the use of fat saturation bands 
placed around the scalp, depicted in blue on Figure 5-3. The saturation bands consist of a 90o 
RF pulse in combination with a gradient at right angles to the imaging plane to restrict the 
band to a select region of the FOV. This is applied just prior to imaging such that the 
longitudinal magnetisation in this region is saturated and unavailable to be excited by the RF 
pulse.  
2.3 Challenges to data quality in MRSI 
Achieving good quality MRSI data is not as straight forward as in conventional anatomical 
MRI. Since the signals from the metabolites are very low in comparison to the water signal, it 
is essential to obtain good SNR and water suppression as well as achieving high spectral 
resolution and good quality shimming. Due to the nature of the 2D phase encoding of the 
MRSI acquisition, low spatial resolution and lengthy scan duration are also considerable 
challenges to data quality as discussed in (section 2.2.2.1). 
The difficulties often encountered in obtaining spectra are outlined below: 
 Inter-Voxel contamination (Bleed Through) 2.3.1
Inter-voxel contamination or ‘Voxel bleeding’ is a major challenge in MRSI limiting its spatial 
integrity. Inter-voxel contamination can lead to partial volume effects and possible 
 21 
misidentification of tissue. This is of particular concern for the delineation of the extent of 
tumour infiltration into surrounding healthy tissue.  
 As previously mentioned MRSI data is measured by uniformly stepping through k-space and 
sampling at each location (kx,ky) (section 2.2.2). If an infinitely small point (dirac delta 
function) were imaged, its acquisition in k-space would require sampling an infinite 2D 
plane. In reality, the rectangular image matrix, truncates k-space sampling. The Fourier 
transform is effectively the representation of a signal as the summation of sin and cosine 
basis functions of various frequencies. The reduction in the maximum available spatial 
resolution in k-space, limits the possible higher frequency Fourier basis functions available 
for the inverse FT to real space (x,y). As a consequence the point signal broadens and it 
exhibits side lobes referred to as ‘Gibbs ringing’ (Vikhoff-Baaz, Starck et al. 2001; Kirchner, 
Fillmer et al. 2015). This transformed signal shape is known as the Point Spread Function 
(PSF) (Posse, Otazo et al. 2013). A 1D version of the PSF is depicted in Figure 2-7. In MRSI the 
image is a convolution of the true object and the PSF. The broadening of the main central 
lobe of the PSF degrades MRSI spatial resolution causing the metabolite signal from one 
voxel to spread to its adjacent neighbours. The Gibbs ringing causes either an increase or 
decrease in voxel signal as metabolite information from distant voxels bleeds into them. The 
spread across voxels is termed ‘voxel bleeding or ‘inter voxel contamination’. The Gibbs 
ringing can be particularly problematic if subcutaneous fat is inadvertently excited. If the 
lipid signal is not sufficiently suppressed by the saturation bands, it can bleed into the voxels 
of normal healthy tissue (section 2.2.5). 
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Figure 2-7- A depiction a 1D Point Spread Function (PSF). 
 
A method to reduce the side lobes of the PSF is to apply post acquisition k-space filtration. 
Filtration consists of the application of variable weighting to the k-space samples, which 
decreases towards the periphery. The actual filter utilised varies between manufacturers but 
they achieve a similar result. A typical filter utilised in MRSI is the Hamming filter (Skoch A 
2008), given by equation Equation 2-7. 
𝑯(𝒏) = 𝟎. 𝟓𝟒 − 𝟎. 𝟒𝟔 𝒄𝒐𝒔  𝟐𝝅𝒏 𝑵⁄               Equation 2-7 
The result of filtration is a reduction in Gibbs ringing but at the expense of spatial resolution, 
as it broadens the main central lobe, as depicted in Figure 2-7. It is suggested that the 
reduction in spatial resolution due to the application of such a filter is around 50% (Barker 
and Lin 2006). The application of a k-space ringing filter is a standard default in clinical MRSI. 
Therefore, the actual spatial resolution in clinical MRSI is worse than its nominal voxel size. A 
significant objective in MRSI research is to find a method of eliminating inter-voxel 
contamination by reducing Gibbs ringing without loss in spatial resolution (section 6.3.2). 
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 Signal to Noise Ratio (SNR) 2.3.2
The SNR of MRSI is much lower than that of conventional anatomical MRI. This is due to the 
very low abundance of metabolites relative to that of water in the human brain. The SNR is 
directly related to the voxel volume. Increasing the voxel volume to enhance SNR will 
however reduce spatial resolution and vice versa. The SNR can be improved by either 
increasing the Number of Signal Averages (NSA) or increasing the voxel dimensions. Both of 
these solutions have associated problems. Increasing NSA increases the already lengthy scan 
time. 
 Chemical Shift Displacement 2.3.3
Gradient driven volume selection methods in MRSI such as PRESS (section 2.2.1) utilise 
frequency encoding to determine the VOI by exciting spins resonating at the Larmor 
frequency within this volume only. Metabolites however resonate at different frequencies, 
resulting in different VOI selections for differing metabolites as shown in Figure 2-8. 
 
Figure 2-8 - Molecules of Choline experience a different spatial localisation from the 2D gradient 
selection to that experienced by NAA. This results in a slight shift in the VOI indicated in blue for 
Choline, and yellow for NAA. 
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The distance a VOI will be chemically shifted is related to the bandwidth of the excitation 
from the RF, and the refocusing pulses.  At increasing field strength the chemical shift 
displacement artefact is also enhanced (Lange 2006; Scheenen, Klomp et al. 2008).  The 
inherent chemical shift displacement of PRESS maybe corrected for by using oversized VOI’s 
(half a voxel boundary on Philips 3T) (Edden, Schär et al. 2006). The disadvantage of 
increasing the VOI size is that it may become too large for whole brain studies, or it may 
extend into undesirable anatomical locations such as subcutaneous fat. 
2.4 Post-processing of MRSI datasets 
After the MRSI data has been acquired the FID signals are usually processed offline. A 
Fourier transform is applied to convert the time domain signal to frequency, producing the 
NMR spectrum associated with each voxel. The detected FID is complex, comprising of real 
and imaginary components from the spins in the transverse magnetisation plane section 
(2.1.1). The real frequency component is conventionally displayed as parts per million (ppm) 
against signal. There are several post processing steps which are needed in order to enhance 
the data quality of the resulting spectra and provide quantification of the metabolites 
present. The main considerations are outlined as follows: 
 Residual water removal 2.4.1
As mentioned in (section 2.4.1), the water suppression does not always entirely remove the 
water peak. This can lead to peaks at around 4.7ppm known as residual water. These peaks 
are often removed in post-processing using an HSVD algorithm (Pijnappela 1992). This is 
based on the estimation of the water FID and its subsequent removal from the time domain 
signal. This method is successfully utilised in MRSI post-processing however the residual 
water can distort the spectrum baseline which can have consequences for quantification of 
neighbouring metabolite peaks.  
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 Baseline correction 2.4.2
Small baseline distortions can be rectified by a simple shift of the spectrum up or down. This 
is often achieved by taking the average signal from a stable portion of noise in the spectrum, 
and subtracting this from the entire spectrum. The correction of the baseline distortion due 
to severe residual water contamination as mentioned above may be impractical. 
 Peak phasing 2.4.3
The real component of the complex spectra is normally displayed. The Real data spectra 
sometimes exhibit a mixture of positive and negative peaks above and below the baseline. 
This is due to frequency offset errors and pulse sequence delays between excitation and 
receive. Spectra can be re-phased in either the time or frequency domain after acquisition in 
order to correct this, or the magnitude data can be displayed although this broadens the 
peaks. 
 Apodisation and Line broadening (time domain filtering) 2.4.4
The SNR in MRSI is inversely proportional to the height of the noise intensity of the FID. If 
noise could be reduced then SNR is improved. This is often achieved by multiplying the time 
domain FID by an exponential function containing a line broadening term (lb), such as the 
one below: 
𝑨(𝒕) = 𝒆−𝒍𝒃 𝒕    Equation 2-8 
It follows from Fourier theory that the more rapid the decay of an exponential the broader 
will be its Fourier Transform, hence the line broadening term in the above equation. 
Therefore, the optimum SNR will be achieved when the line broadening term matches the 
signals own width. Since line width is metabolite dependent, a single line broadening term 
will not be optimised for every peak, however an average is often utilised. 
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Apodisation can also be used to improve spectral resolution by enhancing the extremity of 
the FID. This may however result in a significant decrease in SNR.  
 Zero Filling 2.4.5
Zero filling is a method to artificially improve the spectral resolution. It really only improves 
the appearance of the resolution but not the actual spectral resolution. Zero filling consists 
of the addition of zero valued data points to the end of the FID without adding additional 
noise. The main advantage of zero filling is that if a metabolite is very closely coupled, zero 
filling will make its components more distinguishable in the frequency domain.  
 The quantification of brain metabolite concentration 2.4.6
The relative concentrations of the metabolites within brain tissue are indicators of disease 
state (section 8.1.1). A major component of post processing is the quantification of these 
metabolites. The absolute quantification of the concentrations of each metabolite within the 
human brain is subject to much research. The concentration of an individual metabolite is 
age, location and disease dependent. There is evidence suggesting differences in metabolite 
concentrations between grey and white matter (Pouwels and Frahm 1998). In a healthy 
human brain the MRS detectable concentrations are of the order of 1-10mM. 
Methods of absolute quantification of the concentrations of brain metabolites obtained 
from NMR spectroscopy are available in software packages. Quantification of in-vivo 
metabolite concentration is not a simple linear relationship between peak height and 
quantity (Reynolds 2008). There are many automatic systems available aiming to achieve 
optimum quantification. They utilise a variety of algorithms based on either integration of 
peak area, peak fitting or basis-set methodologies (Poullet, Sima et al. 2007). Integration 
methods (typically employed by scanner spectrometer manufacturers) work in the 
frequency domain on simple spectra by summing the area under the metabolite peak of 
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interest. This methodology is prone to inaccuracy when quantifying short-TE, MRSI due to 
the complexity of the spectra of some metabolites (Wilson, Reynolds et al. 2011). Other 
methods of spectral interpretation attempt to overcome the problems encountered by this 
integration method by utilising known spectral data as a set of basis functions of the 
metabolites to provide a mathematical fitting. Non-linear Least Squares fitting is employed 
in the AQSES (Automated Quantitation of Short Echo time MRS Spectra) system (Poullet, 
Sima et al. 2007). A method of constrained least squares analysis to obtain (approximately 
maximum-likelihood) estimates of model parameters such as metabolite concentrations, 
phases, referencing shift, lineshape, baseline, and uncertainties in the concentrations, is 
employed in the Linear Combination, LCModel (Provencher 2001). Another recently 
developed system known as TARQUIN (Totally Automatic Robust QUantitation In Nmr), is 
based upon a quantum mechanical simulation of spectra in the time domain (Wilson, 
Reynolds et al. 2011). TARQUIN is a fully automatic system producing reproducible 
quantification for multi and single voxel spectroscopic data. 
2.5 Introduction to Compressed Sensing 
The essence of CS is a mathematical concept stating that a signal may be accurately 
reconstructed from a few randomly distributed measured samples, the number of samples 
being much less than that normally measured.  If the signal is compressible after the 
application of a specific mathematical transform, the random measurements will produce 
incoherence artefacts within it. If the signal also has a sparse representation, it will contain a 
few high energy components described in the transform domain which signify the true signal 
above the level of noise like incoherence. With the application of a convex, nonlinear 
reconstruction algorithm, the major high energy components can be extracted and the data 
reconstructed to its original domain. 
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According to the Nyquist-Shannon sampling theorem, the sampling rate must be at least 
twice the highest analogue frequency component of the signal. Failure to follow this theory 
results in signal aliasing after reconstruction; however CS is a method which has been proven 
to overcome the Nyquist-Shannon sampling allowing much fewer samples to be collected 
without such artefacts. 
 Signal Aliasing in MRSI 2.5.1
Aliasing is the misrepresentation of the frequency components of a signal. Figure 2-9 
demonstrates this concept showing that for the signal represented in blue, if it is only 
sampled at the points shown in black, after reconstruction of these few data points, it will 
appear as the signal shown in red possessing a very different frequency to that of the 
original signal. 
 
Figure 2-9-An Illustration of 1D signal aliasing. The full signal is represented in blue. The data is 
sampled at the points shown in black. The resultant representation after under-sampling is the red 
signal which misrepresents the frequency of the original signal. 
 
The effect of aliasing in MRSI was investigated as a preliminary to this research. In MRSI 
signal aliasing manifests itself as a misrepresentation of the spatial location of metabolites. 
This was demonstrated for 2D MRSI in this study by writing MATLAB software to simulate a 
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reduced Field of View (FOV) scenario. According to the Nyquist-Shannon sampling theorem a 
bandlimited signal will exhibit aliasing when data is sampled below a rate equal to twice the 
bandwidth (BW). In MRSI or MRI the bandwidth is in the imaging domain in both x and y 
directions (FOVx, FOVy). The signal is sampled in k-space at a step size of kx and ky 
(section 2.2.2), before inverse transformation to the imaging domain. The Nyquist sampling 
frequency in the x direction is given below: 
   kx < 1/FOVx Equation 2-9    
The software read in an MRSI dataset in DICOM format which had a matrix (x,y,f) size of (14 
x 12 x 1024).  A high signal outside the VOI was added Figure 2-10 a). The MRSI dataset was 
then Fourier transformed to k-space. A reduced FOV measurement scenario was simulated 
by uniformly under-sampling only alternate k-space points thus increasing k in Equation 2-9 
to simulate sampling above the Nyquist rate. The reduced k-space dataset was then 
inversely Fourier transformed back to real space. The distance between k-space samples and 
the FOV are inversely related, so this has the effect of reducing the original FOV in real 
space. The result is demonstrated in Figure 2-10 b). A reduction in the FOV allows a 
reduction in data sampling and therefore reducing real-time acquisition, however it can be 
seen that the large signal from outside the VOI can is folded into the VOI as an aliased signal 
as a result. 
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Figure 2-10 – Demonstration of aliasing in MRSI. The original MRSI a) has a voxel with a high signal 
outside of the VOI. After the size of the k-space steps has been increased, the FOV has reduced b). 
This process has caused the high signal to alias into the VOI. 
 
This aliasing is often prevalent in MRSI where high outer volume signals such as 
subcutaneous lipids or residual water are present. The high signal lobes get bled into the 
region of interest (section 2.3.1). CS is a potential method of reconstructing sub-Nyquist 
sampled datasets without introducing significant aliasing artifacts whilst maintaining spatial 
resolution by sampling enough high spatial frequency data samples (Lustig, Donoho et al. 
2008). 
CS may therefore allow a significant reduction in acquisition time if fewer samples are 
required without causing signal aliasing. Compressed Sensing should theoretically overcome 
the Nyquist limitation by meeting the following three requirements: 
 Signal requires Transform Sparsity 2.5.2
A signal vector which contains a significant amount of information in only a few non-zero 
components is said to be sparse. A sparse signal contains most of its energy in only a few 
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measurements, while the rest of the measurements are either zero or negligible. Such a 
signal may be well represented without a perceptible loss after reconstructing with only 
these few high energy data components.  
A signal has transform sparsity if a transform exists which renders the signal sparse after 
application of that transformation. This forms the basis of data compression techniques. An 
example of transform sparsity is the Fourier transform of a sinusoid. In the time domain the 
signal is continuous, however after transformation, there exists only one frequency 
component which fully represents the entire signal. MR images are naturally sparse in some 
transform domain such as wavelets or FREBAS, making them good candidates for 
compressive sensing techniques(Lustig, Donoho et al. 2008; Ito 2011). MRSI spectra are also 
naturally sparse in the frequency domain(Bostock, Holland et al. 2012). It has not yet been 
determined in which domain MRSI data is most sparse, which may be application 
specific(Geethanath 2012). 
 Random Sampling is required 2.5.3
The data in MRI and MRSI is collected in k-space (section 2.2.2). In order to reduce the 
aliasing artifacts (section 2.3.1) introduced by the under-sampling of k-space during CS, the 
data is collected in a random pattern, not uniformly. The effect of random under-sampling of 
k-space is to produce noise-like incoherence of the aliasing artifacts in the sparse transform 
domain (Lustig, Donoho et al. 2008). This can be explained by thinking about an image which 
is already sparse in the spatial domain. The point spread function (PSF) is a measure of an 
imaging systems ability to retain the energy of a signal at one single location without leakage 
away from it. This energy leakage in an MRSI context is referred to as ‘bleed through’ 
(section 2.3.1). If an image of a single infinitely small point is fully Cartesian sampled in k-
space and inverse Fourier transformed back to real space, the PSF will be its identity. If it is 
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subject to under sampling of any kind random or uniform before inverse transform, the PSF 
will contain non zero components beyond the single point in all directions. These extra 
components constitute the energy leakage of the system and usually take the form of a sinc 
function. In a 2D MRSI imaging scenario, one particular voxel will experience a combination 
of leakage from all other surrounding voxels. Even if a voxel originally contained zero signals, 
after under-sampling, it may now contain this unwanted signal. CS therefore endeavors to 
reduce this leakage by random under-sampling of k-space such that the combination of the 
leakage is incoherent and spread minimally across the image. 
 Non-Linear reconstruction technique 2.5.4
Since CS requires the enforcement of transform sparsity together with the need to maintain 
data consistency with the measured samples, this therefore lends itself to iterative non-
linear reconstruction. A nonlinear solution is one which provides the reconstruction of data 
modelled by a function written as a series of nonlinear equations. The model fitting usually 
employs an iterative technique based on an initial estimate of the solution. In this case a 
nonlinear convex optimisation model is required. Such a model is required to minimise the 
difference between the measured, and current, estimated data whilst simultaneously 
ensuring the minimisation of the sparse transform coefficients. 
2.6 Literature Review of Fast MRSI techniques 
Using standard clinical methods, significantly enhancing MRSI spatial resolution would 
require scanning to be increased beyond a clinically acceptable time frame. Therefore, 
methods of accelerating MRSI acquisitions, whilst maintaining adequate signal to noise ratio 
and minimizing the effects of aliasing and lipid contamination are of great potential benefit 
in MRSI. There has therefore recently been much interest in fast MRSI acquisition techniques 
(Barker and Lin 2006). 
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 SENSE 2.6.1
One such method for investigation utilises a combination of multiple phased array receiver 
coils for parallel imaging(Dydak 2001). Reduction in the amount of acquired k-space has 
been achieved by combining the measured data with the coil sensitivity in parallel imaging. 
This has been shown to reduce scan time by a factor of 4 (Dydak 2001; Bonekamp, Smith et 
al. 2010). If the number of phase encoding steps is reduced by a chosen factor R, the 
resulting images from each component coil possess both aliasing, and a Field of View (FOV) 
reduced by a factor of 1/R, in the PE directions. In parallel imaging the sensitivity of each coil 
relates to position in the PE directions. This, in combination with each of the component coil 
signals, can be utilised to unfold the aliasing and reconstruct the full image. Reconstruction 
can take place in the image domain for techniques such as SENSitivity Encoding (SENSE), or 
in the frequency or k-space domain in techniques such as SiMultaneous Acquisition of 
Spatial Harmonics (SMASH). Parallel imaging is available on the Philips 3T scanner at 
Birmingham and may be combined with all spectroscopic techniques. A potential pitfall of 
this technique is the inherent artifact due to the unfolding accuracy of the system, 
enhancing any spurious lipid signal (Barker and Lin 2006; Zierhut, Ozturk-Isik et al. 2009). Fat 
suppression bands maybe utilised to overcome this issue. It also requires an additional 
calibration scan to acquire the coil sensitivities, increasing the overall scan time. 
 Reduced Field of View (FOV) 2.6.2
A reduction in the Field of View would produce a reduction in the number of phase encoding 
steps by increasing step size and therefore reducing scan time. A small enough reduction in 
FOV making significant impact on scan time would fall within the anatomy of the brain. This 
will cause an inherent aliasing or ‘fold over’ artefact (de Graaf 2007). Efficient signal 
suppression outside the VOI may compensate for this. Reduced FOV spectroscopy outside 
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the brain anatomy has been investigated on a 1.5T scanner utilising a rectangular FOV 
producing scan times of 65% of full FOV imaging(Golay, Gillen et al. 2002). So far, due to 
insufficient signal suppression this has not been investigated within the brain anatomy.  
 Turbo Spectroscopic Imaging (TSI) 2.6.3
Turbo spectroscopic Imaging (TSI) reduces the scan time by acquiring multiple echoes after 
each excitation pulse, effectively gathering multiple sections of k-space at each 
repetition(Barker and Lin 2006). This technique is available on the Philips 3T and has been 
utilised in combination with parallel imaging (Dydak 2006). It has also shown good results for 
the investigation of the coupled spins of Glutamate and Glutamine(Yahya and Fallone 2009) 
on a Philips 3T. TSI is normally limited to metabolites with longer T2. This is because a long 
echo train is required as a trade off with spectral resolution limiting the minimum allowable 
echo time TE. A long echo train length may induce spatial blurring if a significant degree of 
T2decay has occurred between echoes(de Kok 2007). 
 Non Cartesian Techniques 2.6.4
In conventional phase encoded MRSI, it is the time taken for the readout gradients to 
acquire the spectroscopic data which limits the minimum duration. Therefore, attempts 
have been made to reduce the scan time by acquiring the data in a non-Cartesian fashion. 
Instead of the stepped, 2D phase encoding of k-space, the readout gradients traverse 
through k-space in a non-uniform pattern.  
Non-Cartesian readout gradients have been utilised in Echo Planar Imaging (EPI), Echo Planar 
Spectroscopic Imaging (EPSI) or Proton Echo Planar Spectroscopic Imaging (PEPSI). These 
techniques can dramatically reduce scanning time by the interleaving of an oscillating read 
out gradient, and Spiral-MRSI which has two oscillating gradients, acquire one or two spatial 
dimensions in a single shot. This allows the simultaneous encoding of spatial and spectral 
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information and therefore reducing overall acquisition time. The spatial resolution is 
determined by the readout gradient duration, and the spectral resolution by the overall time 
taken for interleaving each readout module. These techniques, although one of the fastest 
methods of MRSI, can suffer from a reduced SNR relative to conventional MRSI, along with 
spectral broadening and line drifts occurring due to gradient heating (Barker and Lin 2006; 
Posse, Otazo et al. 2013). Echo Planar spectroscopic methods offer technical challenges due 
to the high demands placed on the system for the required rapid gradient switching, and 
requires a degree of data interpolation in reconstruction potentially hindering 
accuracy.(Barker and Lin 2006). Spiral MRSI is actually faster than EPSI but data 
reconstruction can be complex (Posse, Otazo et al. 2013). PEPSI has successfully been 
utilised in 3D prostate spectroscopy in combination with CS, and has successfully been 
utilised with SENSE in the brain (Lin 2007; Furuyama 2012). This technique is not currently 
available at Birmingham. 
A technique which claims MRSI data can be obtained in less than a minute by using a burst 
of low flip angle pulses on a conventional clinical system is also a potential avenue of 
research(Jakob, Ziegler et al. 1995).  An implementation on rat brains of a technique known 
as Gradient and Spin Echo (GRASE) has shown that scan times are reduced with high 
resolution(Dreher and Leibfritz 2000). This technique suffered poor SNR, requires high 
quality gradient switching and achieved using 4.7T only. 
 Steady State Free precession (SSFP). 2.6.5
Steady state Free precession techniques can also offer a significant decrease in scan time 
without loss of sensitivity(Dreher, Geppert et al. 2003). They have a short readout time 
which can however limit the allowable spectral resolution at field strengths of 3T and below. 
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This technique is particularly susceptible to off resonance effects due to imperfections in 
shimming and from eddy currents. 
 Sparse Image based k-space encoding schemes 2.6.6
In the quest for faster imaging and higher spatial resolution, methods have been 
investigated which utilise prior information about the object being imaged. ‘spectral 
localization by imaging’ SLIM is a non-fourier reconstruction technique which aims to 
improve the effective  MRSI spatial resolution(Hu, Levin et al. 1988). This basically uses the 
known spatial resolution of a corresponding high resolution anatomical MR image to identify 
areas of homogeneous signal. This is then used to effectively divide the anatomy into 
metabolite compartments from which spectra can be reconstructed. This technique is 
limited by the assumption that each compartment is uniform. To provide some 
inhomogeneity within the compartments a technique known as ‘Generalised spectral 
localization by imaging’, GSLIM has been introduced(Zhi-pei and Lauterbur 1991). 
 Compressed Sensing in MRSI  2.6.7
The natural sparsity of MRSI data in the frequency and spatial dimensions lends itself to the 
application of CS reconstruction and leads to its potential application for the acceleration or 
increased coverage of pre-existing MRSI methods. MRSI is an inherently noisy technique due 
to the low metabolite signal. Reconstructing with CS in MR has been shown to be an 
inherently de-noising technique (Lustig, Donoho et al. 2007). Application of CS could 
therefore be advantageous over the other fast MRSI techniques such as EPSI, SENSE and 
GRASE which can be limited by SNR. 
Pre-clinical studies have shown successful application of CS to 13C MRSI (Hu, Lustig et al. 
2010; Larson, Hu et al. 2011). Recently a pre-clinical study has demonstrated the feasibility 
of CS applied to 1H phase encoded MRSI(Cao and Wu 2014). The use of CS reconstruction 
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from echo-planar J-resolved spectroscopic imaging (EP-JRESI) datasets of the prostate has 
shown a potential four-fold reduction in scan time (Furuyama 2012). CS has successfully 
been utilised retrospectively on clinical, Point Resolved Spectroscopy (PRESS) acquisitions 
(Section 2.2.1), (Geethanath 2010; Geethanath 2012), and  has also recently been used in 
clinical 31P spectroscopic data(Askin, Atis et al. 2012).  
 
2.7 Conclusion 
To conclude, 2D phase-encoded MRSI is a proven technique useful in the diagnosis and 
monitoring of disease but it has many challenges which limit its clinical utility. One of the 
major limitations to the clinical application of MRSI is long acquisition time which if reduced 
whilst ensuring Nyquist sampling, results in a corresponding reduction in spatial resolution. 
Investigation into reducing MRSI acquisition times is a major area of research. Current 
solutions suffer from poor SNR and possible reconstruction artefacts. CS is a method which 
allows sub-sampling below the Nyquist sampling limit thus reducing acquisition time, 
without detriment to image data quality. CS has had successful application in anatomical 
MRI but could also provide a potential solution to the lengthy scan duration of MRSI. 
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3 Implementation and development of CS-MRSI Software  
3.1 Introduction to CS in MRSI 
Conventionally when a signal is under-sampled below the Nyquist limit, reconstruction 
quality is compromised as a result of aliasing artefacts (section 2.5.1). CS is a reconstruction 
technique allowing the acceleration of signal measurement beyond the Nyquist limit without 
detriment to reconstructed quality (Lustig, Donoho et al. 2008). The technique is reliant 
upon a signal or image having a sparse representation in some transform domain. This 
means that the object of interest maybe reliably reconstructed from few but important data 
coefficients from that transform. A sparsifying transform is applied which maps the image 
content into a vector of sparse coefficients of which the insignificant ones can be omitted. 
This is akin to image compression where the largest components after transform to the 
wavelet domain are retained only, in order to facilitate data transfer. The concept of CS is 
that the signal is compressed during image acquisition instead of afterwards. The aliasing 
artefacts from the under-sampling are minimised by acquiring the measurements in a 
random scheme, such that on transform of the measured samples to the sparse domain the 
aliasing artefacts combine in an incoherent fashion, the first requirement of CS. Acceleration 
from CS is achieved by reconstructing highly under-sampled data which has a sparse 
representation, the second requirement of CS. Utilising a mathematical framework, CS 
ensures data transform sparsity whilst at the same time minimising the differences between 
measured and reconstructed samples, this is the third requirement of CS.  
One of the major limitations to MRSI is its long acquisition time due to its data sampling 
requirements (section 2.2.2.1).  Therefore, the application of CS to MRSI could provide a 
valuable method of overcoming this. CS has been successfully implemented in MRI 
(Chartrand 2009). The data in both MRI and MRSI are acquired in k-space (section 2.2.2). The 
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difference between MRI and MRSI is the addition of the third spectral dimension kt, which in 
k-space is acquired in a single shot at each k-space location (kx,ky). Random acquisition of k-
space locations will render incoherent aliasing in the resultant MRSI image after inverse 
Fourier transform from k-space back to real space. This satisfies the first CS requirement.  
The second requirement of CS is that the images under reconstruction have a sparse 
representation. MRSI has a natural sparsity in the spatial and spectral dimensions. The actual 
useful data in an MRSI is contained within the selected VOI (section 2.2) which is typically 
around 20% of the entire FOV. Therefore the MRSI image is itself sparse. CS has also been 
successfully implemented utilising wavelets as the sparsifying transform to satisfy this 
requirement (Geethanath and Kodibagkar 2013; Cao and Wu 2014). Under-sampling in the 
temporal dimension kt would yield further sparsity. However, since the burden on 
acquisition speed is the phase encoding of k-space and that the sampling scheme required to 
under-sample the temporal dimension would in future necessitate a complex pulse 
sequence with rapid gradient switching, there is little to be gained from this. The 
mathematical optimisation framework needed for the third requirement of CS is readily 
available for MRI which lends itself to adaptation to MRSI. 
The implementation of CS reconstruction code was developed in this study using the Matlab 
development platform Version (2012b). The software was based on the 2D MRI compressive 
sensing code available in the SparseMRI package available at 
(http://wwwmrsrl.stanford.edu/~mlustig/software/). In this research, the code was adapted 
to reconstruct a standard 3D matrix (x,y,f) of MRSI data. A description of the adaption of CS 
to the MRSI data reconstruction is outlined below. 
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3.2 The random under sampling pattern 
Although available as a research tool for MRI, to date there is no system to acquire 
prospective non-uniform data points in k-space in MRSI acquisition. Therefore, all CS data 
reconstruction was either achieved on retrospective data which had been previously 
acquired, or by software simulated MRSI datasets.  
The 2D random style sampling required for CS in MRSI k-space has to take into account the 
fact that there is a balance between the high MRI signal of the points at the centre and the 
high spatial resolution of data at its periphery. This is achieved by implementation of 
pseudo-random sampling which fully samples the very centre of k-space and then samples 
points based on a weighted 2D probability density function decreasing towards the 
periphery. This provides more samples in the centre of k-space than those at the edges 
(Lustig, Donoho et al. 2007). The 2D fully sampled centre is dependent on the inverse of the 
acceleration factor, i.e. smaller fully sampled region for higher acceleration 
factor(Geethanath 2011).  
The pseudo-random under-sampling pattern or k-space mask was based upon the software 
available in SparseMRI software package 
(http://wwwmrsrl.stanford.edu/~mlustig/software/). This scheme has been successfully 
utilised in 2D phase encoded, CS-MRSI (Geethanath 2012; Cao and Wu 2014) and  so the 
same methodology was adopted for this study. The only difference between this previous 
under-sampling scheme and the one in this research was the inclusion of an elliptical shutter 
design to mimic the standard, default k-space shutter available on most scanners (section 
2.2.2.1). Figure 3-1 shows an example of the k-space sampling mask for an acceleration 
factor of x5 (20% of samples acquired) and at x2 (50% of samples acquired). Each point (kx, 
ky) shown in white is sampled. Since the data acquired in k-space is in the form of a matrix 
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(kx ,ky ,kt) (section 2.2.2), the same mask is applied at each time point t in the k-space 
temporal dimension. 
 
Figure 3-1 - Typical random 2D k-space masks for 20% (x5) sampling a) and 50% (x2) sampling b). 
Each white square is a sampled location. The overall shape of the sampling is shaped by the k-space 
shutter. 
 
The ability to acquire real-time under-sampled MRSI datasets in this way is not yet available 
on the scanner. In order to mimic the random acquisition of such a dataset the following 
steps were taken: 
1) The real-time MRSI data acquired from the scanner after post processing, is in the 
form of 2D spatial co-ordinates x and y, and an FID of 1024 associated time points t 
(x,y,t). The number of x and y points depends on the acquired matrix or MRSI grid 
size. 
2) A 1D Fourier transform of the FID time data was achieved to obtain dataset (x,y,f). 
3)  This dataset (x,y,f)  was subject to a 3D Fourier transform to produce data (kx,ky,kt). 
This replicates the form in which the MRSI data is acquired. 
4) A single 2D k-space under-sampling mask as described above was then successively 
applied to the 3D MRSI data set at each temporal kt point. The (kx,ky) locations not 
sampled by the mask were zero filled in (kx,ky,kt). 
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3.3 The sparse representation of MRSI data 
The measured data needs to have a domain in which the data is sparsely represented (2.5.2). 
The particular sparse transform to utilise is an area of much research in the application of CS 
to MRI (CS-MRI), and is yet unproven. In the application of CS-MRI the sparse domains of the 
wavelet, Discrete Cosine Transform (DCT) and the identity transforms have been used 
(Lustig, Donoho et al. 2008; Haifeng, Dong et al. 2009). In previous work on CS-MRSI the 
wavelet transform has been utilised although this has not been proven as the optimal sparse 
MRSI domain. The spectra in the MRSI dataset (x,y,f) exhibit sparsity amidst the peaks 
surrounded by low level noise and for PRESS (section 2.2.1) the data in the image itself is 
sparse given that the useful data in VOI is much smaller than the whole FOV.  It was 
therefore initially decided to utilise the identity transform. The identity transform is 
inherently computationally faster and less complex than other sparsifiying transforms. This 
identity domain was later compared to the wavelet domain.  
 Wavelets 3.3.1
In this research wavelets were also investigated as a sparse domain representation of the 
MRSI data. If a signal possesses variation in frequency with time such as sharp spikes or 
discontinuities, then a Fourier Transform will not appropriately represent the frequencies 
present. The problem is such that it is not always possible to know the exact time-frequency 
representation of a signal due to the finite sampling of the signal. The problem results in the 
exact spectral component at a particular instance of time being undeterminable. What can 
be determined are the time intervals in which a band of frequencies may exist, a resolution 
problem. The use of techniques such as the Short Term Fourier Transform (STFT) may be 
utilised to determine the frequency-time relationship. The STFT segments, or windows the 
signal into intervals where it is assumed to be stationary, and non-varying in frequency with 
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time. The window width must be the same as the stationary portion under analysis.  The 
window starts at t=0 and is multiplied by the signal at this location and then Fourier 
Transformed. The window is then shifted along, the process repeated and the result 
summed. Unfortunately because of the finite width of the window function, the STFT is 
limited in its frequency resolution. It does not give the exact frequencies present in the 
signal, only a band. If a window of infinite length were used to enhance frequency resolution 
then this is identical to the original Fourier Transform. The use of wavelets is a better 
approximation than the STFT. Wavelet analysis is achieved in a similar way to the STFT 
except that the finite window called a wavelet varies in width according to each spectral 
component, and in that the Fourier Transform for each window is not taken. The wavelet is 
contracted for low frequency analysis and dilated for high frequency analysis. The degree to 
which the wavelet contracted or dilated is termed the scale. The initial wavelet used in the 
analysis is termed the ‘Mother Wavelet’ and is a prototype for each subsequent wavelet. 
The choice of mother wavelet can vary dependent upon application. There are different 
wavelet families such as Daubechies, Coiflets and symmlets which vary according to the 
number of coefficients and by the level of iteration. 
The original signal is represented in terms of wavelet expansion using coefficients in linear 
combination of each wavelet function. This therefore allows truncation of the wavelet 
coefficients lending itself to sparse representation. Since this study is examining the ability of 
CS to reconstruct metabolite edges, a step-like wavelet, the Daubechie 1 (Haar wavelet) was 
utilised as the mother wavelet for this application. 
3.4 Image Reconstruction in CS-MRSI 
In CS-MRSI a random k-space sampling pattern is defined 3.2. After acquisition of the 
random data there will be a sub-sample of measured data. In order to fill in the zeros, the 
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minimisation of the square error of the measured and the desired datasets via the following 
objective function are achieved:- 
‖𝑭𝒖𝒎 − 𝒚‖𝟐 <  𝝐 Equation 3-1 
Where: 
m = The desired reconstruction of the MRSI dataset (x,y,f). 
𝐹𝑢 = The Fourier Transform operator of the under-sampling scheme 
y = The sampled k-space data. 
𝝐 = a parameter to control the reconstruction quality, set to be below the level of expected 
noise. 
 
This is combined with the L1 norm of the transform sparsity requirement which can be 
expressed as:- 
‖𝚿𝒎‖ 𝟏 Equation 3-2 
Where: 
m = The desired reconstruction of the MRSI dataset (x,y,f). 
The sparsifying transform. 
The L1-norm is used to maintain the sparsity. This is because the L1 norm will favour fewer 
larger components and hence sparsity, whereas the L2-norm penalises large components, 
maintaining larger datasets of smaller values. The L-norm is expressed as: 
‖𝒙‖𝒑 = (∑ |𝒙𝒊|
𝒏
𝒊=𝟏 )
𝟏/𝒑  Equation 3-3 
The equations 3.2 and 3.3 are combined to express the problem mathematically as:
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𝑚𝑖𝑛𝑖𝑚𝑖𝑠𝑒 ‖Ψ𝑚‖ 1  
𝒔. 𝒕. ‖𝑭𝒖𝒎 − 𝒚‖𝟐 <  𝝐  Equation 3-4 
It has been shown that it is often useful to extend the problem to also include a term for the 
Total Variation (Tsaig and Donoho 2006). The finite differences transform may be used as a 
sparsifying transform. It is referred to as Total Variation, TV(m), and defines the sum of the 
absolute variation in all dimensions. This transform is defined mathematically for an N point 
signal x(n), 1≤ n≤ N as: 
𝑻𝑽(𝒙) = ∑ (𝐱(𝐧) − 𝐱(𝐧 − 𝟏))
𝑵
𝒏=𝟐
 Equation 3-5 
This can also be expressed in matrix form as: 
𝑻𝑽(𝒙) =  ‖𝑫𝒙‖𝟏   Equation 3-6 
Where 
D= matrix of size (n-1) x n of the form: 
(
       −1 1 0 0     ⋯                 0      
⋮    ⋱                 ⋮      
0    ⋯  0 0 − 1  1        
) 
This means that as well as requiring the imaging dataset to be sparse in the specific 
transform domain it is also to be sparse in finite differences which provides an effective 
smoothing of the image. The problem can now be expressed as: 
𝑚𝑖𝑛𝑖𝑚𝑖𝑠𝑒 ‖Ψ𝑚‖ 1 + TV(m) 
𝑠. 𝑡. ‖𝐹𝑢𝑚 − 𝑦‖2 <  𝜖 
Where: 
= weight which determines the importance of the TV term over the sparsifying transform 
In Lagrangian form this may be expressed as: 
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‖𝑭𝒖𝒎 − 𝒚‖𝟐 + 𝝀𝟏 ‖𝚿𝒎‖ 𝟏+𝝀𝟐  𝐓𝐕(𝐦) Equation 3-7 
Where:  
𝜆1= Sparsyfying transform weighting factor 
𝜆2= Weighting factor of TV transform 
The weighting factors 𝜆1and 𝜆2 is also a subject of research. They will be application 
dependent and balanced by the level of expected noise. In this study the values were 
empirically chosen to be 0.002 and 0.005 respectively with due consideration of (Geethanath 
2012; Heikal, Wachowicz et al. 2013). 
The above equation is solved using a non-linear iterative reconstruction technique. The 
iterative technique utilised in this research was conjugate gradient descent, the method 
already utilised in the sparse MRI package. 
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4 Phantom development for assessment of spatial resolution in 
MRSI  
4.1 Introduction 
Previous research on the application of CS in 2D phase-encoded MRSI (CS-MRSI) is limited 
and impact upon subsequent image quality relatively unexplored. A standard method to 
quantify the spatial resolution of MRSI regardless of reconstruction technique has yet to be 
developed.  
To date, only one fully quantitative investigation on the effect of CS-MRSI on spatial 
resolution has been found. The paper investigated the effect of CS on the spatial resolution 
of MRSI for one acceleration factor (section 3.2), x4 (Heikal, Wachowicz et al. 2013). Another 
very recent study examined the use of CS-MRSI on rat brains and on phantom studies at 7T, 
for acceleration factors up to x7 (Cao and Wu 2014) but was limited to qualitative 
assessment of spatial resolution. 
There is currently no known standard method of assessment of the spatial resolution of 
MRSI. A major issue in clinical MRSI is inter-voxel contamination from adjacent and distant 
(Gibbs ringing) voxels (2.3.1).  This is a major detriment to accurate spatial resolution since 
the signal from one voxel may add to or reduce signal in the location of another. Inter-voxel 
contamination may be exacerbated by under-sampled datasets where aliasing and/or loss of 
high spatial frequency data may result (section 2.5.1). After MRSI data has been under 
sampled and reconstructed using CS, methods of assessment of the inter-voxel 
contamination and spatial resolution are therefore desired. This chapter discusses the 
process of the development of a methodology to assess these effects.  
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The impulse response of an imaging system is the PSF (section 2.3.1). The Fourier transform 
of the PSF indicates which spatial frequencies are being transferred in the imaging system. In 
a perfect imaging system the impulse response would be a pure Dirac delta function. The 
Fourier transform of this infinite point source would yield a flat response indicating that all 
frequencies were equally present.  
The measurement of the PSF is complex since to obtain metabolite signal from an infinitely 
small voxel is impractical. However, the measurement of the signal profile perpendicular to a 
boundary of negligible width between regions of contrasting signal is technically less 
challenging. Such a measurement reveals the Edge Response Function (ERF)  (Samei, Flynn et 
al. 1998) . The differential of the ERF reveals the Line Spread Function (LSF). The LSF is 
effectively the one dimensional representation of the two dimensional PSF(Williams 1991). 
The Fourier transform of the LSF would therefore reveal the spatial frequencies present in 
the imaging system. 
Possible methodologies in the assessment of the spatial frequencies present in an image are 
described below. 
 Measurement of the gradient of the edge response 4.1.1
An indirect evaluation of the spatial resolution of an imaging system can be achieved by 
analysis of the ERF. From basic imaging theory, the higher the spatial frequencies present in 
an image the sharper will be the resulting image of an edge(Antoniou 2006). Therefore, the 
measurement of the maximum gradient of the image of an edge will provide an indirect 
measure of the spatial resolution of the system. 
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4.1.1.1 Modelling the ERF 
In MRSI an ‘edge’ would entail a well-defined boundary between regions containing 
different concentrations of a given metabolite or metabolites. Figure 4-1 shows a simple 
two-compartment model system containing a bi-directional edge between two different 
metabolite solutions. 
 
Figure 4-1 - Demonstration of an ideal metabolite edge. Metabolite 1 and metabolite 2 are adjacent 
to each other and ideally are separated by a negligibly thin, impermeable membrane. The red line is 
a profile across this edge used to determine the spatial resolution from its slope. 
 
4.1.1.2 Assessment of the ERF 
A profile of signal from voxels sampled at right angles to the edge (red line on Figure 4-1), 
will provide the edge response function. Voxel signal along the profile can be plotted against 
location. The slope or gradient of the plot will provide a quantitative indication of edge 
response and therefore an objective measure of spatial resolution. 
 Measurement of the Modulation Transfer Function (MTF) 4.1.2
The Modulation Transfer Function (MTF) is a widely used technique to describe the 
modulation of the spatial frequencies present in any imaging system. The MTF is the Fourier 
transform of the LSF (section 4.1). It has been used to evaluate a variety of medical imaging 
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systems techniques including x-ray, CT and MRI (Judy 1976; Fujita, Tsai et al. 1992; Steckner, 
Drost et al. 1994). It measures how faithfully the imaging system reproduces the details 
present in the object under investigation. The normalised MTF is a function of spatial 
frequency. The spatial frequency is conventionally expressed in units of line pairs per mm 
(lp/mm).  One line pair is defined as one black line and one white line of equal width and in 
the same orientation. The value of lp/mm at 50% and 10% of the maximum MTF are often 
used as indicators to quantify the maximum spatial resolution. 
The development of a phantom with a suitable metabolite edge was undertaken in the 
following sections: 
4.2 The Localisation Phantom. 
This pre-existing phantom was designed and developed for multicentre EU project 
(eTUMOUR) primarily for validating localisation of single voxel spectroscopy (Leach, Collins 
et al. 1995). The phantom contains metabolites Creatine (Cr) and Lactate (Lac) in a central 
perspex cube of wall thickness 3mm, and Acetate (Ac) in the remaining portion of the 
perspex cylinder Figure 4-2. This phantom therefore contains a metabolite spatial variation 
across the outer cylinder (containing the acetate) and the central cube (containing the 
Creatine and Lactate). Initially it was hoped that an acquisition and subsequent voxel profile 
plot across this region may indicate the required metabolite edge response.   
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 Method 4.2.1
The phantom data was acquired with parameters listed in Table 1. 
 
Table 1 Acquisition parameters  
A Spin Echo spectroscopic sequence was utilised with an initial voxel dimension of (10mm x 
10mm x10mm), Figure 4-3. An automatic shim volume was utilised. The Field of View (FOV) 
encompassed the whole test-object radius. Water suppression was excitation method.  
Scanner Philips 3T TX Achieva
Coil 8-channel Receive Head coil
TE(ms) 35
TR(ms) 2000
Bandwidth 2000
NSA 1
Ringing filter OFF
Sampled spectral points 1024
Figure 4-2- Photograph of the Localisation Phantom or PIQT phantom. The central 
cube contains metabolites Creatine and Lactate, and the outer cylinder Acetate. 
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 Results 4.2.2
The spectra were displayed using scanner software Figure 4-4. The figure indicates the peaks 
from the four voxels in the central perspex cube at a voxel dimension of (10mm x 10mm x 
10mm).  
 
 
Figure 4-3 -An axial MRI image of the localisation phantom and the MRSI grid (aligned 
to the central cube) for the 10x10x10mm voxels. The yellow square indicates a single 
voxel. The red grid is the Field of View (FOV). The black square at the centre is the 
Perspex cube containing the Creatine and Lactate metabolites. Four voxels were 
chosen which were the furthest away from the air bubble which can be seen in the 
top left hand corner. 
Figure 4-4 The individual spectra (magnitudes) for the 10mmx10mmx10mm are taken 
from within the central Perspex cube containing Creatine and Lactate. 
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Figure 4-4 indicates that the main Creatine peak at 3ppm, on the top left hand spectrum is 
relatively lower than on the other spectra. This may be due to the presence of the air 
bubble. The spectra on Figure 4-4 also indicate small peaks at around 2ppm, indicating that 
the acetate peak is contaminating through into all these voxels. There is a large broad peak 
at greater than 4ppm in the top left voxel corresponding to the location of the air bubble. 
This is the residual water peak, which is high and broad, indicating poor shimming in this 
area. The air bubble is creating a magnetic susceptibility artefact distorting the main 
magnetic field (section 2.2.3).  
 Discussion and conclusions 4.2.3
The localization phantom was a good starting point but the spectra Figure 4-4 indicate 
reasons why it is not an ideal test object for further spatial resolution assessment in MRSI. 
The air bubble formed within the central cube is causing a magnetic susceptibility artefact in 
this area as well as a reduction in metabolite concentration. The central cube has a Perspex 
thickness of (3mm), not a negligibly thin edge. If a phantom could be produced that had a 
perfect edge, with a boundary of negligible thickness, it would enhance the accuracy in the 
assessment of spatial resolution and so it was decided not to re-scan the localization 
phantom after attempting to remove the air bubble. 
4.3 Development of an Imaging Phantom to assess the ERF 
It was therefore decided to develop a phantom which addressed the problems of the 
localization phantom. Desirable features for this phantom would include a negligibly thin 
barrier between compartments containing different metabolite concentrations and 
uniformity of concentration within each compartment. The edge also needs to be flat and 
impermeable to metabolite penetration. The following sections describe the development of 
such a phantom. 
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4.4 Prototype metabolite edge phantom 
 Method - construction 4.4.1
This phantom consisted of a perspex box filled with tap water, containing a smaller perspex 
cup submerged at one end of it, Figure 4-5. The perspex cup contained a Creatine mixture. 
The challenge of how to manufacture a suitable metabolite edge was met by using a piece of 
latex stretched over the end of the cup. The latex would prevent penetration of one 
metabolite to the other, the tension in the glove would keep the glove flat and the latext 
when stretched would be very thin. The piece of latex was stretched and sealed around the 
open end of the cup with a strong elastic band. The Creatine mixture was a common form 
available from health food shops. It was mixed with tap water to produce an approximate 
concentration of 10mM. The cup was placed inside the larger container and maintained in 
position by means of an elastic band to keep it stable. A T1-weighted MRI, coronal image of 
the phantom can be seen in Figure 4-6. 
 
Figure 4-5-The prototype metabolite edge phantom schematic (Plan view). A Perspex cup 
containing Creatine was placed inside another larger Perspex sandwich box containing tap 
water. 
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Figure 4-6-A coronal T1-weighted MRI of the second metabolite Edge phantom. A Perspex 
cup containing a Creatine solution was submerged under water inside another larger 
perspex box. A latex glove was placed over the end of the Creatine containing cup to seal it. 
 Method – data acquisition 4.4.2
The phantom was not water tight at the top so it was placed in the coil such that its longest 
axis was parallel to the scanner’s central axis, perpendicular to Bo. The phantom data was 
acquired according to Table 1. Initially a single (15mm3) voxel PRESS acquisition was 
obtained from within the cup Figure 4-7 a). This was acquired in order to investigate if the 
peaks of Creatine were visible and as expected. 
The phantom was then imaged again using a spin echo MRSI sequence. Spin echo was 
utilised to avoid any chemical shift displacement artifact. The phantom was imaged in the 
sagittal plane to ensure the MRSI slab was across the metabolite edge and that it was central 
in the cup. The MRSI was acquired again according to Table 1, and voxel size of (10mm x 
10mm x 10mm). The matrix size was of 22x10, Figure 4-7 b). 
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Figure 4-7-The single voxel acquisition planning a) and the MRSI planning b).The yellow voxels 
indicate those selected across the metabolite edge. 
 Results 4.4.3
Figure 4-8 depicts the spectrum displayed using scanner software of the single voxel 
acquisition taken from within the inner cup. This shows peaks at 3ppm and 3.9ppm, the 
expected peaks of Creatine. The smaller peak at >4ppm are the suppressed, residual water 
peaks. 
 
Figure 4-8-The single MRS voxel spectrum indicating the peaks of Creatine and residual water 
at >4ppm. 
 57 
Figure 4-9 shows the spectra from the yellow voxels depicted on Figure 4-7 b). The top four 
rows are those voxels within the Creatine containing cup, and the bottom four are those 
within the water area. Voxel rows 2, 3 and 4 appear to contain the Creatine peaks along with 
the residual water at >4ppm. It can be seen that the height of the Creatine peak reduces as 
the voxel location is moved to the far end of the cup away from the latex. The MRSI signal is 
dropping off towards the edges of the phantom due to susceptibility artifacts at the air-
phantom interface, indicated by the increasing width of the residual water peak signal. It can 
also be seen that there are small peaks on the other side of the latex metabolite barrier, 
indicating a degree of inter-voxel contamination from the inherent point spread function in 
this low resolution (10x10x10mm) MRSI. 
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Figure 4-9-The spectra obtained from the MRSI voxels from the second metabolite edge ‘cup’ 
phantom. All graphs plotted on the same scale. 
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 Discussion and conclusions 4.4.4
This phantom was an improvement on the localisation phantom since it contained a thin 
barrier between the metabolite containing area and the water region. The expected 
metabolite peaks can be seen to be prevalent on the expected side of the latex partition 
Figure 4-9. It was concluded that there were two main issues with this phantom. The 
reduction in the signal intensity of the Creatine as the voxels become closer to the end of the 
Creatine cup indicate that shimming over the volume of the cup is a practical challenge. If a 
vessel of larger homogeneous volume were utilised for the Creatine this may help overcome 
this limitation. Secondly, the material from which this phantom is constructed is tap water 
with the addition of Creatine, not representative of human brain tissue. 
4.5 The two-compartment gel metabolite edge phantom 
To produce a phantom which has an negligibly thin metabolite edge, has dimensions enough 
to aid magnetic field uniformity, and constructed of a uniform material similar to human 
brain tissue, an agarose gel two-compartment phantom was developed. This will aid in the 
assessment of the resolution of acquired MRSI data sets and any subsequent reconstruction. 
The use of agarose gel has previously been employed in MRI phantom work(Yoshimura, Kato 
et al. 2003). The phantom contained water and agarose at 1% weight per volume which has 
a T2 of the order of bulk water in brain tissue at 3T (Child and Pryce 1972; Träber, Block et al. 
2004). Once set, the gel will keep its shape and so can be designed as an edge. 
 Method - construction 4.5.1
The phantom consisted of two halves each of 1 litre volume of 1% agarose gel and distilled 
water. Agarose was dissolved in a flask placed in a microwave at maximum power for 
8minutes. The gel was then covered with foil and placed on a magnetic stirrer to cool. 
Metabolites, Creatine (10mM) and NAA (10mM) were added to each flask of agarose at 
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37oC. One gel was poured into a Perspex container via a glass funnel, left to set, then the 
other gel added. The gels were separated by cling film to prevent any possible metabolite 
diffusion between the gels Figure 4-10. The cling film was smoothed by hand prior to the 
addition of the second gel to remove any air bubbles. 
 
 
Figure 4-10 The two-compartment gel edge response phantom 
 
 Method - MRSI Acquisition 4.5.2
Scanning of the two-compartment gel edge phantom was achieved the day after 
construction in order to eliminate any possible degradation of the test object over time. The 
phantom data was acquired according to Table 1. Coronal, Spin Echo spectroscopic MRSI 
scans were acquired with voxel size (10mm x 10mm x 10mm). The FOV encompassed the 
whole test-object radius. Square, water suppressing, saturation bands were used to define 
the VOI to avoid any magnetic susceptibility artifacts due to the indentations in the gel at the 
interfaces on the far right and left edges Figure 4-11. The water suppression method was the 
default excitation (section 2.2.4). In order to achieve an absolute quantification of 
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metabolite concentration, a separate MRSI was also acquired with the same parameters 
except the water data was unsuppressed. 
 
Figure 4-11-The MRSI planning of the two-compartment gel edge response phantom. The VOI is 
defined with the square water saturation bands in blue. 
 
 Method - data processing 4.5.3
A Matlab program version 7.10.0(2010a) was written to reconstruct spectroscopic data and 
produce plots of the integral of the metabolite peaks as a function of distance across the 
image. A flow diagram of the program can be seen Figure 4-12. The program reads in the 
spectroscopy DICOM file. Spectroscopy data from within the file is in a format of a vector of 
alternating real and imaginary numbers corresponding to the Free Induction decay (FID) 
(section 2.1.1). Each FID contains 1024 sampled time points. The Matlab software converts 
this 1D DICOM format to a 3D matrix containing an FID signal within each voxel location (x, y, 
t). The 1D time data is Fourier Transformed in the third dimension to produce spectroscopic 
data (x, y, f). The magnitude of the spectra is calculated to eliminate the need for phasing 
(section 2.4.3). A baseline correction was implemented by calculation of an average of the 
absolute signal from 8-12ppm of each spectrum and subtracting. The Creatine and NAA 
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peaks were integrated over the ranges 2.83-2.93ppm and 1.8-2.0ppm respectively for each 
voxel along a user chosen profile. 
 
Figure 4-12 Flow diagram of Matlab program to produce profile plot 
 
Metabolite signals were normalised to the unsuppressed water MRSI data to account for B1 
field inhomogeneity. The plots are normalised to the signal maximum. 
Line broadening (5Hz) was added (section 2.4.4) to aid quantification by improving the SNR. 
The real peaks were then integrated to produce the profile seen in Figure 4-15 c). 
 Method – metabolite uniformity analysis 4.5.4
To assess uniformity of metabolite concentration of the gels an experiment using single 
voxels placed around the phantom was carried out. Single voxel PRESS measurements were 
acquired according to Table 1. Water suppression was set to excitation and then also to 
CHESS for comparison. NSA=32. Another MRS acquisition was also acquired with 
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unsuppressed water to be utilised in absolute concentration calculation. Measurements 
were taken at locations indicated on Figure 4-13. The concentration of metabolite within the 
single voxel was calculated using TARQUIN software. The calculation employed a value of 
35880mM which is the water concentration of white matter, and a value of 0.7, the 
approximate ratio of exponential decay factors for average metabolite and white matter 
water T2, for short echo MRSI(Wilson 2011) .  
 
Figure 4-13 Single voxel locations indicating the concentration measurement locations within the 
two-compartment edge response phantom. The top half of the phantom is Creatine and the bottom 
half NAA. 
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 Results and discussion 4.5.5
The results of the single voxel concentration measurements can be seen in Table 2. 
Single Voxel Position as 
shown in Figure 4.13 
Metabolite Concentration 
(mM) (CHESS) 
Metabolite 
Concentration (mM) 
(Excitation) 
1 (Cr) 9.9 ± 0.1 10.4 ± 0.1 
2 (Cr) res. Water 8.2 ± 0.1 
3 (Cr) 9.7 ± 0.1 11.7 ± 0.1 
8 (Cr) 6.2 ± 0.1 11.9 ± 0.1 
9 (Cr) 8.8 ± 0.1 res. Water 
4 (NAA) 11.0 ± 0.1 11.3 ± 0.1 
5 (NAA) 10.7 ± 0.1 10.3 ± 0.08 
6 (NAA) 10.1 ± 0.1 10.2 ± 0.1 
7 (NAA) 10.4 ± 0.3 11.7 ± 0.7 
10 (NAA) 11.2 ± 0.3 10.6 ± 0.2 
Mean 10.2 10.7 
Standard Dev. 0.8 1.1 
Table 2 Concentration measurements from MRS of two-compartment gel phantom (10mM for each 
metabolite). The standard deviations as indicated in the brackets are estimates of the fitting error 
produced by TARQUIN. 
Table 2 shows the concentrations calculated using the TARQUIN software. The table shows 
values for acquisitions using both the excitation, and CHESS water suppression methods. The 
fitting of the Creatine was slightly impaired by the presence of residual water at positions 2 
and 8 for the CHESS method, and at 9 for the Excitation method. 
The concentration of Creatine in voxel 4 was noted as being 0mM. This indicated that no 
diffusion of Creatine had occurred into the NAA-half of the phantom at this time. The single 
voxel spectroscopy at the location of voxel 1 was additionally acquired with a correction for 
chemical shift displacement for Creatine. This was achieved in order to prevent the voxel 
being shifted into the NAA area and exciting it. The concentration of NAA in this voxel was 
also 0mM indicating no diffusion of NAA had occurred into the Creatine-half of the phantom 
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at this time. The MRSI spectra as displayed using the scanner software of the two-
compartment gel edge phantom can be seen Figure 4-14. 
 
Figure 4-14 The MRSI of the two-compartment gel edge phantom. The Spectra as depicted on the 
scanner for the voxels shown in yellow. All graphs are plotted on the same scale. 
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On examination of the spectra in this figure the MRSI acquisition of the edge phantom 
indicates that there is a substantial aspartate peak which is close to the main Creatine peak. 
This renders quantification of the Creatine peak problematic using the integration method. 
The profile of the 10x10x10mm voxel size can be seen Figure 4-15 a), b) and c). The dip 
towards the far edge of the NAA region Figure 4-15 a) is due to B1 drop off towards the front 
of the head coil. Therefore the data were normalized to the unsuppressed water peak Figure 
4-15 b). The addition of line broadening of the spectra (5Hz) was used to improve the 
quantification of the real data by reducing the noise(section 2.4.4), Figure 4-15 c). 
 
Figure 4-15 The NAA profile across the metabolite edge phantom a) with normalisation to the 
unsuppressed water b) and with the addition of line broadening c). 
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4.6 Conclusions  
The metabolite concentrations in Table 2 suggest that the two-compartment phantom is 
uniform within 10% using either water suppression method. The uniformity of the edge 
profile was improved along the centre of the phantom by normalising the data to the 
unsuppressed water data and by the application of line broadening to the post processing. 
There also appears to be no penetration of the barrier between the two metabolites at the 
time of acquisition. It was decided to integrate the NAA peak only in analysis to avoid any 
residual water affecting the baseline near the Creatine peak, and any overlap with the NAA 
aspartate peak. It was therefore concluded that this phantom could be utilised in the 
investigation of the effect of CS-MRSI on the spatial integrity of MRSI. 
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5 Investigation of spatial resolution in CS-MRSI with increasing 
acceleration factor 
This chapter investigates the possible negative effects on the spatial resolution of MRSI 
introduced by CS-MRSI, as the acceleration factor is increased. The two-compartment gel 
edge imaging phantom from (section 4.5) was utilised. The rationale for using this phantom 
was explained in section 4.1. The metabolite edge created by the two-compartment 
phantom allowed for the assessment of inter-voxel contamination across it (section 2.3.1). 
The datasets acquired from section (4.5.2) were utilised. The gradient of the profile of 
metabolite concentrations in each voxel across the metabolite edge provided a method of 
quantification of spatial resolution relative to that of the Fully Sampled Standard 
reconstruction (FSSR) MRSI dataset at each acceleration factor. 
To provide a method of assessment of spatial resolution in a realistic clinical scenario an in-
vivo acquisition was also undertaken.  
5.1 Application of CS-MRSI to two-compartment gel phantom 
 Method 5.1.1
The MRSI dataset acquired (section 4.5.2) was retrospectively under-sampled and 
reconstructed. The datasets were under-sampled using acceleration factors of x2, x2.5 x3.3 
x5 and x10. A set of 5 k-space masks (section 3.2) were generated for each individual 
acceleration factor. The same masks were utilised on the in-vivo and the phantom datasets 
for each acceleration factor. Each set of 5 masks had the same value of acceleration factor, 
sampling density, and the central fully sampled area with random sampling to allow 
assessment of inherent variability of the technique. The Software for CS reconstruction was 
developed in house using MATLAB (Version 2012b) (section 3). 
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In this study, the variable shutter technique (section 2.2.2.1) was also applied to 
retrospective datasets by using zero padding at the edges of k-space to vary the uniformly 
circularly, sampled centre. For the purposes of this research this was termed the low 
resolution reconstruction (LRR).  
For each MRSI reconstruction, a profile along the centre of the phantom perpendicular to 
the metabolite edge boundary was defined Figure 5-1 a). This central profile was used since 
the results of the uniformity measurement (section 4.5.4) indicated that this was where the 
phantom was most uniform. The normalized NAA intensity for each voxel was calculated and 
plotted Figure 5-1 (c-g). The maximum gradient of each plot of the profile perpendicular to 
the NAA metabolite edge was calculated. The mean and standard deviation of each gradient 
from five separate masks each of the same acceleration factor were calculated and plotted 
Figure 5-1 b). For all CS-MRSI reconstructed datasets the calculated gradients were plotted 
on the same graph as those calculated for the fully sampled standard reconstruction (FSSR), 
against acceleration factor. In order to assess the success of CS in maintaining spatial 
resolution, each CS-MRSI reconstruction and the resulting gradient of the edge was also 
plotted for the (LRR) against acceleration factor. The theoretical value for the spatial 
resolution for the LRR was also calculated as an additional means to assess the validity of the 
technique, blue triangles on Figure 5-1 b). This was based upon the expected relative 
resolution for a given LRR radius in k-space. For example at an LRR equivalent to x5 
acceleration factor, the resultant radius of the circle it defines in k-space is half the length of 
the radius of that for an acceleration factor of x1. Therefore half the spatial resolution is 
expected and plotted against a factor of x5. 
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 Results and discussion 5.1.2
Figure 5-1 b) is a plot of the maximum gradient perpendicular to the metabolite edge against 
acceleration factor.  
 
Figure 5-1- a) The MRSI planning of the phantom ( yellow line indicates the profile from which data 
was analysed) b) The average maximum gradient of each CS reconstruction of the phantom at each 
acceleration factor, for the LRR time equivalent (red) and the CS-MRSI (green) reconstructed 
datasets. The FSSR is shown as a blue circle. The theoretically calculated LRR is shown as blue 
triangles, c)-g) The Plots of the profile perpendicular to the metabolite boundary edge for NAA at 
each acceleration factor. Each plot shows the profile for the fully sampled dataset (blue), the CS-
MRSI reconstruction (green) and it’s LRR, time equivalent, uniformly sampled reconstruction (red). 
(The lines joining the plotted points are for display purposes only). 
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Figure 5-1 b) shows that the resolution is halved at an acceleration of x5 for both the LRR 
reconstructions and the theoretical equivalent (blue triangles). This is because the sampled 
k-space for LRR at this acceleration factor is equivalent to a circle with a radius of length 50% 
of the fully sampled k-space maximum. The theoretical values on this figure are in general 
good agreement with the measured LRR indicating the reliability of this phantom 
methodology as an implied in-direct measure of resolution. There is variation between the 
LRR and the theoretical value of a maximum of 5% at an acceleration of x10. The variation 
may be due to the assumption that the theoretical k-space sampling area of the LRR is a 
perfect circle. 
The measurement of the gradient perpendicular to the metabolite boundary is an indicator 
of the relative spatial resolution of the imaging system (section 4.1) and is directly related to 
the adjacent inter-voxel contamination (2.3.1). It can also be seen in Figure 5-1 b) that 
relative spatial resolution degrades with increasing acceleration factor for all 
reconstructions. The figure indicates that the rate of degradation is much lower in the CS-
MRSI than the LRR and that the CS-MRSI spatial resolution is consistently higher than the 
equivalent LRR. The spatial resolution from the CS-MRSI appears to remain constant up to an 
acceleration of x3.3 then drops off at x5 and x10 with much larger standard deviation. The 
results appear to indicate that in this phantom scenario utilising the identity transform with 
the chosen CS weighting factors (section 3.4) that CS-MRSI reliably maintains the spatial 
resolution to 87% ( ± 3%) of the resolution of the FSSR with approximately 70% time saving 
(x3.3 acceleration). The figure implies that there may be potential to further reduce scan 
time by a factor of x5 and even x10, which maintain spatial resolution to 78%( ± 14%) and 
64%( ± 14%) of FSSR respectively but these factors exhibit with much higher variation. This is 
compared with a relative resolution measurement of 50% and 41% with LRR for the 
equivalent scan time reductions. This can be attributed to the fact that the CS-MRSI samples 
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and estimates more of the higher spatial frequency data points which are then utilised in the 
CS reconstruction, whereas LRR are effectively low pass filters. These results are consistent 
with previous work showing that CS-MRSI does not produce a significant loss in in-vivo 
metabolite information (RMSE<0.05) for acceleration factors up to x5 (Furuyama 2012; 
Geethanath 2012).  
Figure 5-1 (c-g) shows each individual plot of the profile perpendicular to the metabolite 
boundary for the both reconstructions along with that of the FSSR and the LRR. The figure 
indicates that up to an acceleration factor of x5, the CS-MRSI profiles show a very similar 
edge response to the FSSR as indicated on Figure 5-1 b). Gibbs ringing at an interface is a 
common problem in MRSI (section 2.3.1), causing inter-voxel contamination at a distance. 
Figure 5-1 (c-g) shows a reduction in Gibbs ringing for the CS-MRSI reconstructions 
perpendicular to the phantom’s metabolite interface when compared to LRR. The effect of 
the variable density, random under sampling pattern utilised in the CS-MRSI (section 3.2) 
may aid in the reduction of the ringing artefact due to the incoherence in the resultant 
under sampling artefacts(Lustig, Donoho et al. 2008). 
A brain tumour may be focal in which it has a well-defined border between the diseased and 
healthy tissue, or it may have an ill-defined border where it has infiltrated into the 
surrounding healthy area. It is very important to be able to distinguish between these two 
disease states. Therefore, minimising inter-voxel contamination from adjacent and distant 
voxels is paramount for correct tumour boundary definition. The phantom results from the 
measurement of the maximum gradient of the metabolite edge Figure 5-1 b) imply that CS-
MRSI is able to retain the definition of the boundary edge possibly as well as 78%( ± 14%) at 
an acceleration factor of x5. The results of Figure 5-1 c-g) also imply that the inter-voxel 
contamination at a distance is reduced by the implementation of CS-MRSI at all acceleration 
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factors. Therefore it would appear that increasing the acceleration factor with CS-MRSI in 
this scenario will more accurately aid in determining if a tumour has infiltrated into healthy 
tissue or not. 
5.2 Application of CS-MRSI to in-vivo MRSI  
An attempt to investigate the effect of CS-MRSI on the MRSI spatial resolution in a realistic 
scenario was undertaken. The healthy human brain exhibits low spatial variation in 
metabolite signal. Ventricular CSF is a possible area of high metabolite signal contrast; 
however the ventricles have a complex geometry with irregular boundaries. Coupled with 
the inherent low resolution of MRSI it makes the assessment of in-vivo MRSI spatial 
resolution complex. In order to achieve a metabolite spatial variation an artificially 
suppressed region was introduced during acquisition. 
 Method 5.2.1
The volunteer data was acquired according to Table 1 except for a TE of 144 ms. A 2D MRSI 
spin-echo acquisition with a voxel size 10mm x 10mm x10mm,FOV 200mm x 200mm, 20x20 
matrix was also implemented. An axial slice through the centrum semiovale was scanned in 
the volunteer. In order to allow for a more accurate metabolite quantification and 
assignment, a longer TE was used in order to reduce any potential overlap of shorter T2 
metabolite signals with the NAA peak. 
A succession of outer-volume, fat saturation bands were applied around the edge of the 
scalp in order to reduce lipid contamination (section 2.2.5). In order to provide an area 
artificially subject to metabolite suppression, the MRSI data was acquired with the addition 
of two overlapping, 20mm wide, one water and one fat saturating bands applied sagitally 
through the centre of the two brain hemispheres as shown in Figure 5-2. 
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Figure 5-2  The MRSI planning for the volunteer acquisition. The application of the outer, circular lipid 
suppression bands can be seen in blue, and the central blue metabolite suppression band down the 
centre of the brain is also shown.  
The elliptical k-space shutter on the Philips 3T scanner is routinely applied in the clinic and so 
was utilised during the acquisitions (section 2.2.2.1). Prior to reconstruction the datasets 
were subject to the removal of residual water via the HSVD algorithm(Pijnappela 1992). 
The in-vivo MRSI dataset was under-sampled and reconstructed in the same way as the 
phantom dataset, utilising exactly the same k-space masks (section 5.1.1). 
Each in-vivo reconstruction was processed in TARQUIN (section 2.4.6) to provide metabolite 
quantification. The quantification was achieved within a specified volume of interest (VOI) of 
6x6 voxels chosen to be at least 1cm away from the outer volume lipid saturation bands in 
order to prevent any possible interference from them, indicated as the red box on Figure 
5-3.  
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Figure 5-3 The VOI in red utilised for the contrast measurement. The blue are fat saturation bands to 
eliminate lipid bleed through. 
 
 A profile through the centre of the VOI from the high signal area through the suppressed 
region to the high signal area on the other side was plotted for NAA, Choline and Creatine 
against voxel location, shown in yellow on Figure 5-4 a). Each metabolite profile was 
normalised to the maximum value. 
The mean contrast (mnC) from each of the five masks was calculated between the 
unsuppressed metabolite region (24 voxels), and the metabolite signal suppressed area (12 
voxels) from the VOI on Figure 5-3, according to the equation: 
mnC =(Sn-Ss)/(Sn+Ss)                                  Equation 5-1 
 
Where: 
Sn=Quantified signal from unsuppressed brain area. 
Ss=Quantified signal from metabolite suppressed brain area. 
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A normalised root mean square error (nRMSE) was calculated between the FSSR dataset and 
each reconstruction. The average for each of the five masks at each acceleration factor was 
calculated and compared to that calculated for the time equivalent, uniformly sampled LRR. 
 Results and Discussion  5.2.2
Figure 5-4 b) shows typical reconstructed NAA profiles from the area in yellow on Figure 5-4 
a), through the metabolite suppressed region for the LRR reconstructions and the FSSR 
dataset.  
 
Figure 5-4 -Typical profiles for NAA perpendicular to the boundary between normal brain and the 
metabolite suppressed area. The profiles shown are taken from the yellow voxels depicted in a). The 
profiles from the reconstructions of the equivalent time, LRR, uniformly sampled data and the fully 
sampled dataset are depicted in b). The LRR, time equivalent, uniformly sampled (blue); the full 
dataset (green), and the CS-MRSI (red) reconstructed profiles for x5 and x10 acceleration factors are 
depicted in c) and d) respectively. (The lines joining the plotted points are for display purposes only). 
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Figure 5-4 c) and d) show a typical NAA profile for the CS-MRSI reconstruction of the yellow 
profile, along with its equivalent LRR reconstruction, and that of the FSSR for acceleration 
factors of x5 and x10 respectively. There was no significant difference in the profile plots for 
Choline and Creatine relative to NAA. Figure 5-4 b) indicates that the LRR reconstructions 
produce a reliable edge response relative to the FSSR up to an acceleration factor of x5, but 
that the CS reconstruction Figure 5-4 c) is closer than the LRR to the FSSR dataset even at an 
acceleration of x10, within error. This also indicates that there is less adjacent voxel 
contamination from the CS-MRSI than that from the LRR at x10 acceleration factor only. This 
appears to be a different result to that found with the phantom Figure 5-1. It can also be 
seen that the value of the FSSR at profile position 6 is 60% less than at position 1. This could 
be due to chemical shift displacement artifact (section 2.3.3). 
Figure 5-5 a) is a plot of the mean contrast (mnC) at each acceleration factor after 
quantification with TARQUIN, between the areas of non-suppressed, healthy brain and the 
metabolite suppressed region, against acceleration factor for the CS-MRSI reconstruction 
and its uniformly sampled time equivalent LRR. The mean contrast should give an indication 
of the amount of inter-voxel contamination as a result of reconstruction. The figure indicates 
that the mean contrast is equivalent to the FSSR for both the LRR, time equivalent 
reconstructions, and the CS-MRSI, for acceleration factors up to x3.3 after which there is a 
significant degradation in mean contrast. The CS-MRSI contrast is significantly closer to that 
of the FSSR than that of the LRR at x5 and x10 acceleration factors. 
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Figure 5-5 Mean, normalised contrast from within and outside the metabolite supressed area for 
NAA against acceleration factor a). The signal to noise ratio (SNR) from the unsuppressed area, 
against acceleration factor b). The graphs shows results for the LRR, (red) and those reconstructed 
using compressed sensing (blue). 
 
The results from both figures imply that the in-vivo experiment is less sensitive to changes in 
spatial-resolution at low acceleration factors than the phantom experiment due to the 
imperfect profile of the suppression band and the resulting low spatial frequency variation 
produced by the suppression band. The discrepancy between the experiments may also be 
due to k-space filters applied to the raw data prior to reconstruction. The contrast is not 
much reduced for the LRR above x10 acceleration, Figure 5-4 b), making detection of 
improvements with CS-MRSI at low acceleration more difficult. This is reflected in the mean 
contrast results of Figure 5-5 a) which indicates contrast is equivalent for FSSR, LRR and the 
CS-MRSI, for acceleration factors up to x3.3. The contrast then reduces for both LRR and CS-
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MRSI reconstructions at x5 acceleration. In this in-vivo scenario the saturated region was 
equivalent to two voxels in thickness (50% reduction in nominal spatial resolution). This has 
implication for the use of CS-MRSI when applied to a clinical scenario where the lesion of 
interest is large relative to the voxel size. In such cases, this study implies 95% of the 
contrast of the FSSR may be retained for a reduction in scan time of 80% when using CS-
MRSI, Figure 5-5 a). The mean contrast results after reconstruction for Choline and Creatine 
indicated the same pattern as the NAA. 
Figure 5-5 b) shows the maximum signal to noise ratio (SNR) from the unsuppressed region 
against acceleration factor. This is calculated by the TARQUIN software and defined as the 
ratio between the maximum in the spectrum minus baseline divided by 2xRMS of the 
spectral noise level. The SNR of the FSSR is indicated at acceleration factor of 1. The SNR in 
all cases is higher than that of the FSSR, and the SNR of the CS-MRSI is higher than that of 
the LRR up to x10 acceleration factor.  
 Figure 5-6 shows Bland Altman plots for each metabolite quantified via TARQUIN, at each 
acceleration factor, for LRR and CS-MRSI reconstructions. The plots clearly indicate two 
groups of points for each metabolite, one inside and one outside the metabolite suppressed 
region. The standard deviation in the difference indicated by the dotted blue line on the 
figure gives an indication of the inter-voxel contamination which is larger for the LRR 
compared to the CS-MRSI at all acceleration factors. At an acceleration of x10 the CS-MRSI 
has a mean around zero unlike that of the LRR which is below zero indicating bleed-through 
in agreement with the result of Figure 5-4 c). 
 80 
 
Figure 5-6 Bland Altman plots for voxels located within the area indicated in red are shown for the 
volunteer study which contained a central area of saturated metabolites. Plots for NAA, Creatine and 
Choline metabolites for comparison of the fully sampled dataset with the LRR time equivalent 
reconstructions, and the CS-MRSI reconstructions at x2, x3, x5 and x10 acceleration factors are 
depicted. 
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Figure 5-7 shows typical spectra from the region indicated in red on the figure. This 
demonstrates the large voxel bleed through from the LRR, x10 time equivalent 
reconstruction compared to that of the CS-MRSI reconstruction. The spectra appear 
smoother for both the CS-MRSI and the LRR with increasing acceleration factor, which may 
explain why the SNR is higher for both than that of the FSSR in Figure 5-5 b). The smoothing 
of the spectra with increasing acceleration factor was also noted by (Geethanath 2012) and 
potentially attributed to the contribution of the Total Variation (TV) term in the CS 
reconstruction. There appears to be some inter-voxel contamination at 2ppm within the 
saturated region for the FSSR Figure 5-7 b). This may possibly indicate that CS-MRSI has 
limitations in reproducing low signals as it is not present on the CS-MRSI spectra or more 
likely it could be inter-voxel contamination which is present in the non-filtered FSSR.  There 
is however some baseline distortion at this location which could indicate that the TARQUIN 
software was producing a phase distortion. 
Results indicate that in both scenarios reconstruction with CS-MRSI maintains a higher 
spatial resolution than that of the LRR as acceleration factor is increased. A recent study has 
explored the effect of CS-MRSI reconstruction on the Modulation Transfer Function (MTF) of 
retrospective phantom data(Heikal, Wachowicz et al. 2013). It compared the MTF after 
reconstruction with that of the FSSR, and with a time equivalent, LRR at an acceleration 
factor of x4. It determined that for x4 acceleration the CS-MRSI reconstruction was able to 
maintain greater spatial frequencies than the LRR at 0.1MTF, with an average loss in spatial 
resolution of 32.4% (1.25 lp/cm), compared to 48.6% (0.95 lp/cm) for LRR. In this study 
examination of the graph in Figure 5-1 b) shows a resolution loss due to CS reconstruction at 
an acceleration factor of x4 is near 20% and for LRR 45% which is comparable to the previous 
work. Although the Modulation Transfer Function (MTF) has not been explicitly calculated, a 
method to assess the voxel bleed through is of specific clinical relevance. 
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Figure 5-7 Spectra from each voxel from the region indicated in red a) for the FSSR b) , x2.5 c) , x5 d) 
and x10 e). The spectra for the time equivalent LRR reconstructions are also shown for a time 
equivalent factor of x10 f). All graphs plotted at the same scale (a.u). 
 
5.3 Conclusion 
This chapter demonstrates a practical methodology to assess MRSI spatial integrity after 
retrospective reconstruction of both phantom and in-vivo datasets. This allowed 
investigation into the limits of scan time reduction using CS. Spatial resolution in MRSI is 
linked to inter-voxel contamination (section 2.3.1). Reduction of inter-voxel contamination is 
of paramount importance in correctly distinguishing between focal tumours and those which 
have infiltrated into healthy tissue.  The phantom provided a practical means to assess 
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adjacent voxel contamination by means of the maximum gradient of the perpendicular 
metabolite edge. The phantom also provided a means of assessment of distant inter-voxel 
contamination by assessment of the Gibbs ringing at the edge. 
The two-compartment gel edge phantom indicates good agreement with the theoretical 
values Figure 5-1 b) implying that the phantom methodology for measuring the spatial 
resolution is valid and directly proportional to the Edge Spread function (ERF). It also shows 
that there is a reduction in spatial resolution with increasing acceleration factor as expected. 
This figure demonstrates that the spatial resolution of CS-MRSI is consistently above that of 
the LRR however, and is maintained at 87% ( ± 3%) of the resolution of the FSSR with 
approximately 70% time saving (x3.3 acceleration), Figure 5-1 b).  This implies that inter-
voxel contamination of the adjacent voxels is reduced in CS-MRSI. The results of Figure 5-1 c-
g) indicate reduced ringing artefact from CS-MRSI as compared to the LRR. This implies less 
inter-voxel contamination from distant voxels.  
The assessment of the in-vivo contrast provided a means of assessment of the inter-voxel 
contamination in a more realistic clinical scenario. The results indicated that the contrast 
remains consistent up to a factor of x3.3 but degrades with increasing acceleration factor 
after this; Figure 5-5 a). The in-vivo methodology appears to only be sensitive to losses in 
spatial resolution of more than 50%. 
The signal to noise ratios indicated on Figure 5-5 b) show that the CS-MRSI maintains a 
consistent SNR above that of the FSSR at all acceleration factors, and an SNR higher than the 
LRR up to a factor of x10. The LRR has a higher SNR at x10 acceleration factor but Figure 5-7 
f) indicates that there is more inter-voxel contamination into the unsaturated region at this 
factor. The consistency in the SNR for the CS-MRSI is a reflection of the smoothing property 
of compressed sensing (Lustig, Donoho et al. 2007; Geethanath 2012).  
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The Bland Altman plots for the in-vivo dataset Figure 5-6 show that the CS-MRSI has a 
consistently reduced standard deviation as compared to the equivalent LRR. Some of the 
plotted points for Choline are above the level of one standard deviation for CS-MRSI at 
acceleration factors of x5 and x10. This may have implication for the use of CS-MRSI for the 
investigation of metabolites with lower concentrations such as my-inositol. This reduction in 
perceived concentration may be as a result of the applied weighting of the TV transform 
which warrants further investigation. 
The reduction in inter-voxel contamination (section 2.3.1) as a result of CS-MRSI for the in-
vivo datasets as compared to LRR at x10 acceleration is visible on the typical spectra 
obtained from the region highlighted in red on Figure 5-7.  
In this work, both phantom and in-vivo results indicate an increase in standard deviation for 
repeated reconstructions as acceleration is increased beyond x3.3. This is likely to be due to 
the very high under-sampling requirement at these acceleration factors and the resulting 
lack of true measured data (Barker and Ernst 2013). The maximum gradient measurements 
were also only based on two data points in the edge response profile. The performance and 
reliability of CS-MRSI at higher acceleration factors is therefore likely to be improved for 
higher spatial resolution datasets with larger matrix sizes.  
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6 Development of digital phantoms for simulating high-resolution 
CS-MRSI 
The objective of this chapter was to provide a means to produce datasets which overcome 
the high sampling requirements at high acceleration factors (section 5.3), to provide a more 
realistic scenario, better statistics and to overcome the problems incurred during real-time 
MRSI acquisition. The measured ERF in the previous chapter only contained 2 data points, 
therefore increasing this will aid in the accuracy of the assessment. 
The objective can most easily be achieved by creating software simulated, higher MRSI 
matrix size datasets (digital phantom). A typical MRSI scan takes between 5-10 minutes to 
acquire. Given that a patient will undergo several MRI scans during one appointment; this is 
prohibitive in terms of time and cost. Even with an adult volunteer there is still potential for 
movement artefacts in that time frame. The creation of software simulations of MRSI data 
can also be designed to provide datasets at a desired resolution, and permit controlled 
analysis of the effects of different reconstruction techniques in MRSI under very controlled 
conditions. Such conditions would include magnetic field strength, SNR, lipid contamination, 
and the addition of features in the MRSI dataset such as tumour spectra and anatomical 
features of particular shape and dimension. Software simulated MRSI data is not subject to 
the challenges often encountered during acquisition (section 2.3). An MRSI software 
simulation system was therefore developed in Matlab version 2012b. 
6.1 Design and development of a digital brain metabolite phantom 
 Anatomical template 6.1.1
A 2D axial, T1-weighted, anatomical MRI image from a 1.5T scanner was utilised in the 
simulation phantom as a template for the anatomy. The image had a 256mmx208mm FOV, 
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with a pixel size of 1mm x 1mm and slice width of 5mm. A 1.5T image rather than 3T image 
was used since the greyscale levels are more consistent across the image at this field 
strength being less subject to field inhomogeneity. Initially a python script was written to 
remove the outer background of the image to crop the 2D image FOV to 200x160mm Figure 
6-1. 
 
Figure 6-1 -Reduction in the Field of View of the anatomical 1.5T MRI image 
 
The croppped MRI image was then read into the Matlab program where it was segmented 
by thresholding greyscale level to reveal the different anatomical structures of white matter, 
grey matter and Cerebral Spinal Fluid (CSF). These can be seen Figure 6-2. Other techniques 
such as the use of an Atlas can also be utilised to achieve this but the figure indicates that 
this method was adequate for this purpose. 
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Figure 6-2 Images of the segmented anatomical MRI. The white pixels indicate the different 
anatomical structures within the brain of grey matter, white matter, lipid and CSF. 
 
 Spectral composition  6.1.2
The spectra used in the simulations were from the basis sets previously developed for 
TARQUIN (section 2.4.6). Basis sets are model spectra of the metabolites present in a healthy 
human brain based on work by (Govindaraju, Young et al. 2000; Wilson, Reynolds et al. 
2011). A basis set consists of a series of complex numbers, each set  represents a spectrum 
appropriate for a particular field strength and echo time(Wilson, Reynolds et al. 2011). The 
basis sets are utilised in TARQUIN for comparison with the NMR spectra obtained from each 
voxel in clinical MRSI. TARQUIN then automatically quantifies the metabolites detected 
within each of the voxels. 
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Figure 6-3 The outline of the process for the creation of the simulated MRSI data. Grey and white 
matter are assigned concentrations according with (Pouwels and Frahm 1998). 
 
For the simulations, each metabolite peak from the appropriate TARQUIN basis set was 
weighted according to the expected concentration for its anatomical location. The 
assignment of the peak weightings for grey and white matter spectra were based upon the 
concentrations given in (Pouwels and Frahm 1998). CSF produces negligible metabolite NMR 
signal so was therefore assigned either zero or a user defined noise level. The process is 
outlined in Figure 6-3. 
Line broadening was applied to each voxel’s FID by multiplying it with a mixture of a time 
domain Lorentzian and Gaussian (Voigt profile) damping functions, Equation 6-1. The 
Lorentzian damping is required to account for small changes in the T2 value, shimming and 
in the chemical environment of the resonant molecules. The Gaussian term is included in 
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TARQUIN to provide modelling of imperfect shimming and susceptibility variations which 
lead to T2* effects (Wilson, Reynolds et al. 2011).The values of and in the equation are 
given by TARQUIN after quantification of MRSI data. The values utilised in the simulations 
were based on average values obtained after examination of existing 3T MRSI datasets. 
These were values of 1.5  and =500. 
𝐁(𝐭) = 𝐛(𝐭)𝐞−𝛂𝐭. 𝐞(−𝛃𝐭
𝟐)     Equation 6-1           
Where: 
= Lorentzian damping constant
= Gaussian damping constant
b(t)= metabolite FID from basis set. 
B(t) = metabolite FID subjected to line broadening 
t= time 
The pixel greyscale determines if it is white matter, grey matter, CSF or lipid.  Each pixel from 
the cropped FOV image Figure 6-1 was assigned an appropriate NMR spectrum which is 
dependent upon the pixel’s greyscale level. Random Gaussian noise was added to each 
spectrum. This was achieved using a Matlab function to produce random values drawn from 
the standard normal distribution, and then scaled to the desired SNR. 
 Digital brain metabolite phantom construction 6.1.3
The software simulation produces an MRSI dataset of (x,y,f) where x and y are the pixel or 
voxel location, and f is the frequency spectrum. After application of the MRSI spectral data 
to each pixel (section 6.1.2), at this stage, the dataset has a voxel size of 1mm x1mm x5mm. 
This is currently not a realistic spatial resolution for MRSI. The simulated MRSI dataset is 
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altered to a more realistic voxel size by applying a 3D Fourier transform of the dataset into k-
space (section 2.2.2), and truncating the maximum 2D k-space (kxmax, kymax) dimension down 
to the required maximum spatial frequency to produce the desired voxel dimension Figure 
6-4. After inverse 3D Fourier transform back to real space, the reduction in maximum spatial 
frequency (kxmax, kymax) produces a corresponding increase in voxel size. This has the effect 
of simulating the appropriate mix of grey and white matter spectra according to inter-voxel 
contamination (section 2.3.1) at this spatial resolution. 
 
Figure 6-4 Diagram of how the voxel size is adjusted by reducing the k-space dimensions. 
 
The effect of the reduction in voxel size can be seen in Figure 6-5. The images to the right of 
this figure are the absolute sum of the metabolite data in f, which shows the total effective 
NMR signal. This gives a representation of the effect of the change in voxel dimension. As 
expected the image becomes less resolved and the spectra on the left of this diagram are 
smoother. This is because part of the higher frequency data present at the edge of k-space 
 91 
has been removed by the k-space reduction process, which effectively acts as a low pass 
filter. 
 
Figure 6-5 Diagram showing the effect of the increase in voxel size produced by the reduction of k-
space dimensions. The spectra become less noisy and the image of the sum of the metabolite data 
becomes less resolved. 
 
6.2 Validation of the digital phantom methodology 
 Method 6.2.1
In order to ensure that the simulation process produced as realistic an MRSI dataset as 
possible a simulation of the MRSI profile of the metabolite edge phantom (section 4.5) was 
created. This simulation could then be compared to that of the profile obtained from the 
phantom acquisition. Despite efforts to be realistically relevant, it is extremely difficult to 
manufacture a physical imaging phantom with the same spin environment as human brain 
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tissue. A physical phantom is subject to different temperature, pH, T2 and water and 
metabolite concentrations to that of healthy brain tissue. Since the physical phantom 
spectra are non-identical to healthy brain spectra the basis set NAA peaks for the brain were 
not implemented in the digital simulation of the two gel metabolite edge phantom. Instead 
an artificially derived NAA peak was created mathematically by approximating a Lorenzian 
FID and multiplying this by a Gaussian, as in Equation 6-1, to provide NAA frequency 
spectrum peaks that matched those of the phantom. 
The FID was then subject to a 1D Fourier transform to produce an NMR peak in the 
frequency domain shown Figure 6-6 a). Random Gaussian noise was added to the spectrum 
using the technique described in section 6.1.2, at an equivalent SNR to the two-
compartment gel edge phantom. The same profile across the metabolite edge in both the 
simulated and the two-compartment gel edge phantom was taken as shown in Figure 5-1 a). 
The simulated and original phantom peaks are displayed perpendicular to the edge profile in 
Figure 6-6. 
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Figure 6-6  Diagram indicating the original edge phantom peaks and the simulated peaks a) 
perpendicular to the metabolite profile edge b) 
 
The initial simulation consisted of a matrix size of 200x200 and a voxel size of 1mm x1mm 
x1mm. The acquired edge phantom voxel size was 10mm x10mm x10mm with a FOV of 200 
x 200mm. Therefore, the original acquired matrix size of the phantom was 20x20. The 
simulated dataset was reduced to a 20x20 matrix size to match the phantom, and therefore 
a 10mm x10mm x10mm voxel size via the technique discussed in (section 6.1.3). This 
increased the voxel dimension and reduced the matrix size for the same FOV, Figure 6-7. 
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Figure 6-7 The full 200x200 matrix size simulation reduced down to a 20x20 matrix size, equivalent to 
the acquired edge phantom matrix size. 
The edge phantom and simulated phantom data were subject to the same post processing 
as described in section 4.5.3. The simulated dataset did not contain an unsuppressed water 
peak so normalisation to this was not necessary. 
 Results and discussion 6.2.2
The resultant profiles of the integrated NAA peak perpendicular to the original edge 
phantom and the simulated edge can be seen in Figure 6-8. The profile perpendicular to the 
edge for both full datasets can be seen in Figure 6-8 a) and for an LRR reconstruction of 50% 
of the data samples in Figure 6-8 b). The nRMSE between the simulated and the original 
profile for the full dataset was 4%, and for the LRR reconstructed datasets was 3.87%.  
The main difference between the two-gel edge phantom and the simulation was that the 
NAA spectra from the two-compartment gel edge phantom were created artificially in the 
digital phantom as discussed (section 6.2). The phantom is also subject to field 
inhomogeneity and potential baseline distortion from residual water. Despite these 
differences the resulting nRMSE above gives confidence in the methodology of the 
simulation technique. 
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Figure 6-8 Profiles perpendicular to the original two-compartment metabolite edge phantom and the 
simulated edge phantom for the full data set a) and an LRR reconstruction of 50% of the data 
samples b). 
  
6.3 Simulations for improved measurement of the edge response in CS-MRSI 
In order to produce a quantitative measure of the effect of CS on the MRSI spatial resolution, 
the two-compartment metabolite edge phantom can be used (section 4.1.1.) to investigate 
the ERF. When using this phantom for the spatial resolution investigation it was found that 
the standard deviation of the mean at higher acceleration factors (x5 and x10) was increased 
relative to factors below these (section 5.3). The two-compartment metabolite phantom 
methodology only provided an edge gradient containing 2 data points which may confound 
this result. The measurement of a profile across an angled edge is a well-established 
technique which provides a more highly sampled ERF than that from a perpendicular profile 
(Judy 1976). The measurement of an angled edge on a real-time acquired phantom presents 
 96 
practical challenges. The digital phantom simulation was therefore adapted to provide a 
metabolite angled edge. The digital phantom permits investigation of the effect of CS on the 
MRSI spatial resolution as acceleration factor is increased. The digital phantom contained 2D 
phase encoded MRSI simulated datasets containing high matrix size, and reduced voxel 
dimensions, without the need for lengthy real-time acquisition.  
 Method 6.3.1
An edge was defined as the line between those pixels containing 100% metabolite signal and 
those containing 20% metabolite signal. A line was drawn at an angle of 11o Figure 6-9. The 
voxels to the left of the line contained 100% metabolite concentration and those to the right 
of the line 20% of the metabolite concentration.  
 
Figure 6-9 Schematic of the simulated edge 
An angled edge was chosen because this effectively allows more data points to be measured 
along the edge response function. This is a technique widely used in medical physics 
applications to measure the resolution of a medical imaging device (Judy 1976). It can be 
seen in Figure 6-10 that pixels 1 and 2 have a relative distance dx from the angled edge. The 
distance dx is given by: 
dx = p sin 11o  Equation 6-2 
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Where: 
p=pixel spacing 
 
 
Figure 6-10 Diagram demonstrating the relative distance dx, of pixel 1 and pixel 2 from the angled 
edge. 
 
The equivalent pixel thickness of the angled line is unknown. Therefore the edge’s width was 
defined by calculating the proportion of the area of the pixel to the left of the dashed line 
Figure 6-11. This area is therefore directly related to the percentage of metabolite 
concentration to assign to that pixel. The area was calculated as follows. The pixels cut by 
the line were divided into rectangles and/or triangles as can be seen on the figure. Each 
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shape’s area was calculated and compared to the area of a full pixel to determine the 
proportion of area to the left of the line. A Matlab program was written to calculate this.  
 
Figure 6-11-Diagram illustrating how the pixel edge thickness was defined. The pixels cut by the line 
were divided into rectangles and triangles, the area of such pixels then calculated, and the 
proportion used to calculate the percentage of metabolite contained to the left of the line. 
 
A spectrum from the TARQUIN basis set was assigned to each pixel. At this stage the pixel or 
voxel size is 1mm x 1mm and depth of 5mm. The basis set was appropriate to the chosen 
field strength. The complete pixels to the left of the line Figure 6-11 were assigned 100% of 
the signal and those to the right were assigned 20%. The lower concentration value was 
utilised in order to be able to investigate negative concentration levels created by Gibbs 
ringing at the edge (section 2.3.1). The other 0o edges and the remaining 90o edge of the 
phantom were graduated so that there was a gradual fall-off in metabolite signal from 100-
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20% in steps of 20%. The reason for this was to prevent any potential aliasing artefact from a 
high contrast area. The phantom voxel or pixel size was then increased to 5mm x 5mm 
x5mm using the method described in (section 6.1.3). The simulated edge phantom at this 
voxel size is depicted in Figure 6-12. 
 
Figure 6-12 Simulated metabolite edge phantom at a voxel size of 5x5x5mm. Voxels highlighted in 
black across the edge were chosen for quantification. 
 
The area of highlighted voxels across the edge depicted in Figure 6-12 were chosen for 
quantification by TARQUIN. TARQUIN provides a value of a metabolite’s concentration for 
each of the voxels shown. The output from TARQUIN is in the form of an excel spreadsheet.  
All profile distances were calculated using the formulae of Equation 6-2. 
The digital metabolite edge phantom was created with a fully sampled dataset subject to an 
elliptical k-space shutter (section 2.2.2). Two FSSR datasets were compared, one with, and 
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one without added k-space filtration. A standard hamming filter was applied to one of the 
datasets (section 2.3.1). It is expected that the filtered (smoothed) version should exhibit 
less inter-voxel contamination at a distance than the non-filtered version but at the cost of 
adjacent inter-voxel contamination and high spatial frequency (section 2.3.1). 
 Results and discussion 6.3.2
A plot of the NAA profiles of the fully sampled non-filtered and filtered datasets are depicted 
Figure 6-13. It can be seen that as expected the non-filtered profile has a sharper edge 
gradient than that of the filtered profile. This indicates that it exhibits higher spatial 
frequency content, however it suffers from the Gibbs ringing (section 2.3.1) not present on 
the filtered version.  
 
Figure 6-13- NAA profiles across the simulated metabolite edge phantom for the FSSR filtered and 
non-filtered datasets.  
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6.4 Conclusion 
The use of software simulated 2D phase encoded MRSI is of great benefit to this 
investigation since it allows the reconstruction of high spatial resolution, high matrix size 
MRSI datasets without lengthy acquisition duration. The simulations are also not subject to 
the potential artifacts which pose a challenge when MRSI data is acquired in real-time 
(section 2.3). The validation of the simulation technique by its application to the simulation 
of the two-compartment gel edge phantom MRSI indicated that the software simulation 
produced an edge response within 4% of that of the two-compartment gel edge phantom 
real-time acquisition dataset. 
The application of the software simulation of an angled metabolite edge was created and 
NAA profiles across the edge were measured to provide the ERF. The non-filtered MRSI 
dataset exhibited a steeper edge response implying higher spatial resolution and prominent 
Gibbs ringing Figure 6-13. The Filtered dataset exhibited no Gibbs ringing but was of lower 
spatial resolution having a slope of lower gradient. This was as expected (section 2.3.1).   
As well as the effect of CS-MRSI on adjacent inter-voxel contamination provided by 
examination of the maximum gradient of the ERF, the non-filtered angled edge simulated 
dataset also permits investigation of inter-voxel contamination by examination of the Gibbs 
ringing after CS-MRSI reconstruction with increasing acceleration factor. The non-filtered 
angled edge MRSI dataset was therefore suitable for high matrix retrospective MRSI 
reconstruction. 
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7 Simulations of the effect of CS on MRSI at High Spatial 
Resolution 
The methodology outlined in (section 4.1.1) to provide a means of quantifying the relative 
spatial resolution in MRSI was successfully applied to a two-compartment gel imaging 
phantom in Chapter 5. The chapter described measurement of the maximum gradient of a 
profile perpendicular to a boundary between areas of low and high metabolite 
concentration. One of the results from this chapter showed a high standard deviation 
(section 5.1.2) at low sampling values (x5 and x10 acceleration factors). This may be due to 
the fact that the gradient calculation was based upon the measurement of two data points 
only, limiting the statistics. The number of data points was governed by the MRSI matrix size 
used in the previous analysis of (20 x 20).  Also, the unrealistically sparse spectrum produced 
by the two-compartment gel phantom may also affect the results of CS-MRSI. CS may 
produce more consistent results at higher acceleration factors when applied to MRSI at 
higher spatial resolution (larger matrix size for the equivalent FOV). 
Real-time acquisition of MRSI at this higher resolution is currently prohibited by scan time, 
so the application of the simulated digital edge phantom as described in section 6.3 was 
utilised to further investigate the effect of CS-MRSI on the relative spatial resolution. This 
would allow investigation of any potential smoothing, blurring, inter-voxel contamination 
and/or aliasing as a result of this technique. Smoothing may occur due to the fact that the k-
space mask (section 3.2) has fewer data points at the outer edges which may reduce noise. 
Smoothing may result however at the expense of spatial resolution (adjacent inter-voxel 
contamination). Aliasing (inter-voxel contamination at a distance) may be an issue due to the 
fact that the data is under-sampled (section 2.5.1). The data is randomly under-sampled in k-
space so theoretically the artifacts should destructively interfere(Lustig, Donoho et al. 2008). 
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Spatial resolution in medical imaging systems is often quantified by means of the 
Modulation Transfer function (MTF) (section 4.1.2) a methodology for its measurement was 
also investigated using the same simulated digital edge phantom.  
7.1 Gradient of the Edge Response Measurement 
 Method  7.1.1
The simulated metabolite edge digital phantom described in section 6.3 was utilised in this 
analysis. In summary this contained a sharp 110 angled metabolite edge. The angle was 
relative to the perpendicular of MRSI matrix. The relative concentration of the metabolites 
was 1:5 on either side of the edge. The dataset had a FOV of 200mm x 160mm with a matrix 
size (40 x 32).The non-filtered MRSI (FSSR) dataset was subject to reconstruction by CS at 
acceleration factors of x2, x3.3, x4, x5 and x10. This was achieved on a simulated software 
phantom created using TARQUIN basis sets for 3T MRSI section 6.3. The experiments were 
achieved with and without noise. Random, Gaussian noise was added to the noise-free 
simulation to give an SNR of 10 which is a realistic clinical value. Reconstruction was also 
achieved with and without noise for the time equivalent, uniformly sampled low resolution 
(LRR) datasets. 
The compressed sensing was implemented as described in Chapter 3. The CS reconstruction 
was achieved using the Identity and also the wavelet transforms. The Daubechie wavelet 1 
was utilised with level 2. This wavelet is also known as the Haar wavelet and looks like a step 
function, therefore appropriate for this application. Level 2 has been successfully 
implemented in other studies(Geethanath and Kodibagkar 2013). The CS reconstruction was 
achieved by under-sampling the non-filtered FSSR dataset with three different k-space 
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masks for each acceleration factor. This resulted in three CS reconstructions for each factor. 
Every reconstruction was then quantified using the TARQUIN software to provide a measure 
of the relative concentrations of each metabolite. 
TARQUIN provides the quantified output of the metabolites within a metabolite spectrum in 
a csv file which can be read into an Excel spreadsheet. Profile plots from the TARQUIN 
output from across the simulated metabolite boundary were calculated (Section 6.3.1). This 
was achieved for NAA which has the largest peak in the spectrum, and for Choline to 
compare the results with another metabolite of lower peak height in a healthy human brain. 
Three profiles were created for each acceleration factor, and a maximum gradient of the 
NAA calculated for each.  The gradient was calculated using linear regression on 9 points 
either side of the centre of the slope. The square of the Pearson product moment 
correlation (R2) for the NAA noise free slopes averaged at 99%. The lowest value was 97%.  
The NAA with SNR10 had an average R2 of 90%, with the lowest value being 85%. For Choline 
the noise free linear regression had an average R2 of 97%, with a minimum of 93%. The 
Choline in the presence of noise SNR 10 had an R2 of 75%, with the lowest value of 71%. The 
presence of noise makes it harder to fit the straight line but with a minimum of 71% for all 
fitting, this is still a good fit. 
A mean and standard deviation of the maximum gradient of the three masks were plotted 
for each acceleration factor along with the FSSR (filtered), FSSR (non-filtered) and the LRR for 
each acceleration factor. The results for the gradient of the slope were normalised to that of 
the non-filtered value to provide a relative spatial resolution measurement. 
 Results  7.1.2
Typical examples of the profiles across the simulated metabolite edge for NAA can be seen 
Figure 7-1. These plots show the profile for the FSSR ( filtered and non-filtered datasets), the 
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LRR, the CS-MRI (Identity) and the CS-MRSI (wavelet) for each acceleration factor x2, x3.3, 
x4, x5 and x10 a) to e). 
 
Figure 7-1 Plots of the NAA profiles across the simulated NAA edge (3T) at acceleration factors of a) 
x2, b) x3.3, c) x4, d)x5 and e) x10. Each plot shows the non-filtered FSSR, the filtered FSSR, CS-
MRSI(identity) , CS-MRSI(wavelet), and the LRR. 
 
 It can be seen that the Gibbs ringing prevalent in the non-filtered FSSR is clearly removed 
with the CS-MRSI up to a factor of x5. The plots also clearly indicate that the CS-MRSI 
maintains the slope (and hence spatial resolution) better than that of the LRR up to a factor 
of x5. This is reflected in the plots of the maximum gradient across the simulated metabolite 
 106 
edge calculated for CS-MRSI Figure 7-2. The plot using the CS-MRSI(Identity) can be seen in 
Figure 7-2 a) and CS-MRSI(wavelet) b).  
 
Figure 7-2 Plot of the maximum gradient of the slope of the simulated NAA edge (3T) against 
acceleration factor (no noise). The CS-MRSI(identity) a) and the CS-MRSI(wavelet) b).  
Examples of the profiles across the simulated metabolite edge with SNR 10 for NAA can be 
seen Figure 7-3 . These plots show the profile for the filtered FSSR and non-filtered FSSR 
datasets, the LRR, the CS-MRSI(identity) and the CS-MRSI(wavelet)  for each acceleration 
factor x2, x3.3, x4, x5 and x10 a) to e). Although it is harder to define the edge at this SNR 
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the figure still indicates that the CS reconstruction provides an edge closer to the FSSR up to 
a factor of x5. Figure 7-4 depicting the gradient of the metabolite edge at each acceleration 
factor also reflects this result. The figures of the average gradients of the metabolite edges 
with and without noise would appear to indicate that the identity transform provides a 
better reproduction of the FSSR than the wavelet transform. This is shown in the result for 
x5 acceleration factor. In the noise free scenario the identity provides an average gradient of 
68 ± 0.3% of the FSSR gradient, and the wavelet, 62% ± 0.8% of the FSSR gradient. In the 
scenario encompassing an SNR of 10, the identity provides 68% ± 5% to that of the FSSR, and 
the wavelet 58% ± 0.2% of the FSSR gradient. Both the compressed sensing reconstructions 
result in significantly higher gradients  as compared to the equivalent LRR up to a factor of x5 
which are 54% (no noise) and 44%(SNR10) at this factor. At x10 there is no gain provided by 
reconstruction with compressed sensing.  
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Figure 7-3 Plots of the NAA profiles across the simulated NAA edge (3T)  with SNR of 10, at 
acceleration factors of a) x2, b) x3.3, c) x4, d)x5 and e) x10. Each plot shows the non-filtered FSSR, the 
filtered FSSR, the CS-MRS (Identity) and CS-MRSI(wavelet), and the LRR. 
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Figure 7-4 Plot of the maximum gradient of the slope of the simulated NAA edge (3T) with SNR 10, 
against acceleration factor. The CS-MRSI(identity) a) and the CS-MRSI(wavelet) b).  
 
The maximum average, gradient plots for the Choline profiles without noise can be seen 
Figure 7-5 and with SNR of 10 Figure 7-6. These again reflect the results of the NAA profiles 
in that the CS reconstruction provides a superior gradient of the edge compared to the LRR 
at the equivalent acceleration factor up to x5, and there is no benefit at a factor of x10. 
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Figure 7-5 Plot of the maximum gradient of the slope of the simulated Choline edge (3T) with no 
noise, against acceleration factor. The CS-MRSI(identity) a) and the CS-MRSI(wavelet) b).  
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Figure 7-6 Plot of the maximum gradient of the slope of the simulated Choline edge (3T) with SNR10, 
against acceleration factor. The CS-MRSI(identity) a) and the CS-MRSI(wavelet) b).  
 
 Discussion  7.1.3
The application of the simulated, angled metabolite edge provided a successful means to 
measure relative spatial resolution using higher data samples across it. Results suggest that 
there is a benefit to utilising CS-MRSI as a reconstruction technique to maintain spatial 
resolution whilst also minimising Gibbs ringing for accelerated MRSI up to a factor of x5. 
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Adjacent inter-voxel contamination will hinder the accurate delineation of tumour borders 
with healthy tissue. Up to an acceleration factor of x5 Figure 7-1 d) indicates that the 
gradient of the edge appears to be maintained close to that of the non-filtered FSSR, 
implying that there is little introduction of adjacent voxel contamination at this acceleration 
factor. The figure also indicates that the CS-MRSI when using either sparse transform, 
appears to improve the inter-voxel contamination at a distance (Gibbs ringing) compared to 
the non-filtered FSSR at all acceleration factors. The variable k-space mask samples to the 
outer edges of k-space (3.2) which is why the spatial resolution is maintained, but also due 
to the variable density towards the outer edges, the mask has a filtering effect reducing the 
ringing. These results suggest MRSI real-time acquisition could be potentially five times 
quicker using CS-MRSI whilst maintaining tumour boundary definition. The CS profiles also 
show a slight ripple artefact along its length. This is most likely due to the noise-like 
incoherence artefacts due to the random under-sampling (section 2.5.3).  
Figure 7-2 shows the maximum gradient across the NAA edge in a noise free environment. 
This figure serves to demonstrate that the spatial resolution degrades with increasing 
acceleration factor and that the CS-MRSI reconstructions are above those of the LRR up to a 
factor of x5. CS-MRSI(identity) appears to retain 68% ± 0.2% of the spatial resolution as 
compared to the non-filtered FSSR at an acceleration factor of x5, and 62% ± 0.01% for the 
CS-MRSI(wavelet). This is compared to 54% for the LRR at this factor. It can also be seen that 
at an acceleration factor of x10 the spatial resolution drops to around 40% and that there is 
no advantage of CS-MRSI over the LRR at this factor for both Identity and wavelet 
reconstructions.  
Figure 7-3 indicates the equivalent NAA profiles of Figure 7-1 except that noise was added to 
the spectra to provide an SNR of 10. This is a more realistic scenario. The plots also indicate 
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that the inter-voxel contamination at a distance (Gibbs ringing) is reduced when CS-MRSI is 
utilised, although this is not as obvious as it is in the noise-free environment. Figure 7-4 
indicates that at acceleration factor of x5 the spatial resolution for NAA is retained to an 
average of 68% ± 5% for CS-MRSI (Identity), CS-MRSI (wavelet) 58% ± 0.2% and 44% LRR. 
This is similar in trend to that of the noise-free scenario in which the adjacent inter-voxel 
contamination is again less than that of the LRR at x5 acceleration factor when employing 
CS-MRSI. The advantage of CS-MRSI over the LRR at an acceleration factor up to x5 is also 
reflected in the maximum average gradient results for choline both with and without noise, 
Figure 7-5 and Figure 7-6. Again there is an advantage of CS-MRSI up to x5 acceleration 
factor but not at x10 over the LRR. The noise free results for Choline Figure 7-5, indicate that 
the CS-MRSI (Identity) at x5 acceleration provides a maximum average gradient of 89% ± 
0.6% of that of the non-filtered FSSR, for CS-MRSI (wavelets) 80% ± 6% and 52% for LRR. 
When a realistic level of noise is added to produce an SNR of 10, the values for the relative 
spatial resolution for Choline were CS-MRSI (identity) 80% ± 7%, CS-MRSI (wavelets) 67% ± 
1.6%, and 40% for the LRR. A recent study also found that CS-MRSI produced a significant 
degradation in results at an acceleration factor of x10 compared to those at x5 (Geethanath 
2012).  
The spatial resolution results appear to be significantly better for the Choline metabolite 
than for the NAA both with and without noise. This could be related to the chosen CS 
weighting factors in particular the TV weighting which may favour spectral peaks of different 
signal height or possibly that the TARQUIN peak fitting is more suitable for Choline than NAA 
at short echo times. 
The results for both NAA and Choline also imply that CS-MRSI utilising the identity transform 
provide an advantage over the wavelet transform in terms of spatial resolution at x5 
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acceleration factor. The use of wavelets may have a filtering effect upon the image or the 
performance of the CS-MRSI(wavelet) could be related to the chosen mother wavelet which 
warrants further investigation. 
Results from the angled edge simulation agree with those of the real-time acquired two-
compartment gel edge phantom (section 5.2.2) in that the spatial resolution provided by the 
CS-MRSI reconstructions are higher than those utilising LRR up to an acceleration factor of 
x5, and that the spatial resolution reduces with increasing acceleration factor. The spatial 
resolutions at factors of x5 and x10 had high standard deviations for the two-compartment 
gel edge phantom and both appeared above the LRR. The simulated angled edge spatial 
resolution measurement was not above the LRR using CS-MRSI at x10. The voxels measured 
in the gel phantom scenario were four times the area of those utilised in the simulation, 
which limited the number of edge samples to two. The major difference between the two 
scenarios is that the number of sampled data points used in the calculation of the gradient 
across the digital phantom angled edge was 9 times that of the two-compartment gel edge, 
ensuring better statistical accuracy. The quantification method in both scenarios was also 
different. The gel phantom was quantified by summing up the area under the metabolite 
peaks whereas the simulations were quantified using TARQUIN (Wilson, Reynolds et al. 
2011). However despite the differences in the two, the results still agree that there may be 
an advantage in using CS-MRSI up to an acceleration factor as high as x5, particularly when 
compared to the LRR.  
It is interesting to note that the filtered FSSR results in all scenarios produce a maximum 
edge gradient (spatial resolution) from the simulated angled edge which is 45-50% below 
that of the non-filtered FSSR. This is in agreement with the suggestion that the application of 
certain MRSI k-space filters can double the voxel size (Barker and Lin 2006). The advantage 
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of using the filter is that it reduces the side lobes of the PSF (section 2.3.1) and therefore 
inter-voxel contamination particularly from distant voxels. The results of this study suggest 
that the CS-MRSI also reduces these side lobes and reconstructs with consistently higher 
spatial resolution than the filtered FSSR. The ringing filter is currently implemented in all 2D 
phase encoded clinical MRSI acquisitions. Therefore, CS-MRSI could potentially be utilised in 
the clinic in place of the filter to reduce the side lobes of the PSF with the added advantage 
of increased spatial resolution, whilst at the same time accelerating MRSI acquisition by up 
to 80%! 
7.2 MTF Measurement 
The modulation Transfer Function (MTF) is an established technique for examining the 
spatial frequencies present in an imaging system (Section 4.1.2). The MTF is therefore a 
useful measure for the examination of the spatial frequencies present in MRSI after it has 
been reconstructed using compressed sensing. The software simulation of an angled 
metabolite edge from (Section 6.3) provides a way of establishing the edge response of 
these reconstructions. This can then be differentiated and a 1D Fourier transformed applied 
to reveal the modulation of the spatial frequencies of the reconstruction. This research 
examined the feasibility of this technique in its application to the metabolite edge 
simulations. The Filtered and non-filtered FSSR datasets were initially examined.  Datasets 
reconstructed with CS were compared to those of the uniformly sampled LRR 
reconstructions at each acceleration factor. Reconstruction was then repeated utilising the 
wavelet transform as the sparsifying transform (Section 3.3.1) and compared with the use of 
the identity transform. 
The addition of noise providing an SNR of 10 and its effect upon the MTF calculation was also 
investigated on the filtered and unfiltered FSSR datasets. 
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 Method 7.2.1
The simulated metabolite edge phantom described in section 6.3 was utilised in this analysis. 
Initially the noise free version was investigated. The non-filtered MRSI (FSSR) dataset was 
subject to reconstruction by CS at acceleration factors of x2, x3.3, x4, x5 and x10 for both the 
identity transform, CS-MRSI(identity) and the wavelet, CS-MRSI(wavelet) sparse transforms. 
The LRR reconstructions at each equivalent acceleration factor were also examined along 
with the filtered and non-filtered FSSR. The reconstructions for each dataset from section 
7.1 were utilised. 
A Matlab program was written in order to calculate the MTF for each reconstructed dataset. 
The edge responses which are the profile plots calculated from the TARQUIN output across 
the simulated metabolite angled boundary were calculated according to section 6.3.1. The 
edge responses for NAA, at each acceleration factor without noise can be seen Figure 7-1. 
The program initially reads in the edge response. The calculation is based upon the Fourier 
transform of the Line Spread Function (LSF). The LSF is calculated by finding the approximate 
derivative of the edge profile using the Matlab function ‘diff ‘implemented as diff(X)/diff(Y). 
It can be seen on seen Figure 7-1 that the edge responses are not are not perfectly smooth 
which introduces gradient anomalies within the profiles. This is due to approximation errors, 
and small errors in the TARQUIN quantification process. The edge profiles were therefore 
subject to mathematical smoothing. The smoothing was achieved using a 7 span averaging 
filter in Matlab. Figure 7-7 shows the smoothing of the non-filtered and filtered FSSR 
datasets. The smoothing does not detract from the gradient of the slope which is the 
fundamental indicator of the spatial frequency response. 
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Figure 7-7 The edge response profiles across the metabolite edges for the non-filtered a) and the 
filtered b) MRSI datasets with smoothing. 
 
Once the data is smoothed the LSF is calculated as above. This is then 1D Fourier 
transformed to produce the MTF. Each MTF is normalised. Figure 7-8 shows the difference in 
the MTF calculation between the smoothed and the unsmoothed profiles. If no smoothing is 
utilised it introduces high frequency noise to the profile and thus distorts the MTF. 
 
Figure 7-8 The MTF calculated for the non-filtered and filtered FSSR without smoothing a) and with 
smoothing b). 
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The MTF50 (section 4.1.2) was calculated using a linear interpolation of the MTF curve to 
find the spatial frequency response at an MTF of 50%. Although an arbitrary cut-off this is a 
common indicator of the spatial frequency response. 
The CS-MRSI reconstructed edge response profiles were processed utilising the MTF 
program to determine the effect on the spatial frequency response in a noise free scenario. 
The reconstructions for each dataset from section 7.1 were utilised. Each reconstructed edge 
response was subject to smoothing in the same way as the filtered and non-filtered FSSR.  
 
 Results 7.2.2
The ERF can be seen on the left hand side of Figure 7-9 a-e) for each acceleration factor x2, 
x3.3, x4, x5 and x10. The equivalent LRR edge response can be seen to the right hand side of 
each CS-MRSI edge profile. 
The smoothing does not appear to alter the profile in a way which greatly reshapes the 
overall profile and the gradient of slope of the edge is maintained. It can be seen that the 
profile becomes less like a step function and more rounded at the edges at an acceleration 
factor of x10. 
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Figure 7-9 The NAA edge responses indicating unsmoothed data points and the smoothed 
approximations at each acceleration factor a-e). The compressed sensing reconstructions are 
indicated on the left and the equivalent LRR on the right. 
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The plots of the MTF at each acceleration factor can be observed Figure 7-10 for the CS-
MRSI(identity) and Figure 7-11 for the CS-MRSI(wavelet). The calculated MTF50 can be seen 
in Table 3. The MTF50 calculation and the plots all indicate that the CS reconstruction 
provides a superior spatial resolution up to a factor of x5 after which it starts to degrade.  
This is also reflected in the shape of the edge response profiles Figure 7-9.  
Acceleration 
Factor 
Spatial frequency at 50% of the maximum modulation 
(MTF50) (lp/mm) 
LRR 
CS (identity) CS (wavelet) 
Mean std Mean std 
1 (no filter) 0.98 - - - - 
1 (filtered) 0.63 - - - - 
2 0.86 0.89 0.03 0.83 0.04 
3.33 0.7 0.77 0.07 0.75 0.08 
4 0.67 0.77 0.05 0.8 0.07 
5 0.63 0.73 0.01 0.67 0.02 
10 0.52 0.5 0.04 0.5 0.04 
 
Table 3 The MTF50 calculated at each acceleration factor (no noise) for each reconstruction. The 
MTF50 for the non-filtered FSSR and the filtered FSSR datasets are shown as LRR with acceleration 
factor of 1. 
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Figure 7-10 MTF curves for CS-MRSI (identity) and LRR at the acceleration factors x2, x3.3 ,x4, x5 and 
x10.(no noise) 
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Figure 7-11 MTF curves for CS-MRSI (wavelet) and LRR at the acceleration factors x2, x3.3 ,x4, x5 and 
x10.(no noise) 
 
In a realistic, clinical MRSI the SNR is around 10. This level of noise was added to the filtered 
and non-filtered FSSR datasets. The NAA profile across the metabolite edge can be seen 
Figure 7-12 a). The corresponding MTF curve can be seen in Figure 7-12 c). 
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Figure 7-12 The Edge response profile with the solid line indicating the smoothing for the non-
filtered FSSR a) and filtered FSSR b). The calculated MTF curves for both FSSRs are shown in c). 
 
 Discussion 7.2.3
Figure 7-8 shows the MTF calculated with b) and without a) smoothing applied to the NAA 
profile edge responses of the FSSR with and without filtering in a noise free scenario. The 
main difference between the two MTF’s is that the smoothed profiles do not exhibit the high 
frequency noise present in the unsmoothed dataset profiles. The MTF50 (Table 3) was 
calculated via linear interpolation was found to be 0.98 lp/cm for the non-filtered FSSR and 
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0.63 lp/cm for the filtered FSSR. The voxel dimension in the x-y plane is 5mm x 5mm, 
therefore one line pair would be 1cm. The value of 0.98 lp/cm for the non-filtered FSSR MTF 
is therefore in close agreement with this providing validity of the technique. It can also be 
seen that the non-filtered MTF is zero at approximately 1.7 lp/cm. Since the data acquisition 
FOV is rectangular and not circular the diagonal extent of k-space is around 40% larger. This 
would correspond to a limiting resolution corresponding to a 3mm voxel size (~1.66 lp/cm). 
In the case of the non-filtered dataset the MTF appears constant up until 1 lp/cm. This is 
expected since k-space is not amplitude modulated as it is for the filtered version.  The MTF 
then rapidly falls away as frequency is increased, between 1-1.66 lp/cm until the resolution 
limitation. The MTF falls to zero for the filtered FSSR at around 1 lp/cm which is the limit of 
resolution. The non-filtered MTF is always higher than that for the filtered dataset which is 
not unexpected as the non-filtered FSSR contains higher spatial frequencies. 
The results from Table 3 indicate that the CS-MRSI(identity) provides up to 73% of the 
resolution of that of the non-filtered FSSR dataset at x5 acceleration factor. The 
corresponding LRR provided 63% spatial resolution at this acceleration factor. This is 
compared to the average gradient (section 7.1.2) which gave a gradient of 68 ± 0.2% of the 
non-filtered FSSR gradient at this acceleration factor. The MTF50 values agree with the 
results of the angled edge gradient evaluation in that the spatial resolution is greater when 
using CS-MRSI up to an acceleration factor of x5. The CS-MRSI degrades at x10 acceleration 
factor where the LRR reconstruction is slightly better. This is in agreement with the ERF 
results of (section 7.1.2). Values between x5 and x10 have not been examined so the exact 
limit of CS-MRSI is yet to be determined. The filtered FSSR dataset has a reduced spatial 
resolution with an MTF50 of 63%, compared to the non-filtered FSSR dataset, and to CS-
MRSI up to an acceleration factor of x5. The LRR reconstruction appears to modulate the 
lower spatial frequencies better than the CS-MRSI for acceleration factors up to x5 after 
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which the CS-MRSI appears to modulate the higher spatial frequencies. This is in agreement 
with the result of (Heikal, Wachowicz et al. 2013) which examined CS-MRSI at an 
acceleration factor of x4 only. At an acceleration factor of x10 the LRR appears to degrade 
less than the CS-MRSI again in agreement with the gradient results of the previous section. 
This result indicates that the use of CS-MRSI is beneficial compared to the LRR 
reconstruction up to an acceleration factor of x5. The wavelet results again also reflect the 
results from 7.1.2. The average MTF50 calculations are consistently higher than those of the 
average gradient calculations; however the results are consistent with the identity transform 
results in that CS-MRSI appears beneficial up to an acceleration factor of x5. 
Even though all the edge response profiles are subject to smoothing, the results of Figure 
7-10 and Figure 7-11 indicate that there is still a degree of high frequency noise present on 
the MTF curves after 1 lp/cm. This also means that examination of a different standard MTF 
the MTF10 is complicated by the presence of this noise and would therefore be unreliable in 
this circumstance. 
Figure 7-12 depicts the NAA ERF’s a) and b) and corresponding MTF curve c) in the presence 
of noise (SNR10). This figure demonstrates a difficulty with the MTF calculation. The non-
filtered dataset can be seen to contain a substantial amount of noise. The edge response is 
therefore not so easily modelled. This is not so prevalent in the filtered FSSR dataset, Figure 
7-12 b) which inherently reduces the level of noise by reducing the outer edges of k-space at 
the cost of spatial resolution. The MTF in this scenario Figure 7-12 c) indicates again that 
even with the addition of data smoothing, the non-filtered FSSR dataset is too noisy to give 
an accurate MTF particularly at higher spatial frequencies. It was therefore decided not to 
utilise this technique for the CS reconstruction of datasets with added noise. 
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7.3 Conclusion 
The use of the digital phantom containing an angled metabolite edge successfully provided 
further means to assess the relationship between the MRSI spatial resolution with increasing 
acceleration factor, providing an increased number of data points in the measurement of the 
edge response.  
It is of paramount importance for an imaging system to discriminate between focal and 
those tumours which have infiltrated into the surrounding healthy tissue. The definition of 
the edge of a tumour is hampered by inter-voxel contamination both from adjacent and 
distant voxels (section 2.3.1). If a tumour is focal and the employed MRSI reconstruction 
introduces inter-voxel contamination into the surrounding healthy tissue then misdiagnosis 
may occur, possibly resulting in the removal of healthy tissue. If the LRR technique is 
employed to accelerate the MRSI acquisition by 80%, results indicate an increase in adjacent 
voxel contamination of 54%, whereas CS-MRSI (identity) only increases it by 32% without 
introduction of distant voxel contamination. 
The gradient of the edge is related to inter-voxel contamination from adjacent voxels 
(section 2.3.1). The results imply that employment of CS-MRSI maintained the MRSI spatial 
resolution up to 24% above the LRR for NAA and 37% above for Choline, in both noisy and 
noise-free environments up to an acceleration factor of x5. There appears no benefit of CS-
MRSI over the LRR at x10 acceleration factor. The CS-MRSI(identity) maintained spatial 
resolution up to 68% ± 5% of that of the FSSR at x5 acceleration factor in both noisy and 
noise free environments. The CS-MRSI wavelet reconstruction had a lower value of spatial 
resolution at all factors when compared to the CS-MRSI using the identity transform. 
Gibbs ringing inherent in the non-filtered FSSR contributing to voxel contamination (section 
2.3.1) appears reduced in the plotted profiles of a noise-free scenario for the CS-MRSI up to 
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x5 acceleration factor. The introduction of noise (SNR10) hampered the assessment of Gibbs 
ringing but it can be seen on the corresponding plots that again this is reduced up to a factor 
of x5 for CS-MRSI reconstructions. 
The MTF calculated from the ERF in a noise free environment confirmed the same trend as 
the gradient calculations; however the MTF methodology did not provide a reliable method 
of MTF calculation once noise was added to the simulation.  
The results of this study suggest that CS-MRSI could have a potential advantage in the clinic 
in place of the standard ringing filter currently used in all MRSI acquisitions. The filter 
reduces the side lobes of the PSF reducing inter-voxel contamination. Similarly, the CS-MRSI 
appears to also reduces this ringing but with the added advantage of increased spatial 
resolution, whilst at the same time accelerating MRSI acquisition by up to 80%! 
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8 Application of CS-MRSI to Optic Pathway Glioma (OPG) 
This chapter examines the effect of CS-MRSI reconstruction on clinical MRSI datasets. The 
effect of CS-MRSI on image integrity and on inter-voxel contamination was investigated with 
increasing acceleration factor. Inter-voxel contamination in MRSI presents challenges to the 
correct delineation of tumour boundaries between healthy and diseased tissue. A tumour 
type for which correct boundary definition is beneficial is called Optic Pathway Glioma 
(OPG). OPG is a low grade brain tumour which due to its proximity to the optic nerve 
presents great challenges in diagnosis and management.  
The effect of CS-MRSI on a retrospective real-time OPG MRSI dataset was investigated along 
with its application to two digital phantom MRSI datasets developed in Chapter 6. Two 
digital phantoms were created one with a focal OPG tumour, and one with the same tumour 
but with the addition of tumour infiltration into healthy tissue.  
8.1 Introduction to Peadiatric Brain tumours 
Brain tumours are the most frequent form of solid cancer in children and exhibit a diversity 
of histopathological subtypes and grades(Walter and Hilden 2004). A paediatric brain tumor 
is defined as a mass (neoplasm) of tissue resulting from abnormal proliferation or cell 
division in the brains of patients who are children or young people. Figure 8-1 indicates an 
approximate summary of the incidence pediatric brain tumours in children (Pizzo, Poplack et 
al. 2006). 
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Figure 8-1 Approximate Incidence of paediatric brain tumours (Pizzo, Poplack et al. 2006) 
 
The gold standard in diagnosis is a biopsy allowing classification via histopathology; however 
this is often hindered by anatomical location or predictability of pathology. Children unable 
to have surgery are classified via relevant clinical information. Medical imaging is an 
important part of this. 
Paediatric brain tumour classification is defined according to cell type and graded according 
to histopathology, and from criteria related to growth and aggressiveness such as mitosis 
and necrosis, as outlined in the 2007 WHO Classification of Tumours of the Central Nervous 
system (Louis, Ohgaki et al. 2007). Table 4 shows a brief summary of common Central 
Nervous System (CNS) pediatric brain tumours, their grade and classifications.  
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Table 4 Common Peadiatric brain tumours 
A range of treatments are available which are tailored dependent upon factors such as 
tumor subtype, patient age, location and stage of disease. It is often difficult to predict when 
clinical intervention is necessary in each case or the best course of action to take in the 
management of the disease. In recent years paediatric brain tumours have exhibited slow 
improvements in outcome compared to other forms of childhood cancer such as leukaemia, 
and remain clinically challenging (Pollack and Jakacki 2011). MRI is an invaluable aid in the 
diagnosis and long term monitoring of this disease and functional imaging methods such as 
spectroscopy are increasingly being used to add information to this. 
 Relevance of MRSI  8.1.1
Brain tumours are generally metabolically inhomogeneous, for example the necrotic core of 
a lesion may have a very different spectral identification to an actively growing tumor edge, 
and likewise odema surrounding a tumour may also have a very different spectrum from its 
invasion into neighboring tissue. Therefore, high resolution multi-voxel spectroscopy MRSI is 
extremely desirable (Lazareff, Bockhorst et al. 1998; Horská and Barker 2010; Stadlbauer, 
Hammen et al. 2012). MRSI provides an assessment of the spatial distribution of brain 
metabolites. Individual spectra can be visually assessed at each voxel location or the 
metabolites can be quantified using available software mentioned in (Section 2.4.6). The 
Type SubType Grade Location Diagnosis
Medulloblastoma IV Cerebellum
Craniopharyigioma I Pituitary Gland
Pineoblastoma IV Pineal gland
Ependymomas II-III peri-ventricular
Astrocytomas
Pilocytic I Supratentorial/Cerebellum
Diffuse II Supratentorial/Cerebellum
Anaplastic III Supratentorial/Cerebellum
Glioblastoma Multiforme IV Supratentorial/Cerebellum
BrainStem Glioma Brainstem
Diffuse Pontine Glioma (DIPG) Mixed
Optic Pathway Glioma Low Supratentorial
Primitive 
Neuroectodermal 
Tumours (PNETs)
Histopathology
Radiology
Glial Tumours (Glioma)
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quantified metabolites are often displayed as a metabolite map across the anatomical 
images. The quantified metabolites or their ratio can be visualized on such maps providing 
the clinician with an insight into the extent of pathology. An example MRSI can be seen in 
Figure 8-2. This figure shows metabolite maps as depicted on MR scanner software. The 
maps show brain metabolites NAA and Cho a), NAA and lipids b) and again NAA and Cho c). 
The spectrum below each map is from the voxel indicated in green on the figure. The green 
voxel is located within a region indicated as tumour on the anatomical MRI in a). The green 
voxel is located outside of the tumour in relatively normal healthy tissue in b), and in c) it is 
located outside the tumour in an area depicted as having a reduced level of NAA relative to 
Choline, possibly indicating tumour infiltration. This last voxel in c) appears normal on the 
anatomical MRI image. Defining the extent of infiltration into the surrounding healthy tissue 
is of paramount importance in the management of OPG. 
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Figure 8-2 MRSI of patient with Optic pathway Glioma. The voxel in a) is taken from an area shown 
from MRI to be within the tumour, b) is outside of this region and c) is also outside the region but 
shows pathology not observed on the MRI. 
 Optic Pathway Gliomas (OPG) 8.1.2
The majority of gliomas are low grade tending to be located in the posterior fossa and 
diencephalic region of the brain. The low grade gliomas are an extremely diverse group in 
terms of histopathology, age at occurrence and anatomical location. One type of glioma 
located around the optic pathway which is particularly difficult to manage is the Optic 
Pathway glioma (OPG) (Hoffman, Humphreys et al. 1993). 
A genetic condition known as Neurofibromatosis Type 1 (NF1) predisposes children to OPG 
(Steen, Taylor et al. 2001). A patient with NF1 exhibits enhancing lesions on MRI termed 
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Neurofibromatosis Bright Objects (NBO). These are benign lesions, healing or regressing over 
time. These patients are often rendered with learning difficulties. The difference between 
NF1 and non NF1 OPG is currently not well understood being undetectable with anatomical 
MRI. A recent study revealed differences in the MRS spectra obtained between these two 
patient groups (Orphanidou-Vlachou, Auer et al. 2013). There has also been recent interest 
in the use of 31-P MRS in the evaluation of choline levels in OPG (Novak, Wilson et al.). The 
grading of OPG is a challenge. For those that are biopsied the majority of OPGs are 
histopathologically characterised as Pilocytic Astrocytoma (PA). A biopsy is often not possible 
however in OPG since it is complicated and risky due to the proximity to the Optic pathway. 
A biopsy also only samples a small portion of the tumour and may not be indicative of the 
overall pathology. Some OPG are more aggressive than others. Due its often diffuse and 
inhomogeneous nature, OPG is not necessarily restricted to a single lesion. Determination of 
the extent of tumour infiltration into surrounding healthy tissue is of primary importance in 
the clinical diagnosis and management of OPG and all brain tumours. 
8.2 Investigation of CS-MRSI for Characterisation of OPG 
The application of CS-MRSI in OPG was investigated in three scenarios. The first was a 
retrospective investigation of CS-MRSI using real-time OPG patient data acquired on a 3T 
scanner at standard voxel size.  This revealed a potential advantage for CS-MRSI compared 
to the equivalent LRR reconstructions for some acceleration factors, but was hampered by 
the low resolution, low data sample size and poor spectral baseline (section 2.2.4 and 2.4.1). 
It was therefore decided to investigate the application of CS-MRSI to OPG using the digital 
phantom developed in Chapter 6. The phantom was of a simulated OPG MRSI dataset 
containing a higher matrix size (40x32). This first simulation was designed to mimic a glioma 
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with a clearly defined metabolite edge. The second simulation, incorporated tumour 
infiltration into the healthy surrounding tissue.  
 Retrospective application of CS-MRSI to in-vivo OPG dataset 8.2.1
8.2.1.1 Method 
An OPG patient was scanned on the Philips 3T Achieva scanner using standard clinical 
protocol with and without the application of the default ringing filter. The data was collected 
and subsequently under-sampled and reconstructed using CS and LRR. Each reconstruction 
was quantified using the TARQUIN software and the normalised metabolite outputs 
examined on Bland-Altman plots. 
A non-NF1 OPG patient was subject to two MRSI acquisitions on the Philips 3T scanner. A 
non-NF1 patient was chosen for the investigation since the lesions tend to be less diffuse. 
Standard clinical protocol was followed for the first scan. This consists of a PRESS acquisition, 
short echo TE=35ms, TR=2000ms, 1024 data points collected. The FOV was (195mm x 
165mm), voxel size (13mm x 13mm x 13mm), matrix size 15x13. The planning of the MRSI 
can be seen in Figure 8-3. 
 
Figure 8-3- The PRESS MRSI planning of the OPG patient 
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The red line in the figure indicates the MRSI slab. The optic pathway is low down in the brain 
so a water and a fat suppression band Section(2.2.5) was added to the scan in order to 
prevent any air-tissue susceptibility artefacts from the nasal sinus’s. The VOI shown in yellow 
on Figure 8-3 consists of 4x4 whole voxels surrounded by a half voxel margin to reduce any 
chemical shift artefact (Section 2.3.3). The first scan was acquired with the k-space shutter 
and application of the ringing filter as required in clinical protocol. The second scan was 
acquired in exactly the same way except the ringing filter was removed. This second 
acquisition was required because section 7.1.3 showed that the addition of filtering may 
reduce the metabolite spatial resolution. This section also indicated that the CS 
reconstruction appeared to reduce the inter-voxel contamination (2.3.1) from distant voxels 
(Gibbs ringing artefact), whilst maintaining the spatial resolution which is hampered by 
adjacent voxel contamination. Residual water removal was achieved prior to reconstruction 
by implementation of the HSVD algorithm ((Pijnappela 1992). The non-filtered MRSI (FSSR) 
dataset was subject to reconstruction by CS at acceleration factors of x2, x3.3, x4, x5 and x10 
using both CS-MRSI(identity) and CS-MRSI(wavelet). The LRR was also reconstructed for each 
equivalent acceleration factor for comparison. The metabolites were then quantified using 
the TARQUIN software (section 2.4.6) and metabolite maps displayed for NAA, Creatine and 
Choline. Bland-Altman statistics were also calculated and plotted for each reconstruction. 
8.2.1.2 Results and Discussion 
The metabolite maps for NAA, Cr and Cho after reconstruction using CS-MRSI utilising the 
Identity as the sparse domain, utilising wavelets as the sparse domain, and the equivalent 
LRR, can be seen in respectively in Figure 8-4, Figure 8-5 and Figure 8-6. Each figure shows 
the map for the FSSR with and without filtration. 
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Figure 8-4 – NAA Metabolite maps for the OPG patient MRSI dataset utilising  CS-MRSI(identity) and 
CS-MRSI(wavelets) and the LRR reconstructions as compared to the FSSR with and without filtering. 
The colour maps are normalised to the highest pixel value. 
 
Figure 8-5 - Creatine Metabolite maps for the OPG patient MRSI dataset utilising  CS-MRSI(identity) 
and CS-MRSI(wavelets) and the LRR reconstructions as compared to the FSSR with and without 
filtering. The colour maps are normalised to the highest pixel value. 
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Figure 8-6 - Choline Metabolite maps for the OPG patient MRSI dataset utilising  CS-MRSI(identity) 
and CS-MRSI(wavelets) and the LRR reconstructions as compared to the FSSR with and without 
filtering. The colour maps are normalised to the highest pixel value. 
 
Since the OPG MRSI dataset is of such low resolution at 13mmx 13mm x13mm voxel size, it 
is difficult to draw conclusions from the metabolite maps. Each metabolite displays variation 
between the filtered and non-filtered datasets. Bland-Altman statistics were plotted to 
provide a quantification of the differences between the reconstructions. 
The Bland-Altman plot for NAA, Cr and Cho after reconstruction using CS-MRSI utilising the 
Identity as the sparse domain, and the equivalent LRR, can be seen in respectively in Figure 
8-7, Figure 8-8 and Figure 8-9. 
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Figure 8-7 Bland-Altman plot of the NAA after reconstruction as compared to the non-filtered FSSR, 
using CS-MRSI(Identity) and the equivalent LRR at each acceleration factor. The nRMSE is indicated 
on each plot. 
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Figure 8-8 - Bland-Altman plot of the Creatine after reconstruction as compared to the non-filtered 
FSSR, using CS-MRSI(Identity) and the equivalent LRR at each acceleration factor. 
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Figure 8-9- Bland-Altman plot of the Choline after reconstruction as compared to the non-filtered 
FSSR, using CS-MRSI(Identity) and the equivalent LRR at each acceleration factor. 
 
The Bland Altman plots for NAA, Cr and Cho again using acceleration factors x2, x3.3, x4, x5 
and x10, can be seen respectively in Figure 8-10, Figure 8-11 and Figure 8-12 for CS-MRSI 
reconstructed using wavelets as the sparse domain. 
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Figure 8-10 - Bland-Altman plot of the NAA after reconstruction as compared to the non-filtered 
FSSR, using CS-MRS (wavelet) and the equivalent LRR at each acceleration factor. 
 142 
 
Figure 8-11 - Bland-Altman plot of the Creatine after reconstruction as compared to the non-filtered 
FSSR, using CS-MRSI(wavelet) and the equivalent LRR at each acceleration factor. 
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Figure 8-12 - Bland-Altman plot of the Choline after reconstruction as compared to the non-filtered 
FSSR, using CS-MRSI(wavelet) and the equivalent LRR at each acceleration factor. 
 
The Bland-Altman plots for each metabolite indicate that there is a potential advantage of CS 
over the LRR reconstructions with a reduction in the standard deviation of the mean 
difference up to an acceleration factor of x5 for both CS-MRSI(wavelets) and CS-
MRSI(identity). The CS reconstructions and the LRR appear to have a consistently positive 
mean difference indicated by the red line on all plots. This implies that both CS and LRR 
reconstructions are slightly underestimating the metabolite concentrations relative to the 
FSSR. 
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The OPG patient MRSI acquisition is of very low resolution at 13mm x13mm x13mm voxel 
dimension. This meant that the VOI contained only 16 data points for analysis. A larger 
matrix size acquisition may greatly help the statistical evaluation of the merits of the CS 
reconstruction by providing a greater number of data points. This may help determine if 
there is a significant advantage of CS-MRSI over the LRR at x5 and x10 acceleration factors. 
Since a real-time acquisition of a high matrix size MRSI dataset is prohibitive due to time 
constraints, the software simulated digital phantom was utilised for the evaluation of CS in 
OPG. 
 Simulations of CS-MRSI in OPG Using Digital Phantoms 8.2.2
The delineation between tumour and healthy tissue is extremely important in the clinical 
management of brain tumours. Inter-voxel contamination (section 2.3.1) which causes signal 
to bleed through from one MRSI voxel to another can incorrectly cause the appearance of 
tumour infiltration. Therefore, it is important that the employed reconstruction technique 
minimises any possible signal bleed through. To test this in a clinical scenario the digital 
phantom developed in section 6 was adapted, once to mimic a single, focal OPG tumour and 
once again to mimic an OPG tumour containing infiltrative disease. 
8.2.2.1 Method - Focal OPG Simulation  
The digital phantom was created using the methodology outlined in section 6.1. In summary 
each 1mm x1mm x1mm pixel is assigned a spectrum relevant to its anatomical location to 
create an MRSI dataset with spatial and frequency dimensions (x,y,f). The spatial resolution 
is then reduced by the truncation of k-space (section 6.1.3). In this scenario the pixel or voxel 
size dimension was reduced from (1mm x 1mm x 5mm) to (5mm x5mm x5mm). The FOV was 
200mm x 160mm so the new matrix size was (40x32). Real-time acquisition of a 2D phase 
encoded MRSI dataset with this matrix size would not be feasible due to the long acquisition 
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time. There was no residual water peak added to the simulated spectra. In reality there is 
always some residual water which may have an effect upon the quality of the spectral 
baseline section (2.4.1). It was decided not to add a residual water peak because the residual 
water signal height in a real-time acquisition is inconsistently distributed. Residual water is 
usually removed post processing and it may have an influence on the compressed sensing 
reconstruction (Cao and Wu 2014). In a real-time acquisition scenario, the residual water 
signal could be removed by scanner software prior to reconstruction. The simulation 
software also assumes a uniform magnetic shim across the head (section 2.2.2.1). Currently, 
in a real-time acquisition scenario this is not the case. Future hardware developments may 
be perfected to reduce shim imperfections. The variation in magnetic field across the head 
can be hard to predict so completely removing this artefact would improve data comparison. 
In a real-time acquisition scenario there is often contamination in the spectra from high 
signal lipid bleed through (section 2.3.1) from subcutaneous fat. Healthy brain tissue does 
not normally produce a high lipid signal. Clinical protocol utlises the PRESS MRSI sequence 
(section 2.2.1). MRSI spectra can be improved by placement of the PRESS VOI central in the 
brain, away from the lipid area around the inside of the skull (section 2.2.5). Therefore, the 
simulation’s VOI was located centrally, encompassing the OPG region. No lipid signal was 
added to the spectra in areas of healthy grey and white matter. In order to assess the 
introduction of inter-voxel contamination from the reconstructions into the surrounding 
healthy brain tissue, a focal tumour with defined edges was initially simulated. An area was 
defined as an OPG lesion Figure 8-13. Although in reality lesion dimensions associated with 
OPG are varied, the simulated OPG region was drawn manually and checked by a clinician for 
authenticity of size and shape. 
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Figure 8-13 – The anatomical MRI template indicating the area of artificial OPG 
 
Each 1mm pixel in the area defined in Figure 8-13 was assigned the spectrum of metabolites 
consistent with an OPG, before increasing the voxel size. The values of metabolite 
concentration used in the simulated lesion were those previously quantified using TARQUIN 
(section 2.4.6) from an existing non-NFI OPG patient, single voxel dataset, previously 
acquired on the 3T scanner. The 3T basis set utilised in the simulation was weighted 
according to these quantified concentrations to obtain the simulated OPG spectrum. An 
example of the simulated spectrum before the addition of noise can be seen Figure 8-14. 
Random, Gaussian noise was then added to all spectra to provide a clinically relevant level of 
noise at an SNR of 10. 
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Figure 8-14- Software simulated, OPG Spectrum before the addition of noise. 
 
After the assignment of the appropriate spectrum to each pixel in Figure 8-13, the area 
shown in Figure 8-15 was defined as the PRESS VOI.  
 
Figure 8-15 The region within the FOV defined as the simulated PRESS acquisition Volume of Interest 
(VOI). 
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Once the appropriate spectra were added to each pixel in the anatomical MRI, the voxel size 
was then increased to (5mm x5mm x5mm) (Section 6.1.3). An FSSR with and without 
filtration was simulated. The filter was the Hamming filter (section 2.3.1). The 
reconstructions at each acceleration factor were achieved on the non-filtered dataset since 
the previous section 7.1.2 indicated that the addition of filtration reduces the maximum 
spatial resolution of the MRSI. 
The CS reconstructions were achieved utilising both the identity and the wavelet transforms. 
Acceleration factors of x2, x3.33, x4, x5 and x10 were reconstructed. The wavelet transform 
employed a Daubechie wavelet 1 (Haar wavelet) with level 2. Reconstruction was also 
achieved for the equivalent LRR at each factor for comparison. After reconstruction the 
datasets were quantified for relative metabolite level with the TARQUIN software. A region 
of interest (13x13 voxels) equivalent to the PRESS VOI was quantified Figure 8-16.  
 149 
 
Figure 8-16 – The TARQUIN screenshots depicting the FSSR PRESS VOI used for quantification. A 
spectrum from the area of healthy tissue is shown in a) and from the OPG region b). 
Bland-Altman plots were constructed for NAA, Creatine, Choline and Myo-Inositol 
metabolites and lipids. Myo-Inositol and lipids were included since these are often elevated 
relative to healthy tissue in OPG(Orphanidou-Vlachou, Auer et al. 2013).  The Bland-Altman 
statistics were calculated relative to the non-filtered FSSR at each acceleration factor. Plots 
for the CS-MRSI and the LRR were plotted together for comparison. The Bland-Altman plots 
were calculated separately for the identity sparse domain, and the wavelet domains, for 
comparison. The normalised Root mean square (nRMSE) at each acceleration factor was also 
calculated. Bland-Altman plots were achieved showing the difference from the non-filtered 
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FSSR against the mean difference for each metabolite for the two different transform 
domains (Identity and wavelet), and the LRR, at each acceleration factor. 
8.2.2.2 Method - Infiltrative OPG Simulation 
The exact same methodology as outlined in section (8.2.2.1) was applied to a second OPG 
simulation. The difference between this and the previous simulation is that there was a 
simulated 15mm border region around the lesion with a different metabolite profile. Each 
pixel within the border contained 50% healthy spectra and 50% OPG spectra, Figure 8-17. 
 
Figure 8-17 – Depiction of the MRSI simulation of an OPG with tumour infiltration into the 
surrounding healthy tissue. 
The data were reconstructed and analysed as described in the previous section. 
8.2.2.3 Results – Focal OPG Simulation 
Bland Altman statistics were calculated and plotted for the NAA, Creatine, Choline and Myo-
Inositol metabolites and lipids based upon the concentrations quantified by TARQUIN. The 
CS reconstruction using the Identity as the sparse domain are depicted alongside those from 
the LRR reconstruction, Figure 8-18, Figure 8-19 and Figure 8-20. 
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Figure 8-18 – Bland-Altman plots for NAA at each acceleration factor. CS-MRSI(identity) is shown on 
the LHS and the equivalent LRR on the RHS. (Focal OPG simulation). 
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Figure 8-19- Bland-Altman plots for Creatine at each acceleration factor. CS-MRSI(identity) is shown 
on the LHS and the equivalent LRR on the RHS. (Focal OPG simulation). 
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Figure 8-20 - Bland-Altman plots for Choline at each acceleration factor. CS-MRSI(identity) is shown 
on the LHS and the equivalent LRR on the RHS. (Focal OPG simulation). 
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Figure 8-21 - Bland-Altman plots for Myo-Inositol at each acceleration factor. CS-MRSI(identity) is 
shown on the LHS and the equivalent LRR on the RHS. (Focal OPG simulation). 
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Figure 8-22 - Bland-Altman plots for lipids at each acceleration factor. CS-MRSI(identity) is shown on 
the LHS and the equivalent LRR on the RHS. (Focal OPG simulation). 
 
The nRMSE, the standard deviation and the mean diff relative to the FSSR (no filtering) for 
CS-MRSI(identity), CS-MRSI(wavelet) and LRR, were plotted against acceleration factor for 
metabolites NAA, Creatine, Choline, Myo-Insositol and for lipids Figure 8-23, Figure 8-24, 
Figure 8-25, Figure 8-26 and Figure 8-27. 
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Figure 8-23 – The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR.for NAA. (Focal OPG simulation). 
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Figure 8-24– The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR.for Cr. (Focal OPG simulation). 
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Figure 8-25– The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR.for Cho. (Focal OPG simulation). 
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Figure 8-26– The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR.for Ins. (Focal OPG simulation). 
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Figure 8-27– The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR.for lipids. (Focal OPG simulation). 
 
Metabolite maps calculated by Tarquin are shown in Figure 8-28 for NAA, Figure 8-29 for 
Creatine, Figure 8-30 for Choline, Figure 8-31 for Myo-Inositol, and Figure 8-32 for lipids. 
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Figure 8-28 – NAA Metabolite maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet) and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Focal OPG simulation). 
 
Figure 8-29 - Creatine Metabolite maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet) and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Focal OPG simulation). 
 162 
 
Figure 8-30 - Choline Metabolite maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet) and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Focal OPG simulation). 
 
Figure 8-31 - Ins maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet)and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Focal OPG simulation). 
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Figure 8-32 – Lipid maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet)and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Focal OPG simulation). 
 
8.2.2.4 Results – Infiltrative OPG Simulation 
Bland Altman statistics were calculated and plotted for NAA, Creatine, Choline, Myo-Inositol 
and lipids based upon the metabolite concentrations quantified by TARQUIN. The CS 
reconstruction using the identity as the sparse domain are depicted alongside those from 
the LRR reconstruction, Figure 8-33, Figure 8-34, Figure 8-35, and Figure 8-37. 
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Figure 8-33 - Bland-Altman plots for NAA at each acceleration factor. CS-MRSI(identity) is shown on 
the LHS and the equivalent LRR on the RHS. (Infiltrative OPG simulation). 
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Figure 8-34 - Bland-Altman plots for Creatine at each acceleration factor. CS-MRSI(identity) is shown 
on the LHS and the equivalent LRR on the RHS. (Infiltrative OPG simulation). 
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Figure 8-35 - Bland-Altman plots for Choline at each acceleration factor. CS-MRSI(identity) is shown 
on the LHS and the equivalent LRR on the RHS. (Infiltrative OPG simulation). 
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Figure 8-36 - Bland-Altman plots for Myo-Inositol at each acceleration factor. CS-MRSI(identity) is 
shown on the LHS and the equivalent LRR on the RHS. (Infiltrative OPG simulation). 
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Figure 8-37 - Bland-Altman plots for lipids at each acceleration factor. CS-MRSI(identity) is shown on 
the LHS and the equivalent LRR on the RHS. (Infiltrative OPG simulation). 
The nRMSE, the standard deviation and the mean difference relative to the FSSR (no 
filtering) for CS identity, CS wavelet and LRR, were plotted against acceleration factor for 
NAA, Creatine, Choline, Myo-Insositol and lipids Figure 8-38, Figure 8-39, Figure 8-40, Figure 
8-41, and Figure 8-42. 
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Figure 8-38 - The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR, for NAA. (Infiltrative OPG 
simulation). 
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Figure 8-39 - The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR, for Cr. (Infiltrative OPG 
simulation). 
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Figure 8-40 - The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR, for Cho. (Infiltrative OPG 
simulation). 
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Figure 8-41 - The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR, for Ins. (Infiltrative OPG 
simulation). 
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Figure 8-42- The normalised Root mean square error, the standard deviation and the mean 
difference between each reconstruction and the non-filtered FSSR, for lipids. (Infiltrative OPG 
simulation). 
 
Metabolite maps as depicted by Tarquin are shown for NAA Figure 8-43, Creatine Figure 
8-44 Choline Figure 8-45, Myo-Inositol Figure 8-46 and lipids Figure 8-47. 
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Figure 8-43 - NAA Metabolite maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet) and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Infiltrative OPG simulation). 
 
 
Figure 8-44 - Creatine Metabolite maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet) and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Infiltrative OPG simulation). 
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Figure 8-45 - Choline Metabolite maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet) and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Infiltrative OPG simulation). 
 
Figure 8-46 – Myo-Inositol Metabolite maps for the simulations reconstructed with CS-MRSI 
(identity), CS-MRSI(wavelet) and the LRR as compared to the FSSR with and without filtering. The 
colour maps are normalised to the highest pixel value. (Infiltrative OPG simulation). 
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Figure 8-47- Lipid Metabolite maps for the simulations reconstructed with CS-MRSI (identity), CS-
MRSI(wavelet) and the LRR as compared to the FSSR with and without filtering. The colour maps are 
normalised to the highest pixel value. (Infiltrative OPG simulation). 
8.2.2.5 Discussion – OPG Simulations 
The use of the larger matrix size 40x32 simulated MRSI datasets provides increased data and 
consistency compared to the real-life OPG (15x13) acquisition. The Bland Altman plots of the 
real-time acquisition OPG did not indicate as conclusive an advantage of CS-MRSI over LRR 
as did the simulated focal lesion dataset reconstructions. This may in part be due to the fact 
that the real-time acquisition OPG patient dataset did not have a clearly defined lesion 
boundary as had the focal tumour in the simulation. The real-time acquisition OPG MRSI had 
a large voxel size of 13mm x13mm x13mm which meant an inherently very low spatial 
resolution. Therefore, the advantages of CS-MRSI noted in previous chapters at maintaining 
spatial resolution over the LRR reconstructions (section 7.1.2) are not as easily apparent. The 
real-time acquisition OPG MRSI dataset is subject to baseline distortion from the residual 
water peak and imperfect shimming (section 2.3).  This inevitably affects the quality of the 
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metabolite TARQUIN quantification (section 2.4.6). The real-time OPG MRSI result therefore 
demonstrates some of the challenges inherent in the acquisition of real-time MRSI (section 
2.3), strengthening the argument for utilising the software simulations in this study. 
The focal lesion results and those for which there is tumour infiltration into healthy tissue 
both indicate that the CS-MRSI reconstruction relative to the non-filtered FSSR provides a 
lower nRMSE, standard deviation and mean difference for all metabolites, than the LRR, up 
to an acceleration factor of x5 Figure 8-23 to Figure 8-26 (focal OP lesion), and Figure 8-38 to 
Figure 8-41 (OPG lesion with infiltration).  All values positively correlate with increasing 
acceleration factor. At x10 acceleration factor this is reversed which may be due to the CS 
reconstruction not having enough data samples at the centre of k-space at this factor to 
provide as good a reconstruction as those of the LRR for which sampling is entirely central. 
The result appears to agree with the results of the digital phantom metabolite edge 
response investigation, section 7.1.2 where the enhancement in spatial resolution from the 
CS reconstruction relative to the LRR appeared to break down at x10 acceleration factor. The 
Bland-Altman plots and the metabolite maps also appear to agree with this result. The 
nRMSE for NAA, Creatine and Choline for the focal lesion at an acceleration factor of x5, 
reconstructed with CS-MRSI(identity) was 10%(NAA), 9.7%(Cr) and 10%(Cho) respectively, 
for the corresponding LRR it was 16%(NAA), 16%(Cr) and 15%(Cho) and CS-MRSI(wavelets) 
was 13%(NAA), 12%(Cr) and 12%(Cho). The corresponding nRMSE values for the infiltrated 
lesion with CS-MRSI(Identity) was 10%,(NAA) 9.7%(Cr) and 10%(Cho) respectively, for the 
LRR was 12% (NAA), 13%(Cr) and 12%(Cho) and for CS-MRSI(wavelets) 12%(NAA), 12%(Cr) 
and 12%(Cho). Given that there is an approximate 10% error in the TARQUIN reconstruction 
this may be evidence to suggest that CS-MRSI(identity) could be useful to reduce scan time 
up to 80%. If the spatial resolution of the OPG patient was doubled so that the matrix size 
for the FOV increased from (15 x 13) to (30 x 26), the scan time would be increased from 6.5 
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to 26 minutes. If an acceleration factor of x5 was possible, the high resolution MRSI scan 
time would reduce from 26 to 5.2 minutes which is clinically more feasible.  
A paper in which CS reconstruction using wavelets was investigated on a real-time 
acquisition claims a nRMSE of less than 5% at this x5 acceleration factor (Geethanath 2012). 
The paper does not however state the particular metabolite this result refers, or the tumour 
type the technique was applied. Metabolite spectra vary between tumour type and it is 
currently unknown if CS-MRSI reconstruction is consistent across all spectral profiles. The 
metabolite quantification technique utilised in the paper was also different, and k-space 
filtration had been applied to the MRSI acquisition. 
Myo-Inositol and lipids are often elevated relative to healthy tissue in OPG lesions (section 
8.2.2.1). The nRMSE and standard deviation for Myo-inositol for CS-MRSI(identity) was 11% 
and 17% respectively at x5 acceleration factor, for the focal lesion Figure 8-26. The 
corresponding value for the LRR was 17% and 26%, again showing a potential benefit of CS-
MRSI at this factor. The result for the infiltrated lesion also showed an advantage; CS-MRSI 
(identity) 11% and 18%, and for the LRR 13% and 23% Figure 8-41. The metabolite map for 
Myo-Inositol appears to show a uniform distribution across the tumour and the grey and 
white matter. Although Myo-Inositol is usually elevated relative to that of healthy tissue in 
OPG patients, the particular patient dataset utilised in this study did not exhibit such a 
marked variation.  Myo-inositol has a complex multiplet at around 3.6 ppm at 3T and is also 
more difficult to evaluate than some of the other metabolites. 
The use of CS-MRSI to reconstruct lipid data is yet to be reported in the literature. In this 
study the CS-MRSI(identity and wavelet) results for nRMSE, standard deviation and mean 
difference for lipids compared to the LRR in the focal lesion, does not indicate the same 
advantage of CS-MRSI over LRR as it does for the metabolites. The nRMSE, standard 
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deviation and mean difference all appear to be comparable for all acceleration factors for 
the lesion with infiltration Figure 8-42 for both the CS-MRSI and the LRR. The scenario 
containing the focal lesion shows a marked improvement in the statistics for the LRR over 
the CS-MRSI at x10 acceleration factor, Figure 8-27.  The result implies that for lipids it 
maybe signal that is important in reconstruction. The lipid peaks are only present in the 
lesion and are low compared to the metabolite peaks in healthy tissue Figure 8-14 and 
Figure 8-32.  The larger signal peaks of the metabolites in the healthy tissue reconstruct well 
with CS-MRSI but it may be struggling with the lower signal lipid peaks. For example, the 
Creatine peaks are also low in the lesion but are comparatively high in healthy tissue. The 
higher healthy Creatine peaks maybe well reconstructed with CS-MRSI and therefore 
produce a significant contrast between the healthy and diseased tissues. This is indicated in 
the metabolite maps Figure 8-29 and Figure 8-32.  It could be that the low signal lipid peaks 
require increased, high signal sampling at the centre of k-space for good CS-MRSI 
reconstruction. This has implications for the k-space sampling mask which may require 
optimisation for lipids (section 2.6.6).  Also, lipid signal peaks like Myo-Inositol are hard to fit 
and therefore evaluate on the Tarquin software which may also have an affect upon results. 
The CS-MRSI Identity transform results are on average 1% better the wavelet transform 
results for the metabolites. The similarity in results may be due to the Daubechie (level 1) 
Haar wavelet which is a step function, producing a similar effect as the identity transform. 
There is potential for the investigation of a different mother wavelet and level (section 
3.3.1). The difference between the two transforms is not as apparent as it is in the 
measurement of relative spatial resolution (section 7.1.2).  
The TARQUIN metabolite maps Figure 8-28 to Figure 8-32 (focal lesion), Figure 8-43 to Figure 
8-47 (lesion with infiltration) appear consistent with the Bland Altman, the nRMSE, standard 
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deviation and mean difference results. On examination of these maps the difference in 
tumour margin can be clearly visualised between the maps for the focal and infiltrated 
lesions. It can be seen that the tumour margin deteriorates in all cases at x10 acceleration 
factor. If the metabolite maps for the tumour infiltration Figure 8-43 to Figure 8-47 are 
compared to those of the focal lesion the area of infiltration is clearly visible. The maps for 
the focal tumour for metabolites NAA, Creatine and Choline indicate the CS-MRSI at 
acceleration factors of x2 to x5, appear to retain the shape of the tumour as depicted in the 
non-filtered FSSR map but have a degree of smoothing as depicted in the filtered FSSR map. 
This is because the CS-MRSI as noted in the previous chapter has reduced the appearance of 
the Gibbs ringing from distant inter-voxel contamination thus smoothing the image whilst 
retaining the spatial resolution by reducing the adjacent inter-voxel contamination. 
The misrepresentation of a tumour boundary appears to be more likely with an LRR than 
with CS-MRSI. If the Creatine metabolite maps are examined for the focal tumour, Figure 
8-29 and the tumour with tissue infiltration Figure 8-44, it can be seen that the LRR 
reconstructions of the focal tumour of Figure 8-29 at acceleration factors x3.3 to x5 are 
closer in appearance to the infiltrated, non-filtered FSSR Creatine map of Figure 8-44. The 
LRR metabolite maps could therefore potentially lead to a misdiagnosis in tumour extent by 
exhibiting the appearance of tumour infiltration from inter-voxel contamnination. 
8.3 Conclusion 
The implementation of the digital phantom with larger matrix size (40x32) provided 
increased data points and therefore increased statistics compared to the real-life OPG 
(15x13) acquisition. The digital phantoms provided a useful methodology for the assessment 
of the quality of the CS-MRSI reconstruction and it’s comparison with the non-filtered FSSR 
and uniformly sampled, time equivalent LRR reconstructions with increasing acceleration 
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factor. The Bland Altman statistic and the metabolite maps appear to correspond well with 
the results of Chapter 5 in that the CS-MRSI results improved upon those of the LRR up to an 
acceleration factor of x5. The metabolite maps clearly indicate the difference between the 
focal and the tumour with an infiltrative border region. The result for lipids is not as 
conclusive as it is for the metabolites. There does not appear to be any advantage of CS-
MRSI over the LRR reconstructions for lipids. This may in part be due to the difficulty in the 
accurate quantification of lipids and also due to their relatively low signal. The investigation 
of CS for low signal peaks may warrant further investigation. 
In conclusion the use of CS-MRSI could provide up to 80% reduction in acquisition time 
whilst preserving brain metabolite spatial information. Alternatively, MRSI voxel size could 
be reduced providing increased spatial resolution for a clinically feasible scan time utilising 
this acceleration. The reduction in voxel size may have possible implications for SNR which 
would need confirmation with prospective CS-MRSI, once the k-space acquisition of random 
under-sampling becomes available on the scanner. 
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9 Conclusions and Further Work 
9.1 First Objective -The development of CS reconstruction software applicable 
to MRSI. 
The first objective was to develop suitable CS reconstruction software applicable to MRSI 
(CS-MRSI). This was completed by the modification of existing CS software applicable to MRI 
(section 3). The modification successfully adapted the existing software to allow the CS 
reconstruction of a dataset containing an additional; third dimension representing the 
spectral information of MRS. The verification of this newly developed CS software to 
accurately represent the real MRSI dataset after different degrees of under-sampling was 
the primary focus of this research.  
 Future work  9.1.1
The computational optimisation of the CS reconstruction software was not the focus of this 
work, however the application of different non-linear iterative reconstruction techniques 
other than conjugate gradient descent (the method utilised in this study), may be of future 
interest.  
The repetition of this analysis with different CS weighting factors λ1 and λ2 for the sparse 
domain and the TV term (Section 3.4) may further optimise the CS. 
9.2 Second Objective-Methodology for the assessment of the spatial 
resolution of MRSI 
The second objective was to devise a practical technique providing a measure of relative 
spatial resolution in MRSI. This was tackled in four ways. The first was the development of an 
imaging edge phantom (section 4.5). This resulted in the construction of a two-compartment 
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imaging phantom consisting of two metabolite containing gels separated by a non-
permeable polymer membrane. The phantom successfully allowed the assessment of the 
edge response of MRSI and calculation of the relative edge gradient between the non-
filtered FSSR, the CS-MRSI and LRR (section 5) at 10mm x 10mm x10mm voxel dimension. 
Figure 5-1 b) indicated that the phantom provided an informative measure of MRSI spatial 
resolution for acceleration factors between x2 and x10.  
The second method was to use a saturation band prior to the MRSI acquisition applied 
perpendicular and central to an axial slice within the brain of a healthy volunteer. This 
provided a means to assess the inter-voxel contamination of each reconstruction by 
examination of the relative contrast between the saturated and unsaturated regions. Figure 
5-5 a) and Figure 5-4 indicate that by saturating out the metabolites from within a band of 
two voxels wide the CS-MRSI and the LRR maintain an equivalently high mean contrast up to 
a factor of x5. This suggests that the relatively low metabolite spatial frequency variation 
imposed by this technique is only relevant for testing spatial frequencies greater than half 
the maximum spatial frequency of the full MRSI dataset.  
The phantom work was found to be constrained by the low matrix size available on real-time 
acquisitions, so a digital phantom to simulate MRSI datasets at higher matrix size was 
developed (section 6). The validation of the simulation (section 6.2) indicated that the 
nRMSE between the acquired dataset from the two-gel phantom and the fully sampled 
simulation was a maximum of 4%. The adaptation of this phantom to contain an angled, 
metabolite edge allowed the assessment of a more highly sampled edge response (section 
7.1 and section 6.3). The simulated angled metabolite edge allowed measurement of the 
relative spatial responses of non-filtered FSSR MRSI data with the filtered FSSR, CS-MRSI and 
LRR at acceleration factors of x2,x3.3,x4,x5 and x10 (section 7.1.2). Further adaption of the 
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digital phantom allowed the same investigation but with application to two clinical 
scenarios. One for which the digital phantom contained a single simulated focal OPG lesion 
and another simulated lesion without a clear border between diseased and healthy tissue.  
The fourth method of spatial resolution assessment investigated in this research was the 
calculation of the Modulation Transfer Function (MTF). The MTF can be calculated from the 
edge response of an imaging system and so was applied to the simulated angled edge. This 
methodology worked well for MRSI datasets without noise (section Error! Reference source 
not found.) however the addition of noise rendered difficulties in the required 
differentiation of the edge response. This therefore hinders the use of the calculation of the 
MTF in MRSI with a metabolite edge that contains noise.  
 Future Work 9.2.1
A previous study calculated the MTF of MRSI utilizing an imaging phantom containing 
Perspex wedges arranged in a fan pattern within a metabolite containing solution (Heikal, 
Wachowicz et al. 2013). Square waveform profiles were obtained at differing radii from arc 
profiles across this spatial variation. The MTF was calculated by comparing the resultant 
profiles to the idealized square wave profile at a particular radius. It may therefore be a 
useful exercise to develop a software simulation of this phantom and calculate the MTF 
using this methodology instead of the angled edge scenario. 
9.3 Third Objective – Exploration of the limits of CS-MRSI by comparison of 
the spatial resolution of CS-MRSI at different acceleration factors. 
The calculation of the relative spatial resolution from both the imaging, two-compartment 
gel phantom (section 5.1.2) and those of the digital phantom which contained the angled 
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metabolite edge (section 7.1.2) both indicate that the spatial resolution degrades with 
increasing acceleration factor.  
Both scenarios agree that the CS-MRSI provides a superior resolution relative to that of the 
LRR up to a factor of x5. The digital phantom is the more reliable measurement since the 
gradient of the edge response contains a higher number of samples relative to the imaging 
phantom. The two-compartment gel phantom results revealed a relative spatial resolution of 
78% ± 14% of that of the non-filtered FSSR respectively for NAA at an acceleration factor of 
x5. This is compared to 50% for the LRR. For the digital phantom these values were 68% ± 5% 
for CS-MRSI and 44% for the LRR. The filtered FSSR produced a relative value of 48%. In 
current MRSI the use of a k-space ringing filter is standard. One of the most interesting 
outcomes of this work is that the CS-MRSI results imply not only a reduction in ringing but a 
spatial resolution consistently higher than that of the filtered FSSR, with the added benefit of 
reducing acquisition time by up to 80%. This means that for a conventional, clinical 2D phase 
encoded MRSI acquisition, for which duration is around 5 minutes with a relatively low 
spatial resolution of 48%, using CS-MRSI results suggest that the acquisition can be reduced 
to 1 minute with a relative spatial resolution of 68% ± 5%, and a reduction in Gibbs ringing. 
This is not only advantageous in terms of patient throughput but will reduce possible 
movement artefacts. The higher spatial resolution will also aid in correct diagnosis and 
management of disease in particular in the delineation of tumour boundaries with healthy 
tissue. 
If the acquisition time of 2D phase encoded MRSI can be reduced this implies that the 
acquired MRSI spatial resolution could also be increased. This may however have 
implications for SNR since the SNR is proportional to the acquired voxel volume. If the 
resolution is doubled in conventional 2D phase encoded MRSI, scan time is quadrupled, and 
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SNR is reduced. The NSA can be increased but at the cost of scan time. Higher field strength 
would also improve SNR but currently most clinical scanners are 3T and below. In order to 
improve the spatial resolution there is future work to be done. 
The effect of CS-MRSI on the SNR is interesting to note. The results of section 5.2.2, Figure 
5-5 b) implies that CS has a de-noising effect exhibiting a higher SNR than the fully sampled 
MRSI dataset for NAA. A possible explanation for this is that the variable density k-space 
sampling scheme results in fewer acquired data points at the periphery of k-space which 
have a lower SNR than the fully sampled centre of k-space. The CS-MRSI reconstruction 
estimates the large proportion of missing data points in the periphery of k-space by 
minimising the differences between the estimated fit and the sampled data points. In 
conjunction with a TV penalty (section 3.4) this results in an inherent smoothing effect which 
reduces certain components of the noise. However, the possible de-noising of the CS 
reconstruction may also smooth out the less prominent metabolites peaks as well as the 
noise peaks. The effect on relative SNR will vary between different metabolites, since those 
such as Myo-Inositol have smaller peaks than others such as NAA, however the potential de-
noising quality of CS-MRSI may be an advantage over other fast MRSI techniques which 
negatively impact on SNR. For example, the very short scan times of PEPSI (section 2.6) 
result in reduced SNR. In SENSE-MRSI, whilst SNR has been improved with the use of phased 
array head coils, it is inherently dependent upon coil geometry resulting in a spatially varying 
SNR which is usually poorest at the centre of the FOV. 
This work implies that there is potential in the use of CS-MRSI in the clinic to accelerate MRSI 
acquisition by up to 80% without detriment to the spatial resolution of MRSI with possible 
benefits in SNR. 
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 Future Work 9.3.1
The cut-off in the ability of CS-MRSI to retain MRSI spatial integrity between acceleration 
factors x5 and x10 is yet to be determined. 
So far CS-MRSI has been applied to retrospective data sets because current clinical scanners 
do not have the software to acquire MRSI data in a random pattern as required by CS.  
Philips has a ‘patch’ available to allow the acquisition of random MRSI datasets, but currently 
do not have the software to perform the CS reconstruction. If the patch were applied to the 
scanner it could allow a true assessment of the quality of CS-MRSI in practise and indicate 
how the SNR fares at smaller voxel sizes. Unfortunately, in order to be given this patch the 
department at BCH requires a research contract with Philips. A research contract has just 
recently been granted to the department, but not within the time scale of this research and 
permission to apply the patch is pending. 
The reduction in acquisition time could be advantageous for the increased coverage of 
current 2D MRSI by allowing the acquisition of multiple slices in the same time scale, or 
indeed when combined with 3D MRSI. 
The combination of CS-MRSI and other fast MRSI techniques is also a possibility to further 
reduce the acquisition time(Thomas, Nagarajan et al. 2014). The simplest combination would 
be CS-MRSI and reduced FOV (section 2.6.2) which could be simulated in software as a 
starting point. CS has previously been combined in a pre-clinical study with an echo-planar 
MRSI sequence (section 2.6.4) which was shown to have successful application to 13C MRSI 
(Hu, Lustig et al. 2010). The use of echo planar spectroscopy at BCH is not currently an 
option but may soon be available. 
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9.4 Fourth Objective – Comparison of different sparse data representations 
The use of CS-MRSI so far in the literature has only employed wavelets as the sparse domain. 
The identity function was investigated in this work due to its simplicity of calculation and the 
fact that an MRSI dataset is itself relatively sparse. The results so far in this work from the 
calculation of the metabolite edge gradient (section 7.1.2) tend to suggest that the use of 
the identity function in the CS-MRSI reconstruction provides a 10% increase in average 
relative spatial resolution for NAA and for Choline compared to wavelets. The application of 
both sparse domains to CS-MRSI reconstructions of a simulated OPG scenario indicate that 
there is on average a slight advantage (1%) in using the identity function. It may be 
concluded from the current results that the use of the identity function will give the best CS-
MRSI reconstruction, however the use of a different wavelet may provide a more sparse 
representation of the data. 
 Future Work 9.4.1
An investigation of different wavelet types and levels would be of interest as a comparison 
with the use of the identity function in this study. Different sparse representations may also 
be of interest for example the discrete cosine or the FREBAS transform which have also been 
employed in conventional MRI reconstruction (Lustig, Donoho et al. 2007; Ito 2011). 
9.5 Fifth Objective – Application of CS-MRSI in OPG  
The OPG simulations in a digital phantom for both a focal and an infiltrating lesion provided 
a framework to investigate the effect of CS-MRSI on tumour margin delineation. It can be 
seen from the results (section 8.2.2.3) that the CS-MRSI provided superior delineation as 
compared to the LRR up to acceleration factor of x5 for NAA, Cr, Cho and Ins. This advantage 
was not apparent for the reconstruction of lipids. However, the standard deviation, nRMSE 
and mean difference were all relatively low. The lipid maps for all reconstructions clearly 
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indicate the tumour outline at all accelerations, which as expected is more clearly defined 
for the focal lesion Figure 8-32 compared to the case where the tumour exhibits infiltration 
Figure 8-47. 
 Future Work 9.5.1
Investigation into the resulting lack of advantage of CS over LRR in lipid signal reconstruction 
is of particular interest to determine if this is due to the difficulty in quantification of lipids or 
if it is due to CS having difficulty in reconstructing low level signals. 
The work was limited to the use of a single lesion which was useful for investigation of the 
delineation of tumour margins. Patients exhibiting OPG often have multiple diffuse lesions 
and cysts.  The simulation of such cases and their subsequent reconstructions would also be 
beneficial in the validation of CS-MRSI. The current OPG simulations do not have any lipid 
contamination from subcutaneous fat which is another challenge in MRSI (section 8.2.2.1). 
The use of fat saturation bands placed over these areas are designed to reduce lipid bleed 
through but they are not always effective if the VOI is located near such areas. The effect of 
lipid contamination on the reconstructions would therefore be of interest. Application of CS-
MRSI to different tumour profiles is also a relevant future simulation. 
9.6 Summary 
The results of this research appear to suggest that implementation of CS-MRSI can 
potentially speed up data acquisition by up to 80% for 2D phase encoded MRSI whilst 
providing a reduction in inter-voxel contamination. In comparison to the uniformly sampled, 
time equivalent LRR, CS-MRSI provided greater improvement in the reduction of inter-voxel 
contamination by maintaining spatial resolution and reducing the side lobes of the PSF. This 
is of particular relevance in the context of current clinical MRSI in which a ringing filter is 
implemented for the reduction of the PSF side lobes. This research suggests that the use of a 
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Hamming filter reduces the MRSI spatial resolution by up to 50%, which is commonly 
expected for post-processing filtration (Barker and Lin 2006). CS-MRSI however, not only 
appears to also reduce the side lobes of the PSF, but maintains a spatial resolution 
consistently higher than the filtered FSSR with the added benefit of reducing acquisition 
time by up to a factor of 5. The implementation of CS-MRSI on prospective 2D phase 
encoded MRSI data would therefore be an interesting area for future research as the 
application of CS-MRSI may greatly enhance the clinical utility of MRSI. The reduction in 
acquisition time reduces the potential of movement artefacts and improves patient 
throughput. CS-MRSI may be beneficial in aiding brain tumour diagnosis and management 
since the inter-voxel contamination present in current MRSI leads to poor image integrity. 
This presents challenges particularly in the delineation between a tumour and it’s boundary 
with healthy tissue. The acceleration of phase encoded MRSI acquisition permitted by CS-
MRSI may allow improvement in spatial resolution by allowing a corresponding reduction in 
voxel dimension within the same time frame. This may however have to be tempered with a 
corresponding loss of signal. The combination of CS-MRSI with other fast imaging techniques 
may improve on any signal loss and further reduce scan times. For standard voxel volume 
MRSI, this work indicates the potential of CS-MRSI to aid in enhanced delineation between 
normal and infiltrative diseased tissue when compared to the current filtered, clinical MRSI 
with the added benefit of reduced scan time. 
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